# Kelly_2020_Alcoholics Anonymous and other 12-step programs for alcohol use disorder.

Cochrane
Library

Cochrane Database of Systematic Reviews

Alcoholics Anonymous and other 12-step programs for alcohol use
disorder (Review)

Kelly JF, Humphreys K, Ferri M

Kelly JF, Humphreys K, Ferri M. 
Alcoholics Anonymous and other 12-step programs for alcohol use disorder. 
Cochrane Database of Systematic Reviews 2020, Issue 3. Art. No.: CD012880. 
DOI: 10.1002/14651858.CD012880.pub2.

www.cochranelibrary.com

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

T A B L E   O F   C O N T E N T S

HEADER.........................................................................................................................................................................................................
ABSTRACT.....................................................................................................................................................................................................
PLAIN LANGUAGE SUMMARY.......................................................................................................................................................................
SUMMARY OF FINDINGS..............................................................................................................................................................................
BACKGROUND..............................................................................................................................................................................................
OBJECTIVES..................................................................................................................................................................................................
METHODS.....................................................................................................................................................................................................
RESULTS........................................................................................................................................................................................................
Figure 1..................................................................................................................................................................................................
Figure 2..................................................................................................................................................................................................
Figure 3..................................................................................................................................................................................................
Figure 4..................................................................................................................................................................................................
Figure 5..................................................................................................................................................................................................
DISCUSSION..................................................................................................................................................................................................
AUTHORS' CONCLUSIONS...........................................................................................................................................................................
ACKNOWLEDGEMENTS................................................................................................................................................................................
REFERENCES................................................................................................................................................................................................
CHARACTERISTICS OF STUDIES..................................................................................................................................................................
DATA AND ANALYSES....................................................................................................................................................................................
Analysis  1.1.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 1: Proportion completely abstinent................................................................................................................
Analysis  1.2.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 2: Percentage days abstinent (PDA)................................................................................................................
Analysis  1.3.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 3: Longest period of abstinence (LPA, months).............................................................................................
Analysis  1.4.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 4: Drinks per drinking day (DDD)....................................................................................................................
Analysis  1.5.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 5: Percentage days heavy drinking (PDHD)....................................................................................................
Analysis  1.6.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 6: Alcohol-related consequences (DrInC).......................................................................................................
Analysis  1.7.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 7: Alcohol-related consequences (SIP)...........................................................................................................
Analysis  1.8.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 8: Alcohol-related consequences (SIP-2R)......................................................................................................
Analysis  1.9.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 9: Addiction Severity Index (ASI).....................................................................................................................
Analysis  1.10.  Comparison  1:  1A  Grouping:  RCT/quasi-RCT,  all  treatments  manualized,  compared  to  different  theoretical
orientation, Outcome 10: Addiction Severity Index (ASI)...................................................................................................................
Analysis 2.1. Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to different theoretical
orientation, Outcome 1: Proportion completely abstinent................................................................................................................
Analysis 2.2. Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to different theoretical
orientation, Outcome 2: Percentage days abstinent (PDA)................................................................................................................
Analysis 2.3. Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to different theoretical
orientation, Outcome 3: Percentage days abstinent (PDA)................................................................................................................
Analysis 2.4. Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to different theoretical
orientation, Outcome 4: Drinks per drinking day (DDD)....................................................................................................................
Analysis 2.5. Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to different theoretical
orientation, Outcome 5: Percentage days heavy drinking (PDHD)....................................................................................................
Analysis 3.1. Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant, Outcome 1:
Proportion of participants completely abstinent...............................................................................................................................
Analysis 3.2. Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant, Outcome 2:
Percentage days abstinent (PDA).........................................................................................................................................................

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1
1
3
4
15
16
16
19
20
22
23
25
26
33
35
36
37
43
86
89

91

92

93

94

95

95

96

96

96

97

98

98

98

99

100

100

i

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.3. Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant, Outcome 3: Days
of use (PDA)...........................................................................................................................................................................................
Analysis 3.4. Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant, Outcome 4:
Drinks per drinking day (DDD).............................................................................................................................................................
Analysis 3.5. Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant, Outcome 5:
Addiction Severity Index (ASI)..............................................................................................................................................................
Analysis 3.6. Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant, Outcome 6:
European Addiction Severity Index (EuropASI)...................................................................................................................................
Analysis 4.1. Comparison 4: 2B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to TSF variant, Outcome
1: Proportion of participants completely abstinent...........................................................................................................................
Analysis  5.1.  Comparison  5:  3B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  different  theoretical
orientation, Outcome 1: Proportion of participants completely abstinent.......................................................................................
Analysis  5.2.  Comparison  5:  3B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  different  theoretical
orientation, Outcome 2: Drinks per drinking day (DDD)....................................................................................................................
Analysis  5.3.  Comparison  5:  3B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  different  theoretical
orientation, Outcome 3: Alcohol-related consequences (SIP)...........................................................................................................
Analysis  5.4.  Comparison  5:  3B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  different  theoretical
orientation, Outcome 4: Alcohol-related consequences....................................................................................................................
Analysis  5.5.  Comparison  5:  3B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  different  theoretical
orientation, Outcome 5: Alcohol addiction severity (Alcohol Dependence Scale)............................................................................
Analysis  6.1.  Comparison  6:  4B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  TSF  variant,  Outcome  1:
Proportion completely abstinent.........................................................................................................................................................
Analysis  6.2.  Comparison  6:  4B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  TSF  variant,  Outcome  2:
Percentage days abstinent (PDA).........................................................................................................................................................
Analysis 6.3. Comparison 6: 4B: Non-randomized, 1+ treatments non-manualized, compared to TSF variant, Outcome 3: Drinks
per drinking day (DDD).........................................................................................................................................................................
Analysis  6.4.  Comparison  6:  4B:  Non-randomized,  1+  treatments  non-manualized,  compared  to  TSF  variant,  Outcome  4:
Addition Severity Index-Lite (ASI-L).....................................................................................................................................................
ADDITIONAL TABLES....................................................................................................................................................................................
APPENDICES.................................................................................................................................................................................................
WHAT'S NEW.................................................................................................................................................................................................
HISTORY........................................................................................................................................................................................................
CONTRIBUTIONS OF AUTHORS...................................................................................................................................................................
DECLARATIONS OF INTEREST.....................................................................................................................................................................
SOURCES OF SUPPORT...............................................................................................................................................................................
DIFFERENCES BETWEEN PROTOCOL AND REVIEW....................................................................................................................................
INDEX TERMS...............................................................................................................................................................................................

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

101

101

101

102

102

104

104

105

105

105

106

107

107

107

107
113
119
119
119
120
120
120
120

ii

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

[Intervention Review]

Cochrane Database of Systematic Reviews

Alcoholics Anonymous and other 12-step programs for alcohol use
disorder

John F Kelly1, Keith Humphreys2, Marica Ferri3

1Recovery Research Institute, Center for Addiction Medicine, Massachusetts General Hospital and Harvard Medical School, Boston,
Massachusetts, USA. 2Veterans Affairs and Stanford University Medical Centers, Stanford University Stanford School of Medicine,
Stanford, CA, USA. 3Best practices, knowledge exchange and economic issues, European Monitoring Centre for Drugs and Drug
Addiction, Lisbon, Portugal

Contact address: John F Kelly, JKELLY11@mgh.harvard.edu.

Editorial group: Cochrane Drugs and Alcohol Group.
Publication status and date: Edited (no change to conclusions), published in Issue 9, 2020.

Citation: Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database
of Systematic Reviews 2020, Issue 3. Art. No.: CD012880. DOI: 10.1002/14651858.CD012880.pub2.

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Background

A B S T R A C T

Alcohol use disorder (AUD) confers a prodigious burden of disease, disability, premature mortality, and high economic costs from lost
productivity, accidents, violence, incarceration, and increased healthcare utilization. For over 80 years, Alcoholics Anonymous (AA) has
been a widespread AUD recovery organization, with millions of members and treatment free at the point of access, but it is only recently
that rigorous research on its effectiveness has been conducted.

Objectives

To evaluate whether peer-led AA and professionally-delivered treatments that facilitate AA involvement (Twelve-Step Facilitation (TSF)
interventions) achieve important outcomes, specifically: abstinence, reduced drinking intensity, reduced alcohol-related consequences,
alcohol addiction severity, and healthcare cost offsets.

Search methods

We  searched  the  Cochrane  Drugs  and  Alcohol  Group  Specialized  Register,  Cochrane  Central  Register  of  Controlled  Trials  (CENTRAL),
PubMed,  Embase,  CINAHL  and  PsycINFO  from  inception  to  2  August  2019.  We  searched  for  ongoing  and  unpublished  studies  via
ClinicalTrials.gov and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) on 15 November 2018.
All searches included non-English language literature. We handsearched references of topic-related systematic reviews and bibliographies
of included studies.

Selection criteria

We included randomized controlled trials (RCTs), quasi-RCTs and non-randomized studies that compared AA or TSF (AA/TSF) with other
interventions,  such  as  motivational  enhancement  therapy  (MET)  or  cognitive  behavioral  therapy  (CBT),  TSF  treatment  variants,  or  no
treatment. We also included healthcare cost offset studies. Participants were non-coerced adults with AUD.

Data collection and analysis

We  categorized  studies  by:  study  design  (RCT/quasi-RCT;  non-randomized;  economic);  degree  of  standardized  manualization  (all
interventions manualized versus some/none); and comparison intervention type (i.e. whether AA/TSF was compared to an intervention
with a different theoretical orientation or an AA/TSF intervention that varied in style or intensity). For analyses, we followed Cochrane
methodology calculating the standard mean difference (SMD) for continuous variables (e.g. percent days abstinent (PDA)) or the relative
risk (risk ratios (RRs)) for dichotomous variables. We conducted random-effects meta-analyses to pool effects wherever possible.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

1

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Main results

Cochrane Database of Systematic Reviews

We included 27 studies containing 10,565 participants (21 RCTs/quasi-RCTs, 5 non-randomized, and 1 purely economic study). The average
age of participants within studies ranged from 34.2 to 51.0 years. AA/TSF was compared with psychological clinical interventions, such as
MET and CBT, and other 12-step program variants.

We rated selection bias as being at high risk in 11 of the 27 included studies, unclear in three, and as low risk in 13. We rated risk of attrition
bias as high risk in nine studies, unclear in 14, and low in four, due to moderate (> 20%) attrition rates in the study overall (8 studies), or in
study treatment group (1 study). Risk of bias due to inadequate researcher blinding was high in one study, unclear in 22, and low in four.
Risks of bias arising from the remaining domains were predominantly low or unclear.

AA/TSF (manualized) compared to treatments with a different theoretical orientation (e.g. CBT) (randomized/quasi-randomized
evidence)

RCTs comparing manualized AA/TSF to other clinical interventions (e.g. CBT), showed AA/TSF improves rates of continuous abstinence at
12 months (risk ratio (RR) 1.21, 95% confidence interval (CI) 1.03 to 1.42; 2 studies, 1936 participants; high-certainty evidence). This effect
remained consistent at both 24 and 36 months.

For percentage days abstinent (PDA), AA/TSF appears to perform as well as other clinical interventions at 12 months (mean difference (MD)
3.03, 95% CI -4.36 to 10.43; 4 studies, 1999 participants; very low-certainty evidence), and better at 24 months (MD 12.91, 95% CI 7.55 to
18.29; 2 studies, 302 participants; very low-certainty evidence) and 36 months (MD 6.64, 95% CI 1.54 to 11.75; 1 study, 806 participants;
very low-certainty evidence).

For longest period of abstinence (LPA), AA/TSF may perform as well as comparison interventions at six months (MD 0.60, 95% CI -0.30 to
1.50; 2 studies, 136 participants; low-certainty evidence).

For drinking intensity, AA/TSF may perform as well as other clinical interventions at 12 months, as measured by drinks per drinking day
(DDD) (MD -0.17, 95% CI -1.11 to 0.77; 1 study, 1516 participants; moderate-certainty evidence) and percentage days heavy drinking (PDHD)
(MD -5.51, 95% CI -14.15 to 3.13; 1 study, 91 participants; low-certainty evidence).

For alcohol-related consequences, AA/TSF probably performs as well as other clinical interventions at 12 months (MD -2.88, 95% CI -6.81
to 1.04; 3 studies, 1762 participants; moderate-certainty evidence).

For alcohol addiction severity, one study found evidence of a difference in favor of AA/TSF at 12 months (P < 0.05; low-certainty evidence).

AA/TSF  (non-manualized)  compared  to  treatments  with  a  different  theoretical  orientation  (e.g.  CBT)  (randomized/quasi-
randomized evidence)

For the proportion of participants completely abstinent, non-manualized AA/TSF may perform as well as other clinical interventions at
three to nine months follow-up (RR 1.71, 95% CI 0.70 to 4.18; 1 study, 93 participants; low-certainty evidence).

Non-manualized AA/TSF may also perform slightly better than other clinical interventions for PDA (MD 3.00, 95% CI 0.31 to 5.69; 1 study,
93 participants; low-certainty evidence).

For drinking intensity, AA/TSF may perform as well as other clinical interventions at nine months, as measured by DDD (MD -1.76, 95% CI
-2.23 to -1.29; 1 study, 93 participants; very low-certainty evidence) and PDHD (MD 2.09, 95% CI -1.24 to 5.42; 1 study, 286 participants;
low-certainty evidence).

None of the RCTs comparing non-manualized AA/TSF to other clinical interventions assessed LPA, alcohol-related consequences, or alcohol
addiction severity.

Cost-effectiveness studies

In three studies, AA/TSF had higher healthcare cost savings than outpatient treatment, CBT, and no AA/TSF treatment. The fourth study
found that total medical care costs decreased for participants attending CBT, MET, and AA/TSF treatment, but that among participants with
worse prognostic characteristics AA/TSF had higher potential cost savings than MET (moderate-certainty evidence).

Authors' conclusions

There is high quality evidence that manualized AA/TSF interventions are more effective than other established treatments, such as CBT,
for increasing abstinence. Non-manualized AA/TSF may perform as well as these other established treatments. AA/TSF interventions, both
manualized and non-manualized, may be at least as effective as other treatments for other alcohol-related outcomes. AA/TSF probably
produces substantial healthcare cost savings among people with alcohol use disorder.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

2

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

P L A I N   L A N G U A G E   S U M M A R Y

Cochrane Database of Systematic Reviews

Alcoholics Anonymous (AA) and other 12-step programs for alcohol use disorder

Review question

This review summarized research comparing the Alcoholics Anonymous (AA) and similarTwelve-Step Facilitation (TSF) programs (AA/TSF)
to other treatments to see if they help people with drinking problems to stay sober, or reduce alcohol consumption and drinking-related
consequences. We also examined whether AA/TSF reduces healthcare costs relative to other treatments.

Background

Alcohol use disorder (i.e. alcoholism) is a concerning individual and public health problem worldwide. Treatment is expensive. AA is a
widespread and free mutual-help fellowship that helps people to recover from alcoholism and to improve their quality of life.

Search date

The evidence is current to 2 August 2019.

Study characteristics

We  identified  27  relevant  studies  that  had  included  10,565  participants.  The  studies  varied  in  design;  and  whether  treatments  were
delivered according to standardized procedures (i.e. manualized); and whether AA/TSF was compared to a treatment that had a different
theoretical basis (e.g. cognitive behavioral therapy (CBT)), or to a different type of TSF (i.e. one that varied in style or intensity from the
AA TSF).

Study funding sources

The Included studies were funded through one or more grants from the United States National Institutes of Health (18 studies), the USA
Department  of  Veterans  Affairs  (8  studies),  and  other  organizations  (e.g.  private  foundations  or  academic  institutions;  8  studies).  Two
studies did not report their source of funding.

Key results

Manualized  AA/TSF  interventions  usually  produced  higher  rates  of  continuous  abstinence  than  the  other  established  treatments
investigated. Non-manualized AA/TSF performed as well as other established treatments.

AA/TSF may be superior to other treatments for increasing the percentage of days of abstinence, particularly in the longer-term. AA/TSF
probably performs as well as other treatments for reducing the intensity of drinking (of alcohol). AA/TSF probably performs as well as
other treatments for alcohol-related consequences and addiction severity. Four of the five economics studies found substantial cost-saving
benefits for AA/TSF, which indicate that AA/TSF interventions probably reduce healthcare costs substantially.

In  conclusion,  clinically-delivered  TSF  interventions  designed  to  increase  AA  participation  usually  lead  to  better  outcomes  over  the
subsequent  months  to  years  in  terms  of  producing  higher  rates  of  continuous  abstinence.  This  effect  is  achieved  largely  by  fostering
increased AA participation beyond the end of the TSF intervention. AA/TSF will probably produce substantial healthcare cost savings while
simultaneously improving alcohol abstinence.

Certainty of evidence

Our certainty in the evidence ranged from very low to high for the different outcomes. Most of the high-certainty evidence was based
on the results from studies with reliable study designs (randomized controlled trials) and good measurement methods. We considered
some evidence to be of low certainty, partly because of inadequate methods for deciding which treatment each person in the study was
to receive, which can allow factors other than the treatments to affect the results.There was some inconsistency in the evidence across
studies that could be due to variation in the clinical characteristics of the participants, times of follow-up, error in participant recall of
certain outcomes, and differences in intervention durations, or therapist effects. Some studies had small sample sizes, which led to less
precise estimates of the longest periods of abstinence, and high variability around estimates of drinks per drinking day.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

3

 
 
C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

4

S U M M A R Y   O F   F I N D I N G S

Summary of findings 1.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol
use disorder (1A)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder (RCT/quasi-RCT evi-
dence)

Patient or population: adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
Setting: outpatient treatment
Intervention: AA/TSF (manualized)
Comparison: other clinical interventions (e.g. CBT)

Outcomes

Anticipated absolute effects* (95% CI)

Risk with other clinical interven-
tions

Risk with AA/TSF

Relative ef-
fect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Abstinence

Proportion of
participants (%)
completely absti-
nent

Study population

345 per 1000

418 per 1000
(356 to 490)

RR 1.21
(1.03 to 1.42)

1936
(2 RCTs)

⊕⊕⊕⊕
High

Follow-up: 12
months

PDA

Follow-up: 12
months

LPA

Follow-up: 6
months

DDD

Follow-up: 12
months

PDHD

Follow-up: 12
months

Drinking In-
tensity

The mean PDA in the comparison
group ranged from 62.3% to 84.0%

MD 3.03 higher
(4.36 lower to 10.43
higher)

The mean LPA in the comparison
group ranged from 0.47 to 1.71
months

The mean DDD in the comparison
group ranged from 4.66 to 5.38

MD 0.60 higher

(0.30 lower to 1.50 high-
er)

MD 0.17 lower
(1.11 lower to 0.77 high-
er)

The mean PDHD in the comparison
group was 13.4%

MD 5.51 lower
(14.15 lower to 3.13
higher)

-

-

-

-

1999
(4 RCTs)

⊕⊝⊝⊝
Very low
a, b, c

136
(2 RCTs)

⊕⊕⊝⊝
Low d, e

1516
(1 RCT)

⊕⊕⊕⊝
Moderate c

91
(1 RCT)

⊕⊕⊝⊝
Low f

No data avail-
able for 12-
month fol-
low-up

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

5

Alcohol-related consequences (as-
sessed with DrInC)

The mean DrInC in the comparison
group ranged from 21.8% to 72.9%

MD 2.88 lower
(6.81 lower to 1.04 high-
er)

-

1762
(3 RCT)

⊕⊕⊕⊝
Moderate c

Follow-up: 12 months

Alcohol addiction severity
(assessed with ASI)

Follow-up: 12 months

One study found an advantage for the AA/TSF intervention relative to the com-
parison intervention in the slope for improvement over a 12-month follow-up pe-
riod (Brooks 2003), as measured by the ASI alcohol composite score (P < 0.05).

112
(1 quasi-RCT)

⊕⊕⊝⊝
Low a, g

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

AA: Alcoholics Anonymous; ASI: Addiction Severity Index; CBT: cognitive behavioral therapy; CI: confidence interval; DDD: drinks per drinking day; DrInC: Drinker Inventory
of Consequences; LPA: longest period of abstinence; MD: mean difference; PDA: percentage days abstinent; PDHD: percentage days heavy drinking; RCT: randomized con-
trolled trial; RR: risk ratio; TSF: Twelve-Step Facilitation

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

Quasi-RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead,
sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/
OFF' type design.
Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different
sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the
same treatment.
a Downgraded due to study limitations (high risk of selection bias)
b Downgraded two levels due to inconsistency (I2 = 91%)
c Downgraded due to imprecision (CI fails to exclude important benefit or important harm)
d Downgraded due to imprecision (moderate sample size (n = 148))
e Downgraded due to study limitations (potential attrition bias and potential blinding of outcome bias)
f Downgraded due to imprecision (small sample size (n = 91) and wide confidence interval)
g Downgraded as narrative synthesis was conducted, therefore estimates are not precise

Summary of findings 2.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized) compared to other clinical interventions for
alcohol use disorder (1B)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized) compared to other clinical interventions for alcohol use disorder (RCT/quasi-RCT evi-
dence)

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

Patient or population: adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
Setting: outpatient treatment; inpatient/residential facility
Intervention: AA/TSF (non-manualized)
Comparison: other clinical interventions (e.g. CBT)

Outcomes

Anticipated absolute effects* (95% CI)

Risk with other clinical inter-
ventions

Risk with AA/TSF

Relative ef-
fect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Abstinence

Proportion of par-
ticipants (%) com-
pletely abstinent

Study population

167 per 1000

RR 1.71

(0.70 to 4.18)

93
(1 RCT)

118 more per 1000
(50 fewer to 530 more)

Follow-up: 9
months

PDA
Follow-up: 9
months

The mean PDA in the compari-
son group was 70%

MD 3.00 higher

(0.31 higher to 5.69 high-
er)

93

(1 RCT)

LPA

None of the studies in this category reported this outcome

Drinking In-
tensity

DDD
Follow-up: 9
months

The mean DDD in the compari-
son group was 8.02

MD 1.76 lower

(2.23 lower to 1.29 lower)

PDHD

Follow-up: 12
months

The mean number of heavy
drinking days in the compari-
son group ranged from 1.44 to
3.89

MD 2.09 higher

(1.24 lower to 5.42 higher)

Alcohol-related consequences

None of the studies in this category reported this outcome

Alcohol addiction severity

None of the studies in this category reported this outcome

⊕⊕⊝⊝
Lowa

⊕⊕⊝⊝
Lowa

No data avail-
able for 12-
month fol-
low-up

No data avail-
able for 12-
month fol-
low-up

No data avail-
able for 12-
month fol-
low-up

93
(1 RCT)

⊕⊝⊝⊝
Very lowb,c,d

286
(1 RCT)

⊕⊕⊝⊝
Lowe,f

-

-

-

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

AA: Alcoholics Anonymous; CBT: cognitive behavioral therapy; CI: confidence interval; DDD: drinks per drinking day; LPA: longest period of abstinence; MD: mean differ-
ence; PDA: percentage days abstinent; PDHD: percentage days heavy drinking; RCT: randomized controlled trial; RR: risk ratio; TSF: Twelve-Step Facilitation

GRADE Working Group grades of evidence

6

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

Quasi-RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead,
sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/
OFF' type design.
Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different
sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the
same treatment.
aDowngraded two levels due to imprecision (small sample size (n = 93)).
bDowngraded due to study limitations (risk of attrition bias).
cDowngraded due to imprecision (moderate sample size (n = 121)).
dDowngraded due to indirectness (the focus on dual diagnosis participants with severe mental illness which may not be the population of interest most associated with AA/TSF).
eDowngraded due to imprecision (moderate sample size (n = 286)).
fDowngraded due to study limitations (having no information reported to assess four different types of bias).

Summary of findings 3.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (manualized) compared to a different type of TSF for alcohol use
disorder (2A)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (manualized) compared to a different type of Twelve-Step Facilitation for alcohol use disorder (RCT/
quasi-RCT evidence)

Patient or population: adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
Setting: outpatient treatment; inpatient/residential facility
Intervention: AA/TSF (manualized)
Comparison: a different type of TSF (i.e. varying in TSF style or intensity)

Outcomes

Anticipated absolute effects* (95% CI)

Risk with different type of
TSF

Risk with AA/TSF

Relative ef-
fect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

Abstinence

Study population

404 per 1000

Proportion of par-
ticipants (%) com-
pletely abstinent

Follow-up: 12
months

113 more per 1000
(0 fewer to 255 more)

RR 1.28

(1.00 to 1.63)

307
(1 RCT)

⊕⊕⊕⊝
Moderatea

C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

7

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
PDA

Follow-up: 12
months

LPA

DDD

Follow-up: 6
months

The mean PDA in the com-
parison group was 67.41%

MD 16.40 higher

(5.12 higher to 27.68 higher)

None of the studies in this category reported this outcome

The mean DDD in the com-
parison group was 6.7

MD 4.10 lower

(10.44 lower to 2.24 higher)

Drinking In-
tensity

PDHD

None of the studies in this category reported this outcome

Alcohol-related consequences

None of the studies in this category reported this outcome

Alcohol addiction severity
(assessed with ASI)

The mean ASI in the com-
parison group was 0.13

MD 0.08 higher

(0.02 higher to 0.15 higher)

Follow-up: 12 months

-

-

-

95
(1 RCT)

⊕⊕⊕⊝
Moderateb

42
(1 RCT)

⊕⊕⊕⊝
Moderatec

No data avail-
able for 12-
month fol-
low-up

307

(1 RCT)

⊕⊕⊕⊝
Moderateb

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

AA: Alcoholics Anonymous; ASI: Addiction Severity Index; CI: confidence interval; DDD: drinks per drinking day; LPA: longest period of abstinence; MD: mean difference;
PDA: percentage days abstinent; PDHD: percentage days heavy drinking; RCT: randomized controlled trial; RR: risk ratio; TSF: Twelve-Step Facilitation

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

Quasi-RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead,
sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/
OFF' type design.
Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different
sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the
same treatment.
aDowngraded due to imprecision (moderate sample size (n = 307)).
bDowngraded due to imprecision (small sample size (n = 95)).
cDowngraded due to imprecision (small sample size (n = 48)).

C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

8

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

9

Summary of findings 4.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized) compared to a different type of TSF for alcohol
use disorder (2B)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized) compared to a different type of TSF for alcohol use disorder (RCT/quasi-RCT evidence)

Patient or population: adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
Setting: outpatient treatment; inpatient/residential facility
Intervention: AA/TSF (non-manualized)
Comparison: a different type of TSF (i.e. varying in TSF style or intensity)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

RR 1.15

(1.02 to 1.29)

382
(1 quasi-RCT)

⊕⊕⊕⊝
Moderatea

Outcomes

Anticipated absolute effects* (95% CI)

Risk with different
type of TSF

Study population

713 per 1000

Risk with AA/TSF

107 more per 1000
(14 more to 207 more)

Abstinence

Proportion of
participants (%)
completely ab-
stinent

Follow-up: 12
months

PDA

LPA

DDD

None of the studies in this category reported this outcome

None of the studies in this category reported this outcome

None of the studies in this category reported this outcome

PDHD

None of the studies in this category reported this outcome

Drinking in-
tensity

Alcohol-related consequences

None of the studies in this category reported this outcome

Alcohol addiction severity

None of the studies in this category reported this outcome

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

AA: Alcoholics Anonymous; CI: confidence interval; DDD: drinks per drinking day; LPA: longest period of abstinence; PDA: percentage days abstinent; PDHD: percentage
days heavy drinking; RCT: randomized controlled trial; RR: risk ratio; TSF: Twelve-Step Facilitation

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

Quasi-RCT: studies where due to potential intervention contamination effects within single sites, it was not possible to do parallel, simultaneous randomization, but instead,
sequential designs were used where the intervention was implemented and then not implemented and then reimplemented with subsequent groups of participants in an 'ON/
OFF' type design.
Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different
sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the
same treatment.
aDowngraded due to study limitations (risk of random sequence generation, allocation concealment, and attrition bias).

Summary of findings 5.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol
use disorder: non-randomized studies (3B)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (manualized) compared to other clinical interventions for alcohol use disorder: non-randomized studies

Patient or population: adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
Setting: outpatient treatment; inpatient/residential facility
Intervention: AA/TSF (manualized)
Comparison: other clinical interventions (e.g. CBT)

Outcomes

Anticipated absolute effects* (95% CI)

Abstinence

Proportion of par-
ticipants (%) com-
pletely abstinent

Follow-up: 12
months

PDA

LPA

Risk with other clinical inter-
ventions

Risk with AA/TSF

Study population

286 per 1000

358 per 1000
(312 to 409)

None of the studies in this category reported this outcome

None of the studies in this category reported this outcome

Relative ef-
fect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

RR 1.25
(1.09 to 1.43)

2692
(2 non- ran-
domized)

⊕⊝⊝⊝
Very lowa

Drinking in-
tensity

DDD
Follow-up: 36
months

The mean DDD in the compari-
son group was 6.28

MD 0.00

-

(3.38 lower to 3.38 higher)

201
(1 non- ran-
domized)

⊕⊝⊝⊝
Very lowb,c

No data avail-
able for 12-
month fol-
low-up

PDHD

None of the studies in this category reported this outcome

C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

1
0

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Alcohol-related consequences (as-
sessed with SIP)

Follow-up: 12 months

The mean SIP in the compari-
son group ranged from 4.1 to
5.3

MD 0.71 lower

(1.68 lower to 0.27 higher)

Alcohol addiction severity
(assessed with ADS)

The mean ADS in the compari-
son group was 3.5

MD 0.30 lower

(2.20 lower to 1.60 higher)

Follow-up: 36 months

-

-

647

(1 non- ran-
domized)

201
(1 non- ran-
domized)

⊕⊝⊝⊝
Very lowa,b

⊕⊝⊝⊝
Very lowb,c

No data avail-
able for 12-
month fol-
low-up

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

AA: Alcoholics Anonymous; ADS: Alcohol Dependence Scale; CI: confidence interval; DDD: drinks per drinking day; LPA: longest period of abstinence; MD: mean difference;
PDA: percentage days abstinent; PDHD: percentage days heavy drinking; RCT: randomized controlled trial; RR: risk ratio; SIP: Short Inventory of Problems; TSF: Twelve-
Step Facilitation

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

Non-randomized: prospective, parallel, group design studies in which intact intervention groups receive either an AA/TSF intervention or a comparison intervention without
being randomly assigned to interventions.
Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different
sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the
same treatment.
aDowngraded due to study limitations (the lack of control of sample selection and non-randomized nature).
bDowngraded due to indirectness (comparability of cohorts for baseline characteristics and outcome measures, and protection against contamination).
cDowngraded due to imprecision (being a single study with a moderate sample size (N = 201)).

Summary of findings 6.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized) compared to a different type of TSF for alcohol
use disorder: non-randomized studies (4B)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized) compared to a different type of TSF for alcohol use disorder: non-randomized studies

Patient or population: adults (> 18 years) with alcohol use disorder, alcohol abuse, or alcohol dependence
Setting: inpatient/residential facility
Intervention: AA/TSF (non-manualized)
Comparison: a different type of TSF (i.e. varying in TSF style or intensity)

C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

1
1

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Outcomes

Anticipated absolute effects* (95% CI)

Risk with different
type of TSF

Risk with AA/TSF

Study population

203 per 1000

49 more per 1000
(10 more to 94 more)

Relative effect
(95% CI)

№ of partici-
pants
(studies)

Certainty of
the evidence
(GRADE)

Comments

RR 1.24

1870

(1.05 to 1.46)

(1 non-

⊕⊝⊝⊝
Very lowa

The mean PDA in the
comparison group was
92.4%

MD 0.01 lower

-

(7.14 lower to 7.12
higher)

randomized)

195
(1 non-ran-
domized)

⊕⊝⊝⊝
Very lowa,b

No data available for 12-
month follow-up

Abstinence

Proportion of
participants
(%) complete-
ly abstinent

Follow-up: 12
months

PDA

Follow-up: 6
months

LPA

None of the studies in this category reported this outcome

Drinking In-
tensity

DDD
Follow-up: 6
months

One study (Grant 2018) reported DDD based on n = 25 across both
groups who were participants who drank any alcohol during the fol-
low-up period and found no evidence of a difference between the
more (mean 17.63, SD 23.71) and less (mean 11.47, SD 5.94) inten-
sive AA/TSF interventions, P = 0.49.

195
(1 non- ran-
domized)

⊕⊝⊝⊝
Very lowa,b,c

Data were not pooled be-
cause authors reported only
those participants that drank
any alcohol and not the to-
tal proportion of participants
that drank. They also did not
provide numbers by treat-
ment intervention.

No data available for 12-
month follow-up

PDHD

None of the studies in this category reported this outcome

Alcohol-related consequences

None of the studies in this category reported this outcome

Alcohol addiction severity (as-
sessed with ASI-L)

Follow-up: 6 months

The mean ASI-L in the
comparison group was
0.16

MD 0.01 higher

-

(0.05 lower to 0.07
higher)

140
(1 non- ran-
domized)

⊕⊝⊝⊝
Very lowa,b

No data available for 12-
month follow-up

*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and
its 95% CI).

C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

1
2

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

AA: Alcoholics Anonymous; ASI-L: Addiction Severity Index-Lite; CI: confidence interval; DDD: drinks per drinking day; LPA: longest period of abstinence; MD: mean differ-
ence; PDA: percentage days abstinent; PDHD: percentage days heavy drinking; RCT: randomized controlled trial; RR: risk ratio; TSF: Twelve-Step Facilitation

GRADE Working Group grades of evidence
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

Non-randomized: prospective, parallel, group design studies whereby intact intervention groups receive either an AA/TSF intervention or a comparison intervention without
being randomly assigned to interventions.
Manualized: the treatment is based on standardized content delivered in a linear or modular fashion to ensure that the same treatment is delivered across time and different
sites where the intervention may be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using the
same treatment.
aDowngraded due to study limitations (risk of attrition bias).
bDowngraded due to imprecision (a single study with a moderate sample size (N = 195)).
cDowngraded as narrative synthesis was conducted, therefore estimates are not precise.

Summary of findings 7.   Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) compared to other clinical interventions and a different type of
TSF for alcohol use disorder: cost-effectiveness studies (5)

Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) compared to other clinical interventions and a different type of TSF for alcohol use disorder: cost-effec-
tiveness studies

Patient or population: alcohol use disorder
Setting: outpatient treatment; inpatient/residential facility
Intervention: AA/TSF
Comparison: other clinical interventions and a different type of TSF

Outcomes

№ of participants
(studies)

Certainty of the evidence
(GRADE)

Impact

Healthcare cost savings
(assessed with total med-
ical care cost savings)

5348
(4 studies)

⊕⊕⊕⊝
Moderatea

Follow-up: 6 months to 7
years

Four studies contributed five separate published reports. In three studies (four
study reports), AA/TSF had higher healthcare cost savings than outpatient treat-
ment, CBT, and no AA/TSF treatment. One other study found that total medical
care costs decreased for participants attending CBT, MET, and AA/TSF treatment,
but that AA/TSF had higher cost-savings potential compared to MET among partic-
ipants with worse prognostic characteristics.

AA/TSF: Alcoholics Anonymous/Twelve-Step Facilitation; CBT: cognitive behavioral therapy; MET: motivational enhancement therapy

GRADE Working Group grades of evidence

1
3

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
High certainty: we are very confident that the true effect lies close to that of the estimate of the effect.
Moderate certainty: we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is
substantially different.
Low certainty: our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.
Very low certainty: we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect.

aDowngraded due to random sequence generation bias, and problems with comparability of cohorts at baseline; protection against contamination between study interventions.

C
o
p
y
r
i
g
h
t

©
2
0
2
0
T
h
e
C
o
c
h
r
a
n
e
C
o

l
l
a
b
o
r
a
t
i
o
n

.

P
u
b

l
i
s
h
e
d
b
y
J
o
h
n
W

i
l
e
y
&
S
o
n
s
,
L
t
d

.

A
l
c
o
h
o
l
i
c
s
A
n
o
n
y
m
o
u
s
a
n
d
o
t
h
e
r
1
2
-
s
t
e
p
p
r
o
g
r
a
m
s
f
o
r
a
l
c
o
h
o
l
u
s
e
d
i
s
o
r
d
e
r

(
R
e
v
i
e
w

)

1
4

L
i
b
r
a
r
y

C
o
c
h
r
a
n
e

B
e
t
t
e
r
h
e
a
l
t
h
.

T
r
u
s
t
e
d
e
v
i
d
e
n
c
e
.

I
n
f
o
r
m
e
d
d
e
c
i
s
i
o
n
s
.

C
o
c
h
r
a
n
e
D
a
t
a
b
a
s
e
o
f
S
y
s
t
e
m
a
t
i
c
R
e
v
i
e
w
s

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

B A C K G R O U N D

Description of the condition

Alcohol use disorder (AUD) confers a prodigious burden of disease,
disability,  and  premature  mortality,  particularly  in  middle-  and
high-income countries (Stahre 2014). With 3.3 million attributable
deaths each year globally, alcohol is responsible for approximately
10  times  the  mortality  rate  for  all  illicit  drugs  combined,  as  well
as 5.1% of the total global burden of disease (WHO 2014). Alcohol
misuse is the leading risk factor for death and disability among 15-
to 59-year-olds worldwide (WHO 2014) and, on average, moderate-
to-severe  AUD  shortens  lifespan  by  20  to  30  years  (Rosenbaum
2015). The financial burden associated with alcohol misuse is also
enormous - amounting to approximately USD 250 billion annually
in the USA alone due to lost productivity, crime and incarceration,
and  increased  healthcare  utilization  (Sacks  2015).  The  response
to  these  problems  is  multipronged,  and  includes  a  broad  array
of  specific  professional  treatment  services  in  diverse  settings.  In
addition,  a  number  of  low-cost  or  free  recovery  support  services
have  emerged  to  prevent  relapse  and  aid  recovery  (e.g.  mutual-
help  organizations,  sober  living  environments)  (White  2012).
Alcohol-focused recovery mutual-help organizations include Blue
Cross (Austria), Vie Libre (France), Danshuakai (Japan), Abstainer's
Clubs  (Poland),  and  the  Links  (Sweden)  (Humphreys  2004).  The
oldest  and  by  far  the  largest  of  these  AUD  recovery  supports  is
Alcoholics Anonymous (AA).

Description of the intervention

AA  consists  of  several  million  members 
in  181  countries
(Humphreys 2004), and is a worldwide, nonprofessional, peer-to-
peer  support  organization  intended  to  help  those  suffering  from
AUD  to  achieve  abstinence  from  alcohol  and  increase  quality  of
life  (Alcoholics  Anonymous  2001).  In  many  world  regions,  AA  is
widely  accessed.  In  North  America,  for  example,  it  is  the  most
commonly sought source of help for AUD (Caetano 1998; Hedden
2015; Room 2006). Although it was originally an all-male and white
organization, AA now attracts a diverse membership of women and
men from a wide range of racial and ethnic backgrounds (Hoffman
2009;  Humphreys  1994;  Jilek-Aall  1981;  OSG  2018).  As  such,  AA
is  part  of  the  de  facto  system  of  care  for  AUD.  Given  that  AUD  is
highly prevalent worldwide, especially in middle- and high-income
countries,  and  is  susceptible  to  relapse  and  reinstatement  over
the  long  term,  the  free  and  widespread  availability  of  AA  gives
the  organization  potential  to  serve  large  numbers  of  people  for
extended  periods.  AA  holds  meetings  in  local  community,  rented
accommodation (e.g. churches/synagogues, hospitals, community
centers, colleges). Group meetings typically last 60 to 90 minutes,
during which members share personal narratives of their alcohol
addiction and recovery experiences, and help one another practice
the principles encompassed in a 12-step program that is intended
to increase psychological well-being, improve interpersonal skills,
enhance  the  ability  to  cope  with  stress,  and  facilitate  adaptation
to abstinence and a sober lifestyle (Kelly 2009a). The widespread
adoption  of  AA  and  its  influence  on  the  professional  treatment
industry  in  some  countries  has  spurred  increasing  efforts  to
evaluate its clinical and public health impact.

In  addition  to  peer-led  AA  mutual-help  groups,  researchers  have
also  evaluated  clinical  interventions  that  have  adapted  the
methodology  and  concepts  of  AA.  These  Twelve-Step  Facilitation
(TSF) interventions include extended counseling, adopting some of

Cochrane Database of Systematic Reviews

the techniques and principles of AA, as well as brief interventions
designed to link individuals to community AA groups (Humphreys
1999).  These  interventions  vary  in  session  length,  format,  and
duration of treatment. For example, TSF interventions can consist
of  a  single  session  lasting  a  few  minutes  to  multiple,  hour-
long  sessions  delivered  over  several  months  (see  Table  1).  TSF
interventions  can  also  be  delivered  clinically  in  individual  or
group sessions. The goal of TSF interventions is to engage people
with  AUD  with  AA  during  and,  importantly,  post  treatment,  to
sustain remission over time. TSF interventions have been studied
to  determine  whether  they  succeed  at  linking  individuals  with
AA,  and  whether  this,  in  turn,  results  in  better  alcohol-related
and  other  outcomes  (Ducharme  2006;  Kelly  2013a;  Kelly  2017a;
Knudsen  2016;  Longabaugh  1998;  Litt  2007;  Mann  2006a;  Mann
2006b;  Walitzer  2009;  Walitzer  2015).  In  this  review,  we  use  the
abbreviation  'AA/TSF'  to  refer  to  these  12-step  programs  and  AA
interventions  in  order  to  reflect  both  types  of  12-step  effects  of
interest.

How the intervention might work

The  original  AA  intervention  is  purported  to  work  via  its  social
fellowship  and  12-step  program  (Alcoholics  Anonymous  2001).
The  social  components  operate  through  peer  support  and  role
modeling  of  successful  AUD  recovery,  and  through  providing
close  mentoring  and  recovery  management  oversight  through
'sponsorship'.  The  common  suffering  of  AA  group  members  may
provide  a  sense  of  belonging  or  universality  that  can  help  to
diminish negative affect, particularly shame, loneliness and guilt,
which  is  similar  to  some  forms  of  group  psychotherapy  (Yalom
2008). Furthermore, the observation of others who are sustaining
recovery  in  AA  can  instill  much-needed  hope  for  a  better  future.
AA  also  provides  an  arena  for  members  to  learn,  and  model,
effective  communication  and  coping  skills,  as  well  as  specific
strategies for abstaining from alcohol. Members are encouraged to
obtain a 'sponsor' - a recovery mentor well-established in sobriety
-  who  can  offer  guidance,  daily  support,  and  accountability  to
help  new  members  stay  sober.  The  12-step  program  is  intended
to  facilitate  the  internal  psychological,  emotional,  and  spiritual
changes  deemed  necessary  to  sustain  abstinence  and  lead  to
enhanced  psychological  well-being  and  improved  relationships
that  can  compete  with  the  more  immediate  rewards  provided
by  alcohol  use  (Alcoholics  Anonymous  2001;  Kelly  2013b).  AA
has an ostensibly 'spiritual' basis, which some members consider
central  to  the  program,  and  which  may  underlie  the  altruistic
behavior that can help promote recovery (Zemore 2004). Yet many
members  do  not  consider  the  spiritual  aspects  of  the  program
central  (Alcoholics  Anonymous  2018;  Humphreys  2004).  Rigorous
reviews of the mechanisms of behavior change through which AA
enhances  recovery  have  found  that  AA  typically  confers  benefits
by mobilizing multiple therapeutic factors simultaneously - mostly
through  facilitating  adaptive  changes  in  the  social  networks  of
participants, but also by boosting members’ recovery coping skills,
recovery  motivation,  abstinence  self-efficacy,  and  psychological
well-being, and by reducing impulsivity and craving (Kelly 2009b;
Kelly 2017a).

It  is  likely  that  TSF  interventions  have  quite  similar  change
mechanisms,  as  they  have  been  adapted  directly  from  AA
interventions, but, as they are of short duration and AUD is typically
chronic,  any  long-term  impact  of  TSF  would  be  due  less  to  the

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

15

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

intervention itself than to its ability to connect an individual to long-
term participation in AA.

Why it is important to do this review

AA is not controlled or standardized by professionals, so historically
it  has  been  harder  to  study  than  professionally-designed  and
delivered  treatments  for  which  manuals  are  written,  doses  can
be randomly assigned, and length of contact can be standardized
and  predetermined  (Humphreys  2004;  Kelly  2013a).  However,  AA
researchers  have  become  increasingly  sophisticated  at  finding
methods  to  rigorously  evaluate  AA,  including  in  randomized
clinical  trials.  Reviews  of  this  research  have  been  conducted,
including  a  prior  Cochrane  Review  (Ferri  2006a;  Ferri  2006b;
Kaskutas 2009a; Kelly 2009b), but a flurry of additional empirical
investigations since these reviews were conducted signifies a need
for  a  major  update.  Consequently,  an  additional  rigorous,  high-
quality  systematic  review  is  needed  that  includes  more  recent
studies  to  provide  information  about  the  clinical  and  public
health utility, effectiveness, and cost-effectiveness of AA and TSF.
This  review  updates  and  supercedes  the  previously  conducted
Cochrane Review (Ferri 2006b).

healthcare cost offsets in relation to these interventions (e.g. cost-
effectiveness, cost utility, cost-benefit analyses). Despite the fairly
large number of RCTs and quasi-RCTs available, we included non-
randomized comparative designs in order to compare and contrast
results from these studies with the more scientifically rigorous RCT
designs.

Types of participants

We  included  male  and  female  adults  (18  years  or  older)  with
alcohol use disorder (AUD), alcohol abuse, or alcohol dependence,
as  defined  using  standardized  criteria  (i.e.  the  Diagnostic  and
Statistical  Manual  of  Mental  Disorders,  4th  and  5th  editions  (APA
1994;  APA  2013);  the  9th  and  10th  revisions  of  the  International
Statistical  Classification  of  Diseases  and  Related  Health  Problems
(WHO  2010);  and  validated  screening  or  diagnostic  tools).  We
excluded studies that involved participants who had been coerced
to attend AA meetings (e.g. by court order, employer, etc.).

Types of interventions

In  this  review,  AA  participation  and  TSFs  were  compared  with  at
least one of the following interventions.

O B J E C T I V E S

To  evaluate  whether  peer-led  AA  and  professionally-delivered
treatments that facilitate AA involvement (Twelve-Step Facilitation
(TSF)  interventions)  achieve  important  outcomes,  specifically:
abstinence,  reduced  drinking  intensity,  reduced  alcohol-related
consequences,  alcohol  addiction  severity,  and  healthcare  cost
offsets.

M E T H O D S

Criteria for considering studies for this review

Types of studies

We  included  studies  that  compared  AA  or  TSF  with  other
interventions, such as motivational enhancement therapy (MET) or
cognitive behavioral therapy (CBT), 12-step program variants, or no
treatment.

We included the following study designs:

• randomized controlled trials (RCTs);
• quasi-RCTs  (i.e.  studies  where  due  to  potential  contamination
of  intervention  effects  within  single  sites,  it  was  not  possible
instead,
to  do  parallel,  simultaneous  randomization,  but 
sequential designs were used, where either random blocks were
assigned  to  one  intervention  followed  by  the  other;  or  where
the  intervention  was  implemented,  then  not  implemented,
and  then  reimplemented  with  subsequent  random  groups  of
participants in an 'on/off' type design); and

• non-randomized studies (i.e. prospective, parallel, group design
studies,  with  intact  intervention  groups  that  received  either
an  Alcoholics  Anonymous/Twelve-Step  Facilitation  (AA/TSF)
intervention  or  a  comparison  intervention  without  random
assignment).

Given the potential healthcare cost savings of people using freely
available community-based mutual-help groups such as AA ( either
spontaneously or in response to receiving a TSF/12-step treatment)
we considered any type of economic study that examined formal

• Other 

theoretically  distinct  clinical 

(e.g.
motivational enhancement therapy (MET), cognitive-behavioral
therapies (CBT), etc.).

interventions 

• Other 12-step program variants (e.g. studies comparing different
types of 12-step interventions that varied in style of intensity).

• No treatment (e.g. wait-list control).

'Treatment  as  usual'  (TAU)  was  used  in  several  studies  to  refer
to  a  variety  of  psychosocial  interventions  delivered  in  individual
and group formats that pertained to aspects of psychoeducation
around addiction, relapse prevention skills building, and linking to
recovery-specific  social  support.  For  a  more  detailed  description
of  each  intervention,  please  see  the  Characteristics  of  included
studies.

Types of outcome measures

We examined four primary outcomes and two secondary outcomes
across the included studies.

Primary outcomes

• Abstinence, measured as:

* proportion of individuals who are continuously abstinent.
*
* percentage days abstinent (PDA)

longest period of abstinence (LPA)

• Drinking intensity, measured as:

* drinks consumed per drinking day (DDD)
* percentage days of heavy drinking (PDHD)
* grams of pure alcohol consumed

• Alcohol-related  consequences,  measured  as:  self-reports  of
physical,  social,  and  psychological  sequelae  resulting  from
alcohol  use  (e.g.  Drinker  Inventory  of  Consequences  (DRINC)
(Miller 1995), Short Inventory of Problems (SIP) (Miller 1995), or
similar measures)

• Alcohol addiction severity, measured by: the Addiction Severity

Index (ASI; McLellan 1980); or similar measures.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

16

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

These  outcomes  were  measured  through  self-report  and,  when
available and appropriate, confirmed via bioassay.

Secondary outcomes

• Healthcare cost offsets, measured as:

* changes in addiction
* mental health-related service utilization
*

related monetary impacts

• Indices reflecting quality of life and/or psychological well-being

Search methods for identification of studies

Electronic searches

We  imposed  no  language,  publication  year  or  publication  status
restrictions.  We  identified  published,  unpublished,  and  ongoing
studies by searching the following databases from their inception.

• Cochrane Drugs and Alcohol Group Specialised Register (CDAG)

Specialised Register (inception to 2 August 2019).

• Cochrane  Central  Register  of  Controlled  Trials  (CENTRAL)

(inception to 2 August 2019).

• MEDLINE PubMed (from 1946 to 2 August 2019).
• Embase Ovid (from 1974 to 2 August 2019).
• CINAHL EBSCO (Cumulative Index to Nursing and Allied Health

Literature; from 1982 to 2 August 2019).

• PsycINFO EBSCO (from 1935 to 2 August 2019).

We  modeled  the  subject  strategies  for  databases  on  the  search
strategy designed for CENTRAL (Appendix 1).

We searched the following trial registries.

• World Health Organization International Clinical Trials Registry

Platform (www.who.int/trialsearch) (15 November 2018).

• ClinicalTrials.gov (www.clinicaltrials.gov) (15 November 2018).

We  also  searched  the  above  databases  for  health  economics
evidence.

Searching other resources

identify  other  potentially  eligible  studies
We  attempted  to 
by  searching  the  reference  lists  of  retrieved  included  studies,
systematic  reviews,  and  meta-analyses.  We  discovered  five
additional  articles 
through
handsearching.

these  methods  and 

through 

Data collection and analysis

Selection of studies

Two  review  authors  (JK  and  KH)  independently  scanned  the
abstract,  title,  or  both,  of  every  record  retrieved  to  determine
which  studies  should  be  evaluated  further  for  inclusion.  We
retrieved all potentially relevant articles as full text, and resolved
any  discrepancies  between  the  two  review  authors  through
consultation  and  discussion  with  the  third  review  author  (MF).
When a potential study for inclusion that had been conducted by
one  of  the  review  authors  was  detected,  the  study  reports  were
screened independently by one of the other authors of this review
who was not associated with that study. After discussion among the
authors, we added studies that remained questionable for review
inclusion to the list of articles awaiting assessment. We contacted

Cochrane Database of Systematic Reviews

study authors for clarification when necessary. We delineated the
study selection process in a PRISMA flow chart (Liberati 2009; Moher
2009).

Data extraction and management

Using a standardized data extraction form, two review authors (JK
and  KH)  independently  abstracted  the  relevant  elements  of  the
study, including study design, sample characteristics, description
of  the  experimental  and  control  interventions,  outcomes,  study
funding,  and  conflicts  of  interest.  Any  disagreements  regarding
these details were resolved among all review authors by discussion.
We contacted study authors for clarification when necessary.

Assessment of risk of bias in included studies

Two review authors (KH and MF) independently assessed the risk
of  bias  in  the  included  studies  using  the  criteria  recommended
in the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011a). When included reports had been authored by one
of the authors of this review (e.g. Humphreys 1996), the risk of bias
was rated by the other two review authors to prevent conflicts of
interest and potential bias. The recommended Cochrane approach
for  assessing  risk  of  bias  in  studies  comprises  the  assessment  of
seven domains:

• sequence generation;
• allocation concealment (selection bias);
• blinding of participants and personnel;
• blinding of outcome assessors (detection bias);
• incomplete outcome data (attrition bias);
• selective outcome reporting (reporting bias); and
• other sources of bias including:

* comparability  of  cohorts  for  baseline  characteristics  and
outcome measures on the basis of the design or analysis;
selection of the non-exposed cohort; and

*
* protection against cross-contamination of the intervention.

The  first  part  of  the  assessment  process  involved  describing
what  was  reported  to  have  happened  in  the  study.  The  second
part  involved  assigning  a  judgment  relating  to  the  risk  of  bias
for  that  entry,  in  terms  of  low,  high,  or  unclear  risk.  To  make
these  judgments,  we  used  the  criteria  indicated  in  the  Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011b),
adapted to the addiction field (see Appendix 2 for details).

We addressed the domains of sequence generation and allocation
concealment (avoidance of selection bias) using a single entry for
each study.

Blinding of participants and personnel (performance bias) was not
possible  given  that  the  focus  of  this  review  was  on  psychosocial
interventions. In fact, knowledge of participation in a psychosocial
intervention  is  part  of  the  therapeutic  effect;  therefore,  we  think
that  lack  of  blinding  of  participants  and  personnel  does  not
introduce bias. For this reason, we judged all studies as being at low
risk of performance bias.

We  had  planned  initially  to  assess  blinding  of  outcome  assessor
separately  for  objective  and  subjective  outcomes,  but  all  the
outcomes  reported  in  the  included  studies  were  subjective  (self-
reported  data),  even  though  many  of  these  were  supported  by
objective biological assay (e.g. urine toxicology screens).

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

17

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

We  provided  a  separate  rating  of  bias  for  economic  studies  so
that they could be rated independently from the clinical outcome
analysis. This was done because, even though they came from the
same study, the analytic method for each type of analysis is very
different. Also, one study was purely an economic study and did not
contribute data to the estimate of AA/TSF effects because it did not
have a true comparison group (Mundt 2012).

We  considered  incomplete  outcome  data  (while  also  taking  due
note of any observed attrition bias) for all outcomes.

We  operationalized  'Risk  of  bias'  tables  to  be  used  for  the
assessment  of  RCTs,  quasi-RCTs,  and  prospective  observational
studies  that  included  a  comparison  intervention,  according  to
the  criteria  recommended  by  Cochrane  Drugs  and  Alcohol  (see
Appendix 2 for details).

of  comparison  intervention.  This  is  because,  firstly,  averaging
effects  of  different  comparison  interventions  artificially  assumes
these  interventions  are  conceptually  similar  and  confer  similar
benefit;  and  secondly,  there  are  insufficient  numbers  of  the
same  comparison  intervention  to  justify  separate  analyses  by
comparison group type.

Dealing with missing data

We  appraised  the  presence  and  impact  of  missing  data  on  study
findings. We detailed this in the narrative as appropriate. We also
detailed  in  a  table  how  the  included  studies  handled  missing
data. When necessary, we contacted the original study authors to
attempt to obtain missing data and information of their potential
impact.

Assessment of heterogeneity

We  evaluated  any  economic  studies  using  the  appropriate
Cochrane 'Risk of bias' criteria, along two dimensions, as specified
in the Cochrane Handbook for Systematic Reviews of Interventions
(section  15.5.2;  Shemilt  2011a).  This  included  two  types  of  bias
ratings:

Given the potential high level of heterogeneity across experimental
treatments  and  comparison 
treatments,  we  conducted  a
quantitative  aggregation  (meta-analysis)  that  included  statistical
estimation  of  the  degree  of  heterogeneity  calculated  using  the  Q
value and I2statistic.

• assessment of the risk of bias in results of the effectiveness study
on which the full economic evaluation study is based, informed
by a recognized checklist for effectiveness studies; and

• assessment of the methodological quality of the full economic
evaluation  study,  informed  by  a  recognized  checklist  for
economic  evaluations  conducted  alongside  single  study
designs.

As  recommended  by  Cochrane  (Shemilt  2011a),  we  utilized  the
Evers checklist for rating the certainty of economic studies in the
current review (Evers 2005; Appendix 3).

Measures of treatment effect

We  calculated  the  standardized  mean  difference  (SMD)  for
continuous  variables  (e.g.  percentage  days  abstinent  (PDA)),  or
the  relative  risk  (i.e.  risk  ratios  (RRs))  for  dichotomous  variables
(e.g.  proportion  of  participants  completely  abstinent),  with  the
uncertainty  of  the  estimate  expressed  using  95%  confidence
intervals  (CIs).  We  pooled  and  analyzed  study  effects  wherever
possible using meta-analyses. We used random-effects estimates
to account for potential heterogeneity among studied interventions
in the included studies. We described any remaining studies in table
format  and  described  results  in  the  narrative.  These  are  referred
to  below  in  the  Results  section  as  Analysis  1.1,  Analysis  2.3,  and
Analysis 6.3, and appear in the 'Data and Analyses' section tables
as 'Other Data'.

Unit of analysis issues

In  order  to  avoid  double-counting  (i.e.  unit  of  analysis  errors
that  can  inflate  statistical  significance)  (Higgins  2011b),  and
analyze studies properly where there was one AA/TSF intervention
group  compared  to  two  or  more  comparison  groups,  we
split  the  population  of  the  AA/TSF 
in
the  meta-analyses,  based  on  the  guidelines  outlined  in  the
Cochrane  Handbook  for  Systematic  Reviews  of 
Interventions
(How  to  include  multiple  groups  from  one  study)  (Higgins
2011b).  This  method  was  preferred  over  the  two  alternative
methods:  averaging  the  effects  of  the  comparison  interventions,
or  conducting  completely  separate  analyses  by  distinct  type

intervention  group 

Assessment of reporting biases

We  planned  to  use  visual  inspection  of  funnel  plots  (plots  of  the
effect  estimate  from  each  study  against  the  sample  size  or  effect
standard error) to indicate possible publication bias if there were at
least 10 studies included in the meta-analysis. We did not inspect
funnel plots because there were always less than 10 studies in any
given meta-analysis (Sterne 2011).

Data synthesis

Wherever possible, we conducted pooled analysis and aggregation
of  data  using  a  random-effects  model,  because  we  expected  a
certain  degree  of  heterogeneity  among  trials.  This  was  possible
for the proportion of participants completely abstinent, PDA, DDD,
and PDHD. We analyzed the five observational, prospective, non-
randomized  studies  we  included  separately  (see  Analysis  5.1,
Analysis  5.2,  Analysis  5.3,  Analysis  5.4,  Analysis  5.5,  Analysis  6.1,
Analysis 6.2, Analysis 6.3 and Analysis 6.4).

As  detailed  in  the  Cochrane  Handbook  for  Systematic  Reviews  of
Interventions (section 15.6.3) (Shemilt 2011a), there is currently no
consensus  regarding  appropriate  methods  for  pooling  combined
estimates  of  cost-effectiveness  studies,  in  addition,  there  are
potential  issues  concerning  the  validity  of  such  methods  when
combining  metrics  across  cost-effectiveness  studies.  For  these
reasons,  rather  than  conduct  a  meta-analysis,  we  summarized
results from any cost-effectiveness studies in the narrative.

Subgroup analysis and investigation of heterogeneity

We describe subgroup analyses according to AUD severity, where
appropriate  (e.g.  according  to  the  DSM  IV  criteria  'abuse'  versus
'dependence'; APA 1994).

Sensitivity analysis

We  conducted  sensitivity  analyses  by  examining  studies  across
three major dimensions:

• type of study design (e.g. RCT/quasi-RCT, non-randomized);

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

18

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

• degree  of  manualization  and  verified  clinical  fidelity 

in
implementation  of  the  intervention  (e.g.  documentation  of
regular  audio/video-taped  clinical  supervision  to  monitor
adherence  to  the  treatment  manual  and  measurement  of
clinical competence in its delivery); and

• the  type  of  intervention  to  which  AA/TSF  was  compared  (e.g.
an  intervention  based  on  a  different  theory,  such  as  cognitive
behavioral therapy (CBT), or an intervention based on the same
type of TSF-orientation but that varied in TSF style of intensity).

• Serious  (-1)  or  very  serious  (-2)  inconsistency  between  study

results.

• Some  (-1)  or  major  (-2)  uncertainty  about  directness  (the
correspondence  between  the  population,  the  intervention,  or
the outcomes measured in the studies actually found and those
under consideration in our systematic review).

• Serious  (-1)  or  very  serious  (-2)  imprecision  of  the  pooled

estimate.

• Publication bias strongly suspected.

Grading of evidence

We  assessed  the  overall  certainty  of  evidence  for  the  primary
outcomes  using  the  GRADE  system  (GRADEpro  GDT  2015;
Schunemann  2013),  which  takes  into  account  issues  related  to
internal  and  external  validity,  such  as  risk  of  bias,  directness,
consistency,  precision  of  results,  and  publication  bias.  These
ratings were based on studies that had the 12-month assessment
outcome  time  point.  If  there  was  no  12-month  outcome  within  a
particular  subgrouping  for  a  given  outcome,  then  GRADE  ratings
were  based  on  the  next  closest  outcome  time  point  from  the
evidence available. We used GRADEpro GDT to create the 'Summary
of  findings'  tables  (GRADEpro  GDT  2015).  These  tables  present
the  main  findings  of  the  review  in  a  transparent  and  simple
tabular  format.  Outcomes  are  presented  where  possible  for  12-
month follow-ups,and key information concerning the certainty of
evidence, the magnitude of effect of the interventions, and the sum
of available data for the main outcomes is also shown.

The GRADE system uses the following criteria for assigning grades
of evidence.

• High  certainty:  we  are  very  confident  that  the  true  effect  lies

close to that of the estimate of the effect.

• Moderate  certainty:  we  are  moderately  confident  in  the  effect
estimate; the true effect is likely to be close to the estimate of the
effect, but there is a possibility that it is substantially different.
• Low certainty: our confidence in the effect estimate is limited;
the true effect may be substantially different from the estimate
of the effect.

• Very low certainty: we have very little confidence in the effect
estimate;  the  true  effect  is  likely  to  be  substantially  different
from the estimate of effect.

Grading can be decreased for any of the following reasons.

• Serious (-1 grade) or very serious (-2) study limitation for risk of

bias.

By default, according to the Cochrane system for grading evidence,
all  non-randomized  studies  are  automatically  rated  as  'low
certainty',  and  then  downgraded  from  there  based  on  any  of
the  above-listed  reasons.  Evidence  from  non-randomized  studies
can  be  upgraded  for  large  effects,  specifically,  evidence  of  dose
response and confounding which would be expected to result in an
effect opposite to that observed.

R E S U L T S

Description of studies

We included 27 primary studies with a total of 10,565 participants.
Twenty-six  of  these  primary  studies  contributed  data  to  the
estimate  of  the  effectiveness  of  Alcoholics  Anonymous/Twelve-
Step  Facilitation  (AA/TSF).  Twenty-one  of  these  27  studies  were
randomized  controlled  trials  (RCTs)/quasi-RCTs;  five  were  non-
randomized studies, and one study was used for purely economic
purposes (Mundt 2012), and did not contribute to the estimate of
the effectiveness of AA/TSF, because it did not include a comparison
intervention. Three other studies also included economic analyses
(classified  as  cost-benefit  studies;  e.g.  see  Drummond  2005;
Shemilt 2011a), making a total of four included economic studies
reported across five included papers.

Results of the search

Electronic  searches  yielded  12,733  articles  from  the  databases
specified  in  Electronic  searches.  We  identified  an  additional  five
studies through author correspondence, and three through clinical
trial records, making a total of 12,741 articles. After duplicates were
removed, 5808 records remained. We removed 5758 of these after
screening titles and abstracts, as they were irrelevant to the current
study.  This  left  a  total  of  50  full-text  reports,  which  we  examined
in detail. We excluded 13 of these because they did not meet the
inclusion criteria (documented in Figure 1; see also Characteristics
of excluded studies). This left a total of 37 published study reports
relating to the 27 primary studies that met our inclusion criteria.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

19

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Figure 1.   PRISMA study flow diagram.

Cochrane Database of Systematic Reviews

Included studies

Most studies were conducted in the USA, with one study from the
UK (Manning 2012), and one from Norway (Vederhus 2014). Details
of characteristics and bias ratings for each study are included in the

Characteristics of included studies. Where there were two or more
papers describing different follow-up time points for a given study,
we combined the papers describing the results of the different time
points under that study.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

20

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Although all of the study populations were extremely likely to have
had  various  proportions  of  participants  meeting  clinical  criteria
for  other  psychiatric  disorders  (e.g.  major  depression,  anxiety
disorders  etc.)  in  addition  to  alcohol  use  disorder  (AUD),  these
proportions  were  rarely  explicitly  documented.  There  were  four
studies, however, that met the inclusion criteria that did explicitly
document  the  degree  of  psychiatric  comorbidity  (Bogenschutz
2014;  Brooks  2003;  Herman  2000;  Timko  2011).  Although,  such
dually-diagnosed  samples  are  sometimes  reviewed  separately
(e.g.  Tonigan  2018),  we  included  these  studies  here  because
they  otherwise  met  our  inclusion  criteria.  When  we  performed
sensitivity  analyses,  we  did  not  find  differences  in  the  overall
pattern of findings when we included or excluded these studies.

The  Characteristics  of  included  studies  tables  also  include  two
additional ratings for each study as follows.

• Grading criteria for study adherence/competence rating:

• 0  =  non-manualized  (i.e.  treatments  were  unlikely  to  be
replicable),  or  no  report  of  attempts  to  ensure  adherence/
competence of intervention implementation;

• 1  =  report  of  attempts  to  ensure  adherence/competence

without audio or videotape;

• 2 = report of attempts to ensure adherence/competence with

audio or videotape monitoring and rating.

• Manualization and non-manualization of study interventions:

• M  =  manualized:  treatments  were  replicable  because  they

followed a session-to-session outline of procedures

• NM  =  non-manualized:  treatments  were  unlikely  to  be

replicable

Study design

We  included  a  total  of  27  primary  studies  (21  RCTs/quasi-RCTs,
5  non-randomized,  and  1  purely  economic  study)  that  reported
follow-up results across a total of 36 reports.

Cochrane Database of Systematic Reviews

Participants

The  total  number  of  participants  across  the  27  included  studies
was  10,565,  including  2456  participants  who  contributed  to  the
economic analyses.

The average sample age ranged from 34.2 years old in Brooks 2003
to 51.0 years old in Timko 2011;

The proportion of female participants ranged from 0% in Ouimette
1997 and McCrady 1996 to 49.1% in Humphreys 1996.

The racial composition varied from 7.3% non-white participants in
Litt 2016 to 54% in Ouimette 1997.

In  the  economic  evaluations,  the  average  sample  age  ranged
from  16.1  years  old  at  baseline  in  Mundt  2012  to  43  years  old  in
Ouimette 1997; from 0% female in Ouimette 1997 to 49.1% female
in Humphreys 1996; and from 8% non-white participants in MATCH
1997 to 76.9% in Herman 2000.

Types of comparisons

Experimental  interventions  included  AA  participation  and  TSF.
Comparison  interventions  included  other  psychological  clinical
interventions  (e.g.  motivational  enhancement  therapy  (MET),
cognitive  behavioral  therapy  (CBT),  etc.),  other  12-step  program
variants  (e.g.  studies  comparing  different  styles/intensities  of
12-step  interventions),  and  no  treatment  (e.g.  wait-list  control).
However,  we  identified  no  included  studies  that  contained
a  no  treatment/wait-list  comparison  group.  Interventions  and
comparisons varied by degree of therapy manualization, duration/
number of treatment sessions, whether they were clinician or peer-
led, in a clinical or community setting, and in clinical population
focus.

There  were  three  broad  dimensions  that  characterized  these
included  studies:  the  type  of  study  used;  the  degree  of
treatment  manualization  (signifying  the  degree  of  intervention
standardization  and  replicability);  and  the  types  of  treatments
to  which  AA/TSF  was  compared  (see  Figure  2  and  Figure  3
(the  latter  includes  the  number  of  participants  in  each  of  these
subcategories)).

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

21

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 2.   Manualized = the treatment covers standardized content in a linear or modular fashion to ensure that
the same treatment is delivered across time and different sites where the intervention may be implemented. This
ensures that the treatment can be replicated – a key factor in confirming the findings across different studies using
the same treatment.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

22

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 3.   S = number of studies from Cochrane Review R = number of reports from Cochrane Review N = number of
participants in the cell subcategory Manualized = the treatment covers standardized content in a linear or modular
fashion to ensure that the same treatment is delivered across time and different sites where the intervention may
be implemented. This ensures that the treatment can be replicated – a key factor in confirming the findings across
different studies using the same treatment. aThe total Ns added across study types will not add to 10,565 because
some of the participants that are in the other groupings (e.g. non-randomized designs) are also in the economic
category.
b Walitzer 2009 and its participants are included in both the 1A and 2A grouping in the review, but for the purposes
of this table, the study and its participants (n = 169) are only counted once in the 1A group.
c Ouimette 1997 and its participants are included in both the 3B and 4B grouping, but for the purposes of this table,
the study and its participants (n = 3018) are only counted in the 3B group.

Within  design  types,  studies  varied  in  whether  treatments  were
manualized  or  non-manualized,  and  whether  they  compared
AA/TSF  to  a  different  theoretical  orientation  (e.g.  CBT),  or  to
a  different  type  of  TSF  (i.e.  one  that  varied  in  TSF  style  or
intensity). Among the 21 RCT/quasi-RCT designs (5787 participants;
28  reports),  15  studies  were  manualized  (10  compared  AA/
TSF  to  a  different  theoretical  orientation;  4  compared  AA/
TSF  variants,  1  compared  AA/TSF  to  both  another  theoretical
orientation  and  an  AA/TSF  variant);  4  studies  had  one  or  more
non-manualized  interventions  (2  compared  AA/TSF  to  a  different
theoretical orientation, 2 compared AA/TSF variants); two studies
were  non-manualized  (both  compared  AA/TSF  to  a  different
theoretical  orientation).  Among  the  five  studies  that  were  non-
randomized  (4375  participants;  7  reports),  two  studies  had  at
least  one  intervention  non-manualized  (1  compared  AA/TSF  to
a  different  theoretical  orientation  and  1  compared  AA/TSF  to
an  AA/TSF  variant);  three  studies  had  treatments  that  were  all
non-manualized  (2  compared  AA/TSF  to  a  different  theoretical
orientation  and  1  compared  AA/TSF  to  a  different  theoretical
orientation  as  well  as  an  AA/TSF  variant).  Together,  26  primary
studies  contributed  data  to  the  estimate  of  the  effectiveness
of  AA/TSF.  We  utilized  the  final  included  study  purely  for  its
economic  analysis  (Mundt  2012;  403  participants);  this  study  did
not  contribute  to  the  estimate  of  the  effectiveness  of  AA/TSF,
because it did not include a comparison intervention.

Keeping  these  dimensions  in  mind,  below  we  have  reported  the
findings from the included studies in five summary categories with
subcategories as follows.

• 1a:  studies  that  employed  a  RCT/quasi-RCT  design  with  all
treatments  manualized  and  compared  AA/TSF  to  a  treatment
with a different theoretical orientation (e.g. CBT) (11 studies).
• 1b:  studies  that  employed  a  RCT/quasi-RCT  design  where  at
least one comparison treatment was non-manualized and AA/
TSF  was  compared  to  a  treatment  with  a  different  theoretical
orientation (e.g. CBT) (4 studies).

• 2a:  studies  that  employed  a  RCT/quasi-RCT  design  with  all
treatments manualized and AA/TSF was compared to a different
type of TSF (i.e. varying in TSF style or intensity) (5 studies).
• 2b:  studies  that  employed  a  RCT/quasi-RCT  design  where  at
least one comparison treatment was non-manualized and AA/
TSF was compared to a different type of TSF (i.e. varying in TSF
style or intensity) (2 studies).

• 3a:  studies  that  employed  a  non-randomized  design  with  all
treatments manualized and where AA/TSF was compared to a
different  theoretical  orientation  (e.g.  CBT)  (note:  there  are  no
studies included in this category).

• 3b:  studies  that  employed  a  non-randomized  design  with  at
least  one  non-manualized  treatment  intervention  and  where
AA/TSF  was  compared  to  a  different  theoretical  treatment
orientation (e.g. CBT) (4 studies).

• 4a:  studies  that  employed  a  non-randomized  design  with  all
treatments manualized and where AA/TSF was compared to a
different type of TSF (i.e. varying in style or intensity) (note: there
are no studies included in this category).

• 4b:  studies  that  employed  a  non-randomized  design  with  at
least  one  non-manualized  treatment  intervention  and  where
AA/TSF was compared to a different TSF variant (i.e. in varying in
TSF style or intensity) (2 studies).

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

23

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

• 5: economic studies (e.g. healthcare cost offset) (4 studies).

Length of follow-up

Follow-up length ranged from the end of treatment through to five
years (Table 1). For the economic studies, follow-up length ranged
from one year to seven years.

Outcomes assessed in the studies

We  examined  our  four  primary  outcomes  and  two  secondary
outcomes  across  the  included  studies.  The  primary  outcomes
assessed in the studies were as follows.

• Abstinence, measured as:

* proportion of individuals who are continuously abstinent (17

studies; 23 reports);
longest period of abstinence (LPA) (2 studies; 2 reports); and

*
* percentage days abstinent (PDA) (16 studies; 21 reports).

• Drinking intensity, measured as:

* drinks  consumed  per  drinking  day  (DDD)  (9  studies;  11
reports - note: 1 study was based on grams of pure alcohol
consumed, converted into USA standard drinks per drinking
day);

* percentage  days  of  heavy  drinking  (PDHD)  (4  studies;  4

Thirteen studies included a bioassay (either a breathalyzer, blood,
urinalysis, saliva, or a combination of these), while 13 did not report
the  use  of  one;  the  final  study  was  an  economic  analysis  only,
for  which  use  of  a  bioassay  was  not  appropriate.  The  included
studies  were  conducted  prior  to  the  introduction  of  biological
assays  such  as  ethyl  glucuronide  (EtG)  and  phosphatidylethanol
(PetH),  both  of  which  can  detect  alcohol  for  much  longer  than
the  assays  used  in  the  studies.  Since,  at  that  time,  there  was  a
limited window for detecting alcohol use using breathalyzers and
urinalysis  bioassay,  use  of  bioassays  to  corroborate  self-report
was  less  common  than  it  is  now.  Regardless,  it  is  unlikely  that
any  systematic  bias  would  occur  across  comparison  treatment
interventions because all participants were subjected to the same
procedures and protocols.

Funding sources

Included  studies  were  funded  through  grants  from  one  or  more
of  the  following  sources:  the  United  States  National  Institutes
of  Health  (18  studies);  the  USA  Department  of  Veterans  Affairs
(8  studies);  and  through  various  other  organizations  (e.g.  private
foundations, (academic) or institutions; 8 studies). For two studies
researchers did not report their funding source (Davis 2002; Kahler
2004).

reports).

Excluded studies

• Alcohol-related  consequences,  measured  as:  self-reports  of
physical,  social,  and  psychological  sequelae  resulting  from
alcohol  use  (e.g.  Drinker  Inventory  of  Consequences  (DRINC;
Miller 1995), Short Inventory of Problems (SIP; Miller 1995), or
similar measures; 8 studies; 10 reports).

• Alcohol addiction severity (7 studies; 8 reports), measured by:
the  Addiction  Severity  Index  (ASI;  McLellan  1980)  (6  studies;  7
reports), Alcohol Dependence Scale (ADS; 1 study; 1 report).

Secondary  outcomes  assessed  in  the  studies  consisted  of  the
economic analyses (4 studies; 5 reports) measured by cost-benefit
analysis (see Characteristics of included studies tables for specific
examples).  In  some  instances  either  the  means  or  standard
deviations (SDs), or both, were missing from the published reports.
On  each  occasion,  we  were  able  to  obtain  these  directly  from
the  study  authors  through  personal  correspondence  (i.e.  Kahler
2004;  Litt  2007;  Litt  2016;  MATCH  1997;  Walitzer  2009).  None  of
the  included  studies  reported  indices  reflecting  quality  of  life  or
psychological well-being.

We  excluded  24  studies  from  the  review  because  they  did  not
meet  the  inclusion  criteria  in  terms  of:  study  design  (13  studies),
interventions evaluated (3 studies), participants (6 studies), study
design plus intervention (1 study), or study design plus outcomes
(1 study).

Risk of bias in included studies

As noted in Assessment of risk of bias in included studies, we rated
all reports across seven risk of bias dimensions using the standard
Cochrane  'Risk  of  bias'  ratings  criteria  (see  Appendix  2;  Figure  4;
Figure 5). These criteria apply to risk of bias ratings for randomized
as  well  as  for  observational,  prospective,  studies.  In  the  latter
case, random sequence generation and allocation concealment are
automatically rated as 'high risk'; we awarded such ratings in this
review (i.e. for the 5 included observational, prospective studies).
In future updates of this review, if we include a larger number of
observational,  prospective  studies,  then  it  may  also  be  prudent
to  conduct  a  separate  'Risk  of  bias'  rating  specifically  designed
for evaluating risks in such studies, for example ROBINS-I (Sterne
2016).

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

24

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 4.   Risk of bias graph: review authors' judgments about each risk of bias item presented as percentages
across all included studies.

Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Comparability of cohorts for baseline characteristics and outcome measures
Selection of the non-exposed cohort
Protection against contamination
Blinding of outcome assessment (detection bias): All outcomes
Blinding of outcome assessment (detection bias): Cost-effectiveness only

Low risk of bias

Unclear risk of bias

High risk of bias

0%

25%

50%

75% 100%

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

25

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Figure 5.   Risk of bias summary: review authors' judgments about each risk of bias item for each included study.
Note: 27 primary studies

s
e
m
o
c
t
u
o

l
l

A

:
)
s
a
i
b

e
c
n
a
m
r
o
f
r
e
p
(

l
e
n
n
o
s
r
e
p
d
n
a

s
t
n
a
p
i
c
i
t
r
a
p
f
o
g
n
i
d
n
i
l

B

s
e
m
o
c
t
u
o

l
l

A

:
)
s
a
i
b

n
o
i
t
i
r
t
t
a
(

a
t
a
d

e
m
o
c
t
u
o

e
t
e
l
p
m
o
c
n
I

)
s
a
i
b

g
n
i
t
r
o
p
e
r
(

g
n
i
t
r
o
p
e
r

e
v
i
t
c
e
l
e
S

s
e
r
u
s
a
e
m
e
m
o
c
t
u
o

d
n
a

s
c
i
t
s
i
r
e
t
c
a
r
a
h
c

e
n
i
l
e
s
a
b

r
o
f

s
t
r
o
h
o
c

f
o
y
t
i
l
i
b
a
r
a
p
m
o
C

)
s
a
i
b

n
o
i
t
c
e
l
e
s
(

n
o
i
t
a
r
e
n
e
g

e
c
n
e
u
q
e
s
m
o
d
n
a
R

)
s
a
i
b

n
o
i
t
c
e
l
e
s
(

t
n
e
m
l
a
e
c
n
o
c

n
o
i
t
a
c
o
l
l

A

y
l
n
o

s
s
e
n
e
v
i
t
c
e
f
f
e
-
t
s
o
C

:
)
s
a
i
b

n
o
i
t
c
e
t
e
d
(

t
n
e
m
s
s
e
s
s
a

e
m
o
c
t
u
o
f
o

g
n
i
d
n
i
l

B

s
e
m
o
c
t
u
o

l
l

A

:
)
s
a
i
b

n
o
i
t
c
e
t
e
d
(

t
n
e
m
s
s
e
s
s
a

e
m
o
c
t
u
o
f
o
g
n
i
d
n
i
l

B

t
r
o
h
o
c

d
e
s
o
p
x
e
-
n
o
n
e
h
t

f
o

n
o
i
t
c
e
l
e
S

n
o
i
t
a
n
i
m
a
t
n
o
c

t
s
n
i
a
g
a

n
o
i
t
c
e
t
o
r
P

Blondell 2001
Blondell 2011
Bogenschutz 2014
Bowen 2014
Brooks 2003
Brown 2002
Davis 2002
Grant 2018
Herman 2000
Humphreys 1996
Kahler 2004
Kaskutas 2009b
Kelly 2017b
Litt 2007
Litt 2016
Lydecker 2010
Manning 2012
MATCH 1997
McCrady 1996
Mundt 2012
Ouimette 1997
Timko 2006

-

-

- + - + + ?
-
-
?
+ + -
? + + + + ?
- + + + ? ?
+ + ?
? ? ? + + + + ? ?
-
? ? + + + + ?
+ + ? ? + + + ? ?
-
- + + + ?
? ?
- + + + ? ?
-
-
?
-
? + ? + -
?
? ? + - + -
? ?

? ?
-
-
+ + ? ? + ? + + ?
-
- + - + ? + + ?
+ + + - + + + + ?
+ + -
? + + + + ?
+ + -
? + + + + ?
-
- + + + + + ?
-
+ + ? + + + + ? ?
+ + ? ? + + + + ? ?
+ + ? ? + + + + ?
- + ? + + + +
-
?
- + - + + + + ? +
-

? ?

?

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

26

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cochrane Database of Systematic Reviews

Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Figure 5.   (Continued)

Ouimette 1997
Timko 2006
Timko 2011
Vederhus 2014
Walitzer 2009
Walitzer 2015
Zemore 2018

- + - + + + + ? +

-
+ + ? ? + + + + ?
- + ? + + + + +
-
- + + + + +
-
-
+ + ? + + + + + ?
- + + + + +
+ + ?
-
-
-
? + + + ? +

?

Allocation

For  random  sequence  generation,  we  rated  11  of  the  27  primary
studies  as  potentially  high  risk  for  selection  bias  because  they
either  used  alternation  as  a  non-random  component  in  the
sequence generation process (6 studies) or were non-randomized
(5  studies).  We  rated  half  of  the  studies  (13  studies)  as  low  risk,
and  three  studies  as  being  at  unclear  risk  of  bias.  For  allocation
concealment, we rated 13 studies as low risk and three as unclear
risk.  We  rated  11  studies  as  high  risk  of  selection  bias  because
they  were  either  non-randomized  (6  studies)  or  researchers  who
were  enrolling  participants  could  possibly  foresee  assignment  to
treatment interventions (5 studies).

Blinding

For  detection  bias  we  rated  22  studies  as  being  at  unclear  risk
because  insufficient  information  was  provided  to  enable  us  to
make  a  judgement  of  high  or  low  risk,  four  studies  as  low  risk,
and  one  study  as  high  risk  because  there  was  no  blinding  of
outcome  assessments.  For  the  economic  analyses  (4  studies;  5
reports),  we  rated  three  studies  as  being  at  unclear  risk  of  bias
(Humphreys 1996; Mundt 2012; MATCH 1997), and one study as low
risk (Ouimette 1997).

We rated blinding of participants and personnel (performance bias)
as high in six studies, low in five studies, and unclear in 15 studies.

Incomplete outcome data

We  rated  attrition  bias  as  unclear  in  approximately  half  of  the
studies (14 studies) and low in four studies. In nine studies, we rated
attrition bias as high risk because the studies had moderate (≥ 20%)
attrition  rates  (8  studies),  or  there  was  a  significant  difference  in
attrition rates in the intervention groups (1 study).

Of  the  27  included  studies,  12  did  not  report  how  they  handled
missing  data;  5  used  intention-to-treat  analyses  (with  worst  case
scenario); and the remaining 10 studies used a variety of procedures
to impute or compensate for any missing data (see Table 2).

Selective reporting

There was no evidence of selective reporting bias of outcomes in
any of the reviewed studies; thus, we rated all 27 studies as low risk
for reporting bias.

Other potential sources of bias

is  a  possibility  of 
There 
step  effects  because  comparison 

inadvertent  contamination  of  12-
interventions,  while  not

explicitly facilitating AA participation, cannot realistically prevent
participants  from  attending  AA,  and  it  is  almost  inevitable  that
some  participants  will  elect  to  attend  AA  while  in  a  comparison
group (e.g. participants assigned to a CBT comparison may choose
to  go  to  AA  of  their  own  accord).  Because  AA  participation
predicts improved outcomes (Humphreys 2014), this may diminish
any potential between-intervention effects. Between-intervention
estimates  in  this  review  are  thus  conservative  estimates  of  the
effectiveness of AA/TSF.

Effects of interventions

See: Summary of findings 1 Alcoholics Anonymous (AA)/Twelve-
Step  Facilitation  (TSF)  (manualized)  compared  to  other  clinical
interventions for alcohol use disorder (1A); Summary of findings
2 Alcoholics Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-
manualized)  compared  to  other  clinical  interventions  for  alcohol
use disorder (1B); Summary of findings 3 Alcoholics Anonymous
(AA)/Twelve-Step  Facilitation  (TSF)  (manualized)  compared  to  a
different  type  of  TSF  for  alcohol  use  disorder  (2A);  Summary  of
findings  4  Alcoholics  Anonymous  (AA)/Twelve-Step  Facilitation
(TSF)  (non-manualized)  compared  to  a  different  type  of  TSF  for
alcohol  use  disorder  (2B);  Summary  of  findings  5  Alcoholics
Anonymous  (AA)/Twelve-Step  Facilitation  (TSF)  (manualized)
compared to other clinical interventions for alcohol use disorder:
non-randomized  studies  (3B);  Summary  of  findings  6  Alcoholics
Anonymous (AA)/Twelve-Step Facilitation (TSF) (non-manualized)
compared  to  a  different  type  of  TSF  for  alcohol  use  disorder:
non-randomized  studies  (4B);  Summary  of  findings  7  Alcoholics
Anonymous (AA)/Twelve-Step Facilitation (TSF) compared to other
clinical  interventions  and  a  different  type  of  TSF  for  alcohol  use
disorder: cost-effectiveness studies (5)

1a Studies that employed a RCT/quasi-RCT design with all
treatments manualized and compared AA/TSF to a treatment
with a different theoretical orientation (e.g. CBT)

We included 11 studies reported in 16 articles in this study grouping
(Brooks 2003; Brown 2002; Davis 2002; Kelly 2017b; Litt 2007; Litt
2016;  Lydecker  2010;  MATCH  1997;  McCrady  1996;  Walitzer  2009;
Walitzer  2015).  See  Summary  of  findings  1  for  a  summary  of  the
results for our main outcomes and certainty of evidence for each
result.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

27

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Abstinence

• 36 months (Tau2 = 0.00, P = 0.56; I2 = 0%).

Proportion of participants completely abstinent (continuous
abstinence)

Six studies with 2367 participants contributed data to this outcome
(Davis 2002; Kelly 2017b; Litt 2007; Litt 2016; MATCH 1997; McCrady
1996).

There  was  no  evidence  of  a  difference  for  AA/TSF  at  the  end  of
treatment  on  this  outcome  (risk  ratio  (RR)  1.07,  95%  confidence
interval (CI) 0.92 to 1.25; P = 0.37; 1 study, 1726 participants), but
there were advantages for AA/TSF at all of the other follow-up time
points (Analysis 1.1):

• 6 months: RR 1.66, 95% CI 1.09 to 2.54; P = 0.02; 3 studies, 238

participants;

• 12 months: RR 1.21, 95% CI 1.03 to 1.42; P = 0.02; 2 studies, 1936

participants;

• 24 months: RR 1.37, 95% CI 1.04 to 1.82; P = 0.03; 2 studies, 403

participants;

• 36 months: RR 1.42, 95% CI 1.17 to 1.73; P = 0.00; 1 study, 952

participants.

low
Formal  tests  of  between-study  heterogeneity 
probability of potential heterogeneity ranging from Tau2= 0.00, P
= 0.98; I2 = 0% at the six-month follow-up to Tau2= 0.01, P = 0.16;
I2 = 37% at the 12-month follow-up, suggesting consistency across
reported findings.

indicated 

The GRADE certainty rating for this evidence was high.

Percentage days abstinent

Nine studies, with 2818 participants, assessed this outcome (Davis
2002; Kelly 2017b; Litt 2007; Litt 2016; Lydecker 2010; MATCH 1997;
McCrady 1996; Walitzer 2009; Walitzer 2015), but we were only able
to meta-analyze data from eight of them.

AA/TSF showed a small to moderate advantage for this outcome,
but only at the 24-month (mean difference (MD) 12.91, 95% CI 7.55
to 18.27; P < 0.001; 2 studies, 302 participants); and 36-month (MD
6.64, 95% CI 1.54 to 11.75; P = 0.01; 1 study, 806 participants) time
points (Analysis 1.2). There was no evidence of a difference between
AA/TSF and comparison interventions at the remaining time points:

• end of treatment: MD 1.91, 95% CI -1.42 to 5.24; P = 0.26; 1 study,

1586 participants;

• 6 months: MD -1.21, 95% CI -10.82 to 8.41; P = 0.54; 3 studies, 191

participants;

• 12 months MD 3.03, 95% CI -4.36 to 10.43; P = 0.42; 4 studies, 1999

participants;

• 18 months MD -8.89, 95% CI -30.65 to 12.87; P = 0.38; 1 study; 58

participants.

Formal tests of between-study heterogeneity across points found
high  heterogeneity  at  the  12-month  follow-up  (Tau2=  100.00,  P  <
0.001P < 0.00001; I2 = 91%), but otherwise heterogeneity was very
low:

• 6 months (Tau2 = 0.00, P = 0.54; I2 = 0%);
• 18 months (Tau2 = 0.00, P = 0.86; I2 = 0%);
• 24 months (Tau2 = 0.00, P = 0.38; I2 = 0%);

We  excluded  one  study  (Davis  2002),  and  another  study  report
examining  end  of  treatment  outcome  (McCrady  1996),  from  the
meta-analysis  because  they  reported  the  proportion  of  days
of  alcohol  use  and  we  were  unable  to  calculate  the  standard
deviation.  However,  we  were  able  to  include  the  two  follow-up
reports at six and 18 months for McCrady 1996 (Analysis 1.2).

Also,  because  Walitzer  2009  compared  two  types  of  AA/TSF
interventions  (the  12-step  more 
intensive  and  prescriptive
directive  approach  to  facilitating  AA  (DIR)  and  the  12-step  less
intensive, client-centered, motivational enhancement approach to
facilitating AA (MOT)) to standard cognitive behavioral therapy (the
study authors referred to this as 'treatment as usual' (TAU), but it
was a manualized CBT intervention), we included the comparison
between  DIR  and  TAU  in  this  section  (because  this  comparison
is  comparing  an  AA/TSF  intervention  with  a  different  theoretical
orientation, i.e. CBT) and in section 2a below, we compare DIR to
MOT.

The  GRADE  certainty  rating  for  this  evidence  was  very  low;
we  downgraded  due  to  study  limitations,  inconsistency  and
imprecision.

Longest period of abstinence

Two  studies  with  a  total  of  136  participants  provided  data  for
this  outcome  (Davis  2002;  Kelly  2017b).  There  was  no  clear
difference  between  AA/TSF  and  comparison  interventions  at  6-
month  follow-up  (MD  0.60,  95%  CI  -0.30  to  1.50;  P  =  0.19;  2
studies,  136  participants;  very  low  certainty  evidence;  Analysis
1.3). Measurements of heterogeneity were moderate to substantial:
Tau2= 0.28, P = 0.12; I2 = 60%.

The  GRADE  certainty  rating  for  this  evidence  was  low;  we
downgraded due to study limitations, and imprecision.

Drinking intensity

Drinks per drinking day (DDD)

Five  studies,  with  2295  participants,  assessed  this  outcome  (Litt
2007; Litt 2016; MATCH 1997; McCrady 1996; Walitzer 2015).

AA/TSF  showed  a  small  advantage  on  this  outcome  at  the  36-
month  follow-up  only  (MD  -1.02,  95%  CI  -1.83  to  -0.21;  1  study,
806 participants; P = 0.01; Analysis 1.4). Formal tests of between-
study  heterogeneity  for  each  time  point  found  no  evidence  of
heterogeneity  between  study  groups,  and  ranged  from  very  low
(at the end of treatment, 24-month, and 36-month follow-ups) to
moderate at the 12-month follow-up (Tau2 = 0.29, P = 0.22, I2 = 32%).

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to study imprecision.

Percentage days heavy drinking (PDHD)

Three studies, with 452 participants, assessed this outcome: (Litt
2016;  McCrady  1996;  Walitzer  2009).  We  found  no  difference
between treatment interventions at any time point (Analysis 1.5).
Formal tests of between-study heterogeneity were only conducted
at the 6-month follow-up time point (Tau2= 0.00, P = 0.79, I2 = 0%).
The  other  time  points  only  had  one  study  each  that  contributed
data, and so we did not conduct any formal tests for heterogeneity.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

28

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

The GRADE certainty rating for the evidence at 12 month follow-up
was low; we downgraded two levels due to imprecision and wide
confidence interval.

Alcohol-related consequences

In  terms  of  alcohol-related  consequences,  six  studies  with  2433
participants (Kelly 2017b; Litt 2007; Litt 2016; MATCH 1997; Walitzer
2009; Walitzer 2015), and two additional reports (Litt 2007; MATCH
1997),  reported  this  outcome.  Six  of  these  studies  used  the
same standardized metric, the Drinker Inventory of Consequences
(DRINC), and thus, could be compared using meta-analysis. There
were  no  differences  on  this  measure  at  any  point  (Analysis  1.6).
Formal  tests  of  between-study  heterogeneity  for  each  time  point
found no evidence of heterogeneity between study groups.

Walitzer 2015 used the Short Inventory of Problems (SIP), and found
no  evidence  of  a  difference  between  the  AA/TSF  and  the  anger
management comparison intervention at the six-month follow-up
(MD  0.71,  95%  CI  -4.51  to  5.93;  P  =  0.79;  1  study,  76  participants;
Analysis  1.7).  Kelly  2017b  used  the  SIP  Second  Edition,  Revised
(SIP-2R)), and found a benefit in favor of AA/TSF compared to MET/
CBT at the six-month follow-up (MD -0.10, 95% CI -0.43 to 0.23; 1
study, 59 participants; P = 0.01; Analysis 1.8).

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to study imprecision.

Alcohol addiction severity

Two studies with 448 participants reported this outcome (Brooks
2003; Brown 2002). Brown 2002 found a difference on the Alcohol
Severity  Index  (ASI)  alcohol  composite  score  between  the  AA/
TSF and comparison interventions that favored AA/TSF (MD -0.05,
95% CI -0.09 to -0.01; P = 0.02; 1 study, 336 participants; Analysis
1.9).  Brooks  2003  found  an  advantage  for  AA/TSF  over  the  Self-
Management  and  Recovery  Training  (SMART)  intervention  in  the
slope for improvement over a 12-month follow-up period (Analysis
1.10), as measured by the ASI alcohol composite score (P < 0.05).

The  GRADE  certainty  rating  for  this  evidence  was  low;  we
downgraded  due  to  study  limitations  and  because  a  narrative
synthesis was conducted and therefore estimates are not precise.

Indices reflecting quality of life or psychological well-being, or
both

None of the studies in this category reported this outcome.

1b Studies that employed a RCT/quasi-RCT design where at
least one comparison treatment was non-manualized and AA/
TSF was compared to a treatment with a different theoretical
orientation (e.g. CBT)

included  four  studies 

in  this  category  (Blondell  2011;
We 
Bogenschutz  2014;  Bowen  2014;  Herman  2000).  See  Summary  of
findings 2 for a summary of the results for our main outcomes and
certainty of evidence for each result.

Abstinence

Cochrane Database of Systematic Reviews

month follow-up (RR 1.18, 95% CI 0.80 to 1.73; P = 0.41; 1 study, 126
participants; Analysis 2.1). Similarly, at the nine-month follow-up,
Bogenschutz  2014  observed  no  difference  between  interventions
(RR 1.71, 95% CI 0.70 to 4.18; P = 0.24; 1 study, 93 participants).

The  GRADE  certainty  rating  for  this  evidence  was  low;  we
downgraded two levels due to small sample size.

Percentage days abstinent (PDA)

Three studies reported this outcome (Blondell 2011; Bogenschutz
2014;  Herman  2000),  with  two  observing  no  difference  between
the  AA/TSF  and  comparison  interventions.  Blondell  2011  found
no  difference  between  AA/TSF  and  the  comparison  at  the  three-
month  follow-up  (MD  -3.94,  95%  CI  -14.73  to  6.85;  P  =  0.47;  1
study, 125 participants; Analysis 2.2). At the nine-month follow-up,
untransformed data from Bogenschutz 2014 showed a higher PDA
for AA/TSF than the comparison (MD 3.00, 95% CI 0.31 to 5.69; P =
0.03; 1 study, 93 participants).

Using  a  log-transformed  days  of  drinking  variable,  Herman  2000
found a slight advantage at two-months post-treatment (P = 0.03)
that favored AA/TSF relative to the comparison (Analysis 2.3), but
between two and 18 months post-treatment, there was no evidence
of a difference between the two groups (P = 0.05). The treatment by
time interaction was not reported.

The  GRADE  certainty  rating  for  this  evidence  was  low;  we
downgraded two levels due to small sample size.

Longest period of abstinence

None of the studies in this category reported this outcome.

Drinking intensity

Bogenschutz 2014, using the untransformed measure of drinks per
drinking day (DDD), found an advantage for AA/TSF compared to the
comparison at the nine-month follow-up (MD -1.76, 95% CI -2.23 to
-1.29; P < 0.001;1 study, 93 participants; Analysis 2.4).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded  due  to  study  limitations  (risk  of  attrition  bias);
imprecision  (moderate  sample  size);  and  indirectness  (the  focus
was  on  dual  diagnosis  participants  with  severe  mental  illness,
which may not be the population of interest most often associated
with AA/TSF).

Bowen 2014 reported heavy drinking days in the past 90 days, and
found no difference between treatments (MD 2.09, 95% CI -1.24 to
5.42; P = 0.22; 1 study, 286 participants; Analysis 2.5).

The  GRADE  certainty  rating  for  this  evidence  was  low;  we
downgraded due to imprecision (moderate sample size) and due
to study limitations (having no reported information to assess four
different types of bias).

Alcohol-related consequences

None of the studies in this category reported this outcome.

Proportion of participants completely abstinent

Alcohol addiction severity

Two studies with 271 participants reported this outcome (Blondell
2011;  Bogenschutz  2014).  Blondell  2011  found  no  difference
between  AA/TSF  and  the  comparison  intervention  at  the  three-

None of the studies in this category reported this outcome.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

29

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Indices reflecting quality of life or psychological well-being, or
both

None of the studies in this category reported this outcome.

2a Studies that employed a RCT/quasi-RCT design with
all treatments manualized and AA/TSF was compared to a
different type of TSF (i.e. varying in TSF style or intensity)

We  included  five  studies  reported  in  six  papers  in  this  category
(Kahler  2004;  Timko  2006;  Timko  2011;  Vederhus  2014;  Walitzer
2009). See Summary of findings 3 for a summary of the results for
our main outcomes and certainty of evidence for each result.

Abstinence

Proportion of participants completely abstinent

Three  studies  with  772  participants  reported  the  proportion
of  participants  completely  abstinent  (Timko  2006;  Timko  2011;
Vederhus 2014). There were no differences at the six-month follow-
up (RR 1.07, 95% CI 0.96 to 1.18; P = 0.23; 3 studies, 772 participants;
Analysis  3.1),  or  the  12-month  follow-up  (RR  1.28,  95%  CI  1.00  to
1.63; P = 0.05; 1 study, 307 participants; Analysis 3.1). We conducted
formal tests of between-study heterogeneity only for the six-month
follow-up, for which there was a low probability of heterogeneity
(Tau2 = 0.00, P = 0.55; I2 = 0%). We did not test for heterogeneity at
the 12-month follow-up, as only one study contributed data to that
time point.

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to imprecision (moderate to small sample).

Percentage days abstinent (PDA)

Two  studies  reported  data  for  PDA  (Kahler  2004;  Walitzer  2009).
Kahler 2004 found no difference in PDA at the six-month follow-up
(MD -5.50, 95% CI -25.35 to 14.35; P = 0.59; 1 study, 42 participants;
Analysis  3.2),  and  Walitzer  2009  found  an  advantage  for  AA/TSF
compared to the comparison at 12-month follow-up (MD 16.40, 95%
CI 5.12 to 27.68; P = 0.004; 1 study, 95 participants; Analysis 3.2).

Two  studies  reported  on  days  of  alcohol  use  at  the  six-month
follow-up  (Timko  2011;  Vederhus  2014),  and  found  no  difference
between the more and less intensive AA/TSF interventions studied
(MD -1.93, 95% CI -4.55 to 0.69; P = 0.15; 2 studies, 427 participants;
Analysis 3.3).

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to imprecision (small sample).

Longest period of abstinence

None of the studies in this category reported this outcome.

Drinking intensity

Kahler 2004 found no difference between interventions for drinks
per drinking day (DDD) (MD -4.10, 95% CI -10.44 to 2.24; P = 0.21; 1
study, 42 participants; Analysis 3.4).

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to imprecision (small sample).

Alcohol-related consequences

None of the studies in this category reported this outcome.

Cochrane Database of Systematic Reviews

Alcohol addiction severity

Two  studies  reported  in  three  papers  reported  alcohol  addiction
severity  using  the  ASI  (Timko  2006;  Timko  2011).  There  was
no  difference  between  the  more  and  less  intensive  AA/TSF
interventions at the six-month follow-up (MD 0.03, 95% CI -0.07 to
0.13; P = 0.53; 2 studies, 690 participants; Analysis 3.5), but there
was an advantage for the more intensive AA/TSF intervention at the
12-month follow-up (MD 0.08, 95% CI 0.02 to 0.15; P = 0.01; 1 study,
307 participants; Analysis 3.5).

Vederhus  2014  assessed  alcohol  addiction  severity  using  the
European  version  of  the  ASI  (EuropASI).  Using  the  raw  means
and  SDs  from  the  study,  showed  an  advantage  for  the  more
intensive AA/TSF intervention compared to the less intensive AA/
TSF intervention (MD -0.07, 95% CI -0.08 to -0.06; P < 0.001; 1 study,
113 participants; Analysis 3.6).

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to imprecision (small sample).

Indices reflecting quality of life and/or psychological well-being

None of the studies in this category reported this outcome.

2b Studies that employed a RCT/quasi-RCT design where at
least one comparison treatment was non-manualized and AA/
TSF was compared to a different type of TSF (i.e. varying in TSF
style or intensity)

We included two studies in this category (Kaskutas 2009b; Manning
2012). See Summary of findings 4 for a summary of the results for
our main outcomes and certainty of evidence for each result.

Abstinence

Proportion of participants completely abstinent

Kaskutas 2009b found that the more intensive AA/TSF intervention
had a higher proportion of participants abstinent at the 12-month
follow-up compared to the less intensive AA/TSF intervention (RR
1.15, 95% CI 1.02 to 1.29; P = 0.02; 1 study, 382 participants; Analysis
4.1).  The  Manning  2012  study  reported  data  for  the  three-month
follow-up only, and found no difference between interventions (RR
1.16, 95% CI 0.76 to 1.79; P = 0.49; 1 study, 126 participants).

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded  due  to  study  limitations  (risk  of  random  sequence
generation, allocation concealment, and attrition bias).

Drinking intensity

Neither of the studies in this category reported this outcome.

Alcohol-related consequences

Neither of the studies in this category reported this outcome.

Alcohol addiction severity

Neither of the studies in this category reported this outcome.

Indices reflecting quality of life and/or psychological well-being

Neither of the studies in this category reported this outcome.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

30

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

3a Studies that employed a non-randomized design with all
treatments manualized and where AA/TSF was compared to a
different theoretical orientation (e.g. CBT)

We did not include any studies in this category.

3b Studies that employed a non-randomized design with at
least one non-manualized treatment intervention and where
AA/TSF was compared to a different theoretical treatment
orientation (e.g. CBT)

We  included  four  studies,  reported  in  six  papers,  in  this  category
(Blondell  2001;  Humphreys  1996;  Ouimette  1997;  Zemore  2018).
See Summary of findings 5 for a summary of the results for our main
outcomes and certainty of evidence for each result.

Abstinence

Proportion of participants completely abstinent

Three  studies  with  3979  participants  assessed  this  outcome
(Blondell  2001;  Ouimette  1997;  Zemore  2018).  Of  note,  because
Ouimette  1997  compared  two  types  of  AA/TSF  interventions  (the
purer '12-step' intensive inpatient model and the 'eclectic' AA/TSF-
CBT hybrid inpatient model) and a standard inpatient CBT model
('C-B'), we include here the comparison between 12-step and CBT
(because  this  comparison  compares  an  AA/TSF  intervention  with
a different theoretical orientation - CBT) and in section 4b, below,
we  compare  the  12-step  model  to  the  eclectic  intervention  since
these are two AA/TSF variants. All of these studies favored the AA/
TSF intervention at all three follow-up times: six months (RR 1.50,
95% CI 1.16 to 1.92; P = 0.002; 1 study, 314 participants; Analysis 5.1);
12 months (RR 1.25, 95% CI 1.09 to 1.43; P = 0.002; 2 studies, 2692
participants; Analysis 5.1); and 24 months (RR 1.34, 95% CI 1.20 to
1.49; P < 0.001; 1 study, 1774 participants; Analysis 5.1). Formal tests
of between-study heterogeneity indicated very low probability of
heterogeneity at the six-month follow-up (Tau2 = 0.00, P = 0.46, I2 =
0%) and a moderate probability of heterogeneity at the 12-month
follow-up (Tau2 = 0.01, P = 0.14, I2 = 46%).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded because of study limitations (lack of control of sample
selection and non-randomized nature of the study).

Percentage days abstinent

None of the studies in this category reported this outcome.

Cochrane Database of Systematic Reviews

Alcohol-related consequences

Two  studies  reported  this  outcome  (Humphreys  1996;  Zemore
2018). Zemore 2018 found no difference at the 12-month follow-up
(MD -0.71, 95% CI -1.68 to 0.27; P = 0.15; 1 study, 647 participants;
Analysis 5.3). Similarly, Humphreys 1996 found no difference at the
36-month follow-up (MD 0.20, 95% CI -1.34 to 1.74; P = 0.80; 1 study,
201 participants; Analysis 5.4).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;
we  downgraded  due  to  study  limitations  (lack  of  control  of
sample  selection  and  non-randomized  nature  of  the  study);  and
indirectness (comparability of cohorts for baseline characteristics
and outcome measures, and protection against contamination).

Alcohol addiction severity

Just one study reported alcohol addiction severity in this category;
Humphreys 1996 used the Alcohol Dependence Scale, and found no
difference between interventions (MD -0.30, 95% CI -2.20 to 1.60; P
= 0.76; 1 study, 201 participants; Analysis 5.5).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded  due  to  imprecision  (moderate  sample  size)  and
indirectness (comparability of cohorts for baseline characteristics
and outcome measures, and protection against contamination).

Indices reflecting quality of life or psychological well-being, or
both

None of the studies in this category reported this outcome.

4a Studies that employed a non-randomized design with all
treatments manualized and where AA/TSF was compared to a
different type of TSF (i.e. varying in style or intensity)

We did not include any studies in this category.

4b Studies that employed a non-randomized design with at
least one non-manualized treatment intervention and where
AA/TSF was compared to a different TSF variant (i.e. in varying
in TSF style or intensity)

We included two studies, reported in four papers, in this category
(Grant  2018;  Ouimette  1997).  See  Summary  of  findings  6  for  a
summary  of  the  results  for  our  main  outcomes  and  certainty  of
evidence for each result.

Longest period of abstinence

Abstinence

None of the studies in this category reported this outcome.

Proportion of participants completely abstinent

Drinking intensity

Just one study in this category reported drinking intensity in terms
of  drinks  per  drinking  day  (DDD)  (Humphreys  1996),  which  were
calculated  from  ounces  of  pure  ethanol  consumed  (based  on  a
standard USA drink of 14 g/drink) and found no difference between
interventions at 36-month follow-up (MD 0.00, 95% CI -3.38 to 3.38;
P = 1.00; 1 study, 201 participants; Analysis 5.2).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded  due  to  imprecision  (moderate  sample  size)  and
indirectness (comparability of cohorts for baseline characteristics
and outcome measures, and protection against contamination).

At  six-month  follow-up  Grant  2018  found  no  difference  between
interventions (RR 1.01, 95% CI 0.86 to 1.19; P = 0.90; 1 study, 140
participants), and at the 12-month follow-up Ouimette 1997 found
an  advantage  for  the  more  intensive  12-step-oriented  treatment
(RR 1.24, 95% CI 1.05 to 1.46; P = 0.01; 1 study, 1870 participants;
Analysis 6.1).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded due to study limitations (risk of attrition bias).

Percentage days abstinent

Only  the  Grant  2018  study  reported  this  outcome  and  found  no
difference between interventions (MD -0.01, 95% CI -7.14 to 7.12; P
= 1.00; 1 study, 140 participants; Analysis 6.2).

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

31

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded due to study limitations (risk of attrition bias) and due
to imprecision (moderate sample size).

Longest period of abstinence

None of the studies in this category reported this outcome.

Drinking intensity

As shown in Analysis 6.3, only the Grant 2018 study reported this
outcome, and only at six-month follow-up. It should be noted that
this  study  reported  drinks  per  drinking  day  (DDD)  only  for  those
participants  who  were  not  abstinent  during  the  follow-up  period
(25 participants) and found no difference in DDD between the rural-
adapted  intensive  referral  (RAIR)  (mean  17.63,  SD  23.71)  and  the
standard referral (SR) (mean 11.47, SD 5.94), P = 0.49.

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded due to study limitations (risk of attrition bias) and due
to imprecision (moderate sample size). We conducted a narrative
synthesis and therefore estimates are not precise.

Alcohol-related consequences

None of the studies in this category reported this outcome.

Alcohol addiction severity

Grant 2018 was the only study to report this outcome, measured
with ASI-Lite, and found no difference between interventions (MD
0.01, 95% CI -0.05 to 0.07; P = 0.74; 1 study, 140 participants; Analysis
6.4).

The  GRADE  certainty  rating  for  this  evidence  was  very  low;  we
downgraded due to study limitations (risk of attrition bias) and due
to imprecision (moderate sample size).

Indices reflecting quality of life and/or psychological well-being

None of the studies in this category reported this outcome.

5 Economic analysis studies (e.g. healthcare cost offset)

As noted previously, given that AA/TSF interventions attempt to link
people  with  AUD  to  freely  available  AA  meetings,  and  that  other
individuals may go directly to AA instead of pursuing professionally-
provided  treatment,  an  important  consideration  is  the  extent  to
which participation in such meetings can help reduce healthcare
costs  by  reducing  reliance  on  more  expensive,  professionally-
delivered  treatments  in  favor  of  the  peer-led  AA  groups.  We
included  five  reports  relating  to  four  studies  (1  RCT/quasi-RCT,
and 3 non-randomised) with 2657 participants that addressed the
potential healthcare cost offset from AA participation (Humphreys
1996; Holder 2000 (from the MATCH 1997 study); Humphreys 2001
and Humphreys 2007 (from the Mundt 2012 study); Ouimette 1997).
See Summary of findings 7 for a summary of the results for our main
outcomes and certainty of evidence for each result.

The  GRADE  certainty  rating  for  this  evidence  was  moderate;  we
downgraded due to random sequence generation bias, problems
with comparability of cohorts at baseline; and protection against
contamination between study interventions.

Cochrane Database of Systematic Reviews

Methodological quality

In keeping with the Cochrane recommendations for appraising the
methodological  quality  of  economic  studies  (Shemilt  2011b),  we
evaluated  each  of  the  four  primary  economic  studies  using  a  19-
item  checklist  to  assess  study  quality  (Evers  2005).  Overall,  we
deemed the four studies to be of high quality given that they met
between 16 and 18 of the 19 criteria used in the checklist to appraise
quality (see Table 3).

Healthcare cost savings

Three  out  of  the  four  included  studies  in  this  category  (4  out  of
5  reports;  Humphreys  1996;  Humphreys  2001;  Humphreys  2007;
Ouimette 1997) found an important healthcare cost saving in favor
of the AA/TSF intervention. Humphreys 1996 found that at baseline,
the  AA  group  had  a  worse  prognosis,  as  characterized  by  lower
income,  less  education,  and  more  adverse  consequences  from
alcohol use than did individuals entering professionally-provided
outpatient  treatment.  Despite  this,  across  the  three-year  follow-
up period, AA participants had alcohol-related outcomes similar to
the outpatient treatment group. Furthermore, the treatment costs
for  the  AA  group  were  45%  lower  than  the  outpatient  group,  at
USD  1826  less  per  person  based  on  1994  US  dollars  (equivalent
to  USD  2856  in  2018  US  dollars).  In  the  Ouimette  1997  study,
Humphreys  2001  found  that  compared  with  inpatients  in  CBT
programs, inpatients in AA/TSF programs had greater involvement
in  AA  self-help  groups  at  post-treatment  follow-up.  In  contrast,
participants  treated  in  CBT  programs  averaged  almost  twice  as
many outpatient continuing care visits after discharge (22.5 visits)
as participants treated in 12-step treatment programs (13.1 visits),
and  also  received  more  days  of  inpatient  care  (17.0  days  in  CBT
versus  10.5  in  12-step),  resulting  in  64%  higher  annual  costs  for
the participants initially treated in the CBT programs, or USD 4729
per patient (equivalent to USD 7128 in 2018 US dollars; P = 0.001).
Psychiatric and substance use outcomes were comparable across
treatments,  except  that  AA/TSF  participants  had  higher  rates  of
abstinence at follow-up (45.7% versus 36.2% for participants from
CBT programs; P = 0.001). Similarly, in a subsequent analysis of the
two-year  outcomes  and  healthcare  costs,  participants  initially  in
the CBT programs relied more on outpatient and inpatient mental
health  services,  leading  to  30%  lower  costs  among  participants
initially in the AA/TSF treatment programs. The two-year follow-up
notably  showed  that  in  the  previous  12  months  costs  for  AA/TSF
participants had been reduced by USD 2440 per patient (equivalent
to USD 3678 in 2018 US dollars; P = 0.01).

Mundt 2012 found that for each additional 12-step group meeting
attended,  there  was  an  observed  incremental  medical  cost
reduction  of  4.7%  during  the  seven-year  follow-up.  The  medical
cost  offset  was  largely  due  to  reductions  in  hospital  inpatient
days,  psychiatric  visits,  and  alcohol  and  other  drug  treatment
costs  culminating  in  an  estimated  total  medical  use  cost  savings
of  USD  145  for  each  12-step  meeting  attended  per  year  (USD
180  in  2018  dollars).  In  the  MATCH  1997  study,  Holder  2000
identified  substantial  medical  cost  savings  during  treatment  and
across  follow-up;  the  mean  estimated  monthly  post-treatment
costs  for  the  three  treatments  (MET,  CBT,  AA/TSF)  ranged  from
a  low  of  USD  254  (MET)  to  a  high  of  USD  315  (CBT)  with
AA/TSF  in  between  (USD  310)  (P  =  0.13).  The  total  medical
care  costs  declined  from  pre-  to  post-treatment  overall  and  for
each modality. Although matching effects independent of clinical
prognosis  in  the  analysis  showed  that  MET  had  potential  for

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

32

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

medical  care  cost  savings,  this  was  not  the  case  once  clinical
prognosis indicators were included. Specifically, participants with
poor prognostic characteristics (greater alcohol addiction severity,
psychiatric severity and/or social network support favoring alcohol
use) had better cost savings potential with CBT or TSF, or both, than
with MET.

D I S C U S S I O N

Summary of main results

The  current  review  demonstrates  that  Alcoholics  Anonymous/
Twelve-Step  Facilitation  (AA/TSF) 
is  superior  to  other  well-
established  treatments  when  it  comes  to  increasing  abstinence,
and  is  at  least  as  effective  as  other  well-established  treatments
for other alcohol-related outcomes such as drinking consequences,
drinking intensity, and addiction severity. AA/TSF also appears to
produce important healthcare cost offsets. The benefits of AA and
TSF were observed in rigorous trials, as well as less rigorous, non-
randomized studies. Although AA/TSF was not consistently superior
when  compared  to  well-established  treatments  or  less-intensive
TSF, it was at least as helpful for reducing the intensity of drinking
and  alcohol-related  consequences,  and  in  lowering  severity  of
alcohol  addiction.  In  addition,  when  different  types  of  TSF
interventions  were  tested  against  each  other,  the  more  intensive
TSF  interventions  (e.g.  those  that  include  actively  prescribing
AA  participation  and  ongoing  monitoring  of  AA  attendance  and
related  experiences;  personal  linkages  to  existing  AA  members)
often worked better at improving drinking-related outcomes than
the  'treatment  as  usual  (TAU)  TSF'  intervention.  This  suggests
that although many treatment professionals may believe that they
"already do 12-step" (i.e. implement TSF strategies) because they
hand out 12-step literature or mention 12-step groups to patients,
this  alone  may  not  be  sufficient  to  achieve  a  superior  benefit
(Kelly  2013c).  The  types  of  TSF  strategies  used  matter,  and  the
more intensive strategies, such as those evaluated herein, enhance
participation  rates  and  outcomes  compared  to  the  more  routine
12-step-oriented  TAU.  Some  of  these  strategies  could  be  clinical
linkage  to  existing  members  (e.g.  Manning  2012;  Timko  2006),
or  active  prescription  of  attendance  versus  leaving  it  to  people
to  decide  for  themselves  whether  they  want  to  attend  AA  (e.g.
Walitzer 2009). It is worth noting that, because many participants
in  these  studies  assigned  to  non-TSF  interventions  still  elected
to  attend  AA  (participation  in  which  is  correlated  with  better
outcomes),  the  positive  effects  of  AA/TSF  interventions,  where
observed, are likely to be conservative. Also, as detailed below, the
reason why AA/TSF outperforms other well-established treatments
is because it successfully links people to a free, ubiquitous, long-
term  recovery,  peer  support  organization  (i.e.  AA)  that,  in  turn,
mobilizes  other  therapeutic  mechanisms  -  such  as  increasing
relapse prevention coping skills, abstinence self-efficacy, recovery
motivation, and reducing craving and impulsivity - and facilitates
recovery-supportive  changes  in  people's  social  networks  (Kelly
2009b; Kelly 2017a).

Overall completeness and applicability of evidence

Follow-up  after  intervention  ranged  from  three  to  60  months,
with  a  modal  length  of  12  months  (see  Table  1).  On  the  whole,
study samples were quite large and adequately powered to detect
effects.  However,  sample  sizes  were  highly  variable  and  skewed
across  studies,  ranging  from  a  low  of  48  participants  in  Kahler
2004  to  a  high  of  3018  in  Ouimette  1997,  with  an  average  of

Cochrane Database of Systematic Reviews

400  participants  per  study  (mean  406.4;  SD  616.2;  median  201).
Measurement in the included studies comprised psychometrically
validated assessment tools.

Overall, the review found that in scientifically rigorous, randomized
controlled  trials  (RCTs)  that  compared  AA/TSF  to  interventions
of  a  different  theoretical  orientation  (e.g.  cognitive  behavioral
therapy  (CBT),  motivational  enhancement  therapy  (MET)),  where
all  treatments  were  manualized  and  delivered  with  high  degrees
of  objectively  rated  clinical  fidelity,  AA/TSF  interventions  most
often produced increased rates of continuous abstinence of large
magnitude compared to interventions such as CBT and MET, which
many  people  have  considered  to  be  state-of-the-art  behavioral
interventions  for  alcohol  use  disorder  (AUD).  For  instance,  in
MATCH  1997  the  proportion  of  participants  completely  abstinent
throughout the entire first year following the intervention among
outpatients  who  were  assigned  to  the  AA/TSF  intervention  was
24%,  whereas  15%  and  14%  of  participants  assigned  to  CBT
and  MET,  respectively,  were  completely  abstinent  during  that
timeframe.  This  reflects  an  absolute  advantage  of  9  percentage
points  in  favor  of  AA/TSF,  and  a  relative  advantage  for  AA/TSF
compared to CBT of 60% in the number of participants completely
abstinent, and when compared to MET, reflects an increase of 64%
in  the  number  of  participants  completely  abstinent.  This  pattern
of  relative  advantage  for  AA/TSF  interventions  on  this  outcome
appeared quite consistent across both RCTs/quasi-RCTs and non-
randomized studies.

Also,  although  the  magnitude  was  not  as  large,  the  average
percentage  of  days  on  which  participants  were  abstinent  (PDA),
tended  to  show  an  advantage  in  favor  of  AA/TSF  interventions,
especially  in  the  more  rigorous  RCTs  with  manualized  therapies
compared  to  other  active  treatment  orientations  (e.g.  CBTs),  but
studies involving young people (Kelly 2017b), and couples therapy
(McCrady 1996), showed equivalence, but not advantages for PDA.
Also  of  note,  one  study  with  dual  diagnosis  participants  in  the
Veterans  Administration  (VA)  healthcare  system  (Lydecker  2010),
found a disadvantage for PDA with AA/TSF. This may be because,
although  participants  met  criteria  for  AUD,  the  primary  problem
was  mood  disorder  as  opposed  to  AUD,  which  may  represent  a
poorer fit with AA (Kelly 2003a). That said, a recent meta-analysis
by  Tonigan  2018  found  fairly  consistent  abstinence  benefits  from
participation  in  AA  by  dually-diagnosed  individuals.  Thus,  it  is
currently  not  clear  why  the  Lydecker  2010  study  did  not  find
benefits,  but  similar  to  the  Kelly  2003a  findings,  it  may  relate  to
the specific treatment of severe major depression in particular, or
perhaps idiosyncrasies related to military veterans, or being treated
in the VA healthcare system. More work is needed to clarify this.

For measures of intensity of drinking, AA/TSF most often performed
as  well  as  comparison  interventions.  This  is,  perhaps,  surprising
given that the major focus of AA/TSF interventions is on complete
abstinence,  rather  than  reductions  in  intensity,  which  may  be  of
a focus in CBT-oriented relapse prevention interventions. Of note,
however, was that despite a greater relative emphasis on reducing
the intensity of any drinking that might occur in CBT interventions
(e.g. through a focus on coping with the abstinence violation effect)
in  no  case  did  AA/TSF  fare  worse  on  this  outcome,  and,  where
there were differences, AA/TSF showed an advantage. Consquently,
these  findings  do  not  support  the  once-popular  theory  that  by
emphasizing  the  uncontrollability  of  alcohol  consumption  (i.e.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

33

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

'powerlessness' over alcohol), AA creates an abstinence violation
effect that makes the relapses more severe (Marlatt 1985).

In terms of reductions in alcohol-related consequences and alcohol
addiction  severity,  AA/TSF  most  often  did  as  well  as  comparison
treatments. Notably, however, three out of four of the TSF variant
studies, reflected advantages for more intensive AA/TSF procedures
versus  less  intensive  AA/TSF  procedures  (Brown  2002;  Timko
2006; Vederhus 2014), suggesting that better articulated and more
intensive  TSF  strategies  (e.g.  peer  linkage)  may  produce  better
results for these outcomes.

Importantly,  when  compared  to  TAU  AA/TSF  interventions,  the
Timko 2006 and Kaskutas 2009b studies both showed advantages
for  the  more  intensive  AA/TSF.  This  suggests  the  potential
importance  of  not  just  recommending  and  referring  people  to
AA,  but  of  being  strategic  and  deliberate  in  the  methods  used
to  get  patients  connected  with  AA.  Methods  highlighted  in  these
studies, indicate those strategies (i.e. direct linkage to existing AA
members;  explicit  focus  on  the  major  elements  of  AA  meetings,
sponsorship, and referral with clinical monitoring and discussion
of  AA  participation  during  the  active  AA/TSF  clinical  treatment)
were  clinically  superior.  Notably,  in  the  Walitzer  2009  study
the  more  directive  style  of  TSF  was  superior  to  the  client-
centered motivational interviewing style of TSF, for increasing AA
engagement  and  enhancing  clinical  alcohol  use  outcomes.  Thus,
while motivational interviewing styles are popular, people may be
more likely to have better outcomes if AA participation is actively
prescribed,  recommended,  and  monitored,  by  clinicians,  rather
than left for the patient alone to consider and decide. Furthermore,
when compared to the eclectic/TSF interventions in the Ouimette
1997 study, the purer, more intensive,TSF treatment was superior
for increasing complete abstinence among participants. This was
also  the  case  for  the  Litt  2007  study,  which  found  a  AA/TSF
advantage  for  the  continuous  abstinence  and  PDA  outcomes
that  was  not  enhanced  by  adding  contingency  management.
This  suggests  that  keeping  an  undiluted  and  consistent  central
theoretical  focus  could  yield  better  clinical  dividends  than  a
combination or 'kitchen sink' approach that attempts to include the
'best of' other interventions. That said, more research is needed in
this regard, because when the Walitzer 2009 study combined TSF
and CBT approaches (using a more directive and prescriptive AA/
TSF style), it outperformed the two comparison interventions (CBT
alone and CBT with a motivational interviewing-TSF style).

The economic analyses found benefits in favor of AA/TSF compared
to outpatient treatment, and CBT interventions. The magnitude of
these benefits can be sizeable. For example, the economic analysis
of  the  Ouimette  1997  study  (Humphreys  2001  and  Humphreys
2007) found that, in addition to increasing abstinence rates, AA/TSF
interventions were able to reduce the mental health and substance
use related healthcare costs over the next two years by over USD
10,000 per patient (when 1994 figures are converted to 2018 USD)
compared to CBT interventions delivered in residential VA settings.
More than one million people are treated for AUD in the USA every
year  and  reducing  each  of  their  healthcare  costs  by  this  amount
would  produce  an  enormous  aggregate  economic  saving  (more
than USD 10 billion in the US alone), as well as improving clinical
outcomes.

The goal of TSF is to stimulate AA participation during and following
treatment,  but  TSF  itself  is  not  AA.  The  theoretical  causal  chain
that  may  underlie  the  advantage  of  TSF  clinical  interventions

Cochrane Database of Systematic Reviews

is  that  AA/TSF  leads  to  higher  abstinence  rates  via  its  strong
ability  to  get  people  with  AUD  involved  in  AA  (Kelly  2009b;  Kelly
2017a;  Litt  2007;  Longabaugh  1998;  MATCH  2001;  Walitzer  2009).
Several studies, including two comparative clinical trials that were
included in the current review, have examined this. In these, use
of appropriate temporally-lagged mediational analyses supported
a causal chain in which TSF led to higher AA participation, which
subsequently led to better alcohol use outcomes (Litt 2007; Walitzer
2009).  Specifically,  the  Litt  2007  study  found  post-treatment  AA
attendance  partially  mediated  the  effect  of  the  TSF  Network
Support treatment on PDA (particularly post-treatment PDA), and
Walitzer  2009  found  that  AA  involvement  during  treatment  and
at  six-month  follow-up  increased  subsequent  PDA.  Such  studies
demonstrate  that  TSF  is  able  to  increase  AA  participation  and  by
doing so, AA leads to better alcohol use outcomes.

The  lack  of  reporting  of  any  outcomes  regarding  quality  of  life,
functioning, or psychological well-being was noteworthy.

Certainty of the evidence

The certainty of the evidence in this review was generally appraised
as very low to high using the GRADE rating system (Schunemann
2013).  This  was  driven  by  the  rigor  of  the  included  studies.
Specifically,  both  RCTs/quasi-RCTs  and  non-randomized  studies
were  permissible  as  long  as  they  met  the  other  inclusion  criteria
(e.g. had a comparison intervention). Consequently, by default, we
generally judged the evidence of non-randomized studies (of which
there  were  5  of  27)  to  be  of  low  certainty  (as  recommended  by
the  GRADE  system),  while  we  judged  RCTs/quasi-RCTs  generally
to  be  of  higher  certainty.  There  was  some  inconsistency  in  the
evidence across studies that could be due to variation in the clinical
characteristics of the samples used, follow-up time points, error in
memory recall for certain outcomes, and differences in intervention
durations,  or  therapist  effects.  There  were  some  small  sample
sizes and larger variability around mean estimates of the longest
periods of abstinence, and high variability around mean estimates
of DDD. Although we observed heterogeneity in the magnitude of
the  effects  for  AA/TSF  in  comparison  to  other  treatments  or  TSF
variants, the direction of the findings in almost every case was in
the  same  direction,  with  AA/TSF  doing  as  well  as,  or  better  than,
comparison interventions. There was only one instance where this
was  not  the  case,  as  detailed  above  in  the  results  section  (i.e.
Lydecker 2010).

Potential biases in the review process

AA/TSF  and  comparison  interventions  varied  substantially  in
duration, 
intensity,  style,  theoretical  orientation,  degree  of
manualization, and content. Potential biases may have arisen due
to the decision to pool data from this wide range of studies. This mix
of  interventions,  whilst  not  necessarily  impacting  the  amount  of
statistical variation between the results of the studies, does reflect
a high degree of heterogeneity which can affect generalizability of
the findings.

We  were  not  able  to  perform  an  analysis  of  publication  bias,  but
consider it unlikely that we missed any high quality studies. Also,
in some instances not all relevant information could be obtained,
and in terms of at least some of the bias ratings, such as reporting
bias, they can be difficult to assess and thus, some aspects of these
ratings  remain  unclear.  Despite  this,  the  bias  across  the  multiple
dimensions  was  low  in  the  RCTs/quasi-RCTs,  and  increased  as

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

34

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

expected  in  the  non-randomized  studies  (Figure  4).  Two  studies
focused  on  young  people  (Kelly  2017b;  Mundt  2012),  but  were
included  despite  having  some  participants  under  the  age  of  18
years old at study onset, because the majority (as in Kelly 2017b), or
all of the participants (as in Mundt 2012), were 18 years old or older
during the follow-up periods. (Including or omitting these studies
from the review, did not alter the pattern of findings.) It is worth
noting that most of the studies were conducted in the USA, where
AA  originated  and  is  widely  available.  The  extent  to  which  these
results are generalizable across other cultures where AA may be less
readily available is not clear. Also, studies are needed to determine
if there are ethnic or racial differences in the benefits derived from
AA/TSF within different societies.

analyses indicate that the reason for this benefit is due to the ability
of  the  AA/TSF  to  increase  AA  participation,  and  thereby  increase
abstinence rates. Thus, a relatively brief clinical intervention (AA/
TSF) can help people with AUD to become engaged in a long-term,
freely available, community-based, recovery support resource that
can help them sustain ongoing remission.

If people with AUD are opposed to attending AA, despite the strong
evidence for its potential to aid recovery, clinicians might consider
linkage to alternative mutual-help organizations as they may confer
benefits at similar levels of engagement. Alternatives might also be
considered when a patient has made a sustained effort to engage
AA, but not derived sufficient benefit from it.

Agreements and disagreements with other studies or
reviews

The  evidence  contained  in  this  review  is  similar  to,  and  extends
that of the prior Cochrane Review (Ferri 2006b), which this review
updates  and  replaces,  as  well  as  of  other  narrative  reviews
which  found  overall  positive  effects  for  AA/TSF  interventions
(e.g.  Kaskutas  2009a;  Kelly  2003b).  The  results  presented  in
this  review  are  also  supported  by  other  published  analyses.
One  study  from  Project  MATCH  (Longabaugh  1998),  found  that
regardless  of  whether  outpatients'  pre-treatment  network  was
supportive  or  unsupportive  of  alcohol  use  at  treatment  intake,
AA/TSF  participants  were  more  likely  to  be  involved  with  AA,
which in turn, subsequently explained the observed lower drinks
per  drinking  day  (DDD)  and  greater  PDA  advantages  for  TSF-
treated participants observed at the 36-month follow-up. The prior
Cochrane  Review  contained  eight  studies  with  3417  participants
(Ferri 2006b), and found that on the whole, AA/TSF interventions
were as effective, but not more effective, than the interventions to
which they were compared. This new review is based on 27 studies
reported in 36 articles and has a total of 10,565 participants. It is
considerably  larger,  comprises  more  rigorous  studies,  and  found
that, compared to other active psychosocial interventions for AUD,
AA/TSF  interventions  often  produce  greater  abstinence  -  notably
continuous  abstinence  -  as  well  as  some  reductions  in  drinking
intensity,  fewer  alcohol-related  consequences,  and  lower  alcohol
addiction  severity.  This  review  also  included  economic  analyses,
which  augments  prior  reviews  and  adds  important  information
regarding the cost-benefits of providing AA/TSF in clinical settings.

A U T H O R S '   C O N C L U S I O N S

Implications for practice

The  evidence  suggests  that  compared  to  other  well-established
treatments,  clinical  linkage  using  well-articulated  Twelve-Step
Facilitation  (TSF)  manualized  interventions  intended  to  increase
Alcoholics  Anonymous  (AA)  participation  during  and  following
alcohol  use  disorder  (AUD)  treatment  probably  will  lead  to
enhanced abstinence outcomes over the next few months and for
up  to  three  years.  Findings  also  indicate  AA/TSF  may  perform  as
well as other clinical interventions for drinking intensity outcomes;
however, these results are based largely on low certainty evidence
and so should be regarded with caution.

Economic  analyses  suggest  probable  substantial  healthcare  cost
savings can be obtained when treatment programs proactively and
systematically  link  people  with  AUD  to  AA  using  TSF  strategies,
such  as  those  used  in  the  studies  included  in  this  review.  The

Implications for research

Since the publication of the National Institutes of Health-sponsored
AA research monograph summarizing the research on AA up until
the  early  1990s  (McCrady  1993),  numerous  RCTs/quasi-RCTs  and
well-controlled  comparative  non-randomized  studies  have  been
conducted  using  professionally-delivered  TSF  interventions.  In
addition,  research  into  sophisticated  mechanisms  of  behavior
change  has  been  conducted  to  delineate  the  precise  ways  that
AA  participation  confers  recovery  benefit  (see  Kelly  2009a;  Kelly
2017a). While these reviews have advanced our knowledge in this
area, several further avenues of research remain to be explored.

Most of this research was conducted in the USA; further research
is needed to determine the degree to which results observed here
differ in other countries.

None  of  the  studies  included  in  this  review  reported  on  any
outcomes  regarding  quality  of  life,  functioning,  or  psychological
well-being.  There  is  increasing  interest  and  importance  being
placed on these important indices in addition to substance-related
outcomes  (Kelly  2018),  and  new  studies  should  gather  data  for
these outcomes.

It  is  plausible  that  participation  of  family  members  in  12-step
organizations  designed  specifically  to  help  family  members  cope
with  the  effects  of  active  addiction  in  their  loved  one  (i.e.  Al-
Anon)  may  partially  mediate  the  effects  of  AA  participation  on
the individual with an AUD by altering the family and relationship
dynamics in a therapeutic way. Future research should examine this
and also the broader impact of AA/TSF on other special populations
such  as  adolescents,  senior  citizens,  and  those  who  identify  as
LGBTQ (lesbian, gay, bisexual, transgender, questioning).

Some research has examined the utility of AA for people suffering
from  other  common  substance  use  disorders  (e.g.  disorders
relating  to  cocaine,  cannabis,  opioids  use,  etc.)  either  alone  or
in  combination  with  AUD  (Kelly  2014).  More  research  is  needed
to  understand  the  degree  to  which  these  people  might  benefit
from,  or  be  a  better  fit  in,  other  mutual-help  organizations,  such
as  Narcotics  Anonymous,  or  Cocaine  Anonymous  (Bøg  2017).
Studies also suggest there may be an immense clinical and public
health value and economic benefit of AA participation in reducing
healthcare costs. Such analyses could be expanded to include the
potential gains in economic revenue from increased employment
or productivity, or both, and also reductions in criminal justice costs
related to lowered criminal activity that might result from increased
AA participation.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

35

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Finally, although this review focused on AA/TSF interventions and
alcohol  use  outcomes,  it  is  plausible  that  other  AUD  recovery-
supportive, mutual-help organizations, such as Self-Management
and Recovery Training (SMART), LifeRing, and Women for Sobriety,
that  have  been  growing  in  recent  years,  may  confer  similar
benefits (Kelly 2012; Kelly 2009b). While these organizations may
espouse  different  theoretical  orientations  and  variations  in  their
approaches to help people attain and maintain recovery from AUD,
there  may  be  more  similarity  than  differences  in  the  therapeutic
dynamics operating within these groups (Kelly 2009b; Kelly 2017a),
and  we  need  more  research  to  understand  whether  participants
who  engage  with  these  other  entities  may  derive  benefits  of
similar  magnitude  to  those  derived  from  AA  (Zemore  2017).
More  research  is  needed  to  support  this  conjecture,  but  such
preliminary  results  are  promising  from  a  public  health  and  long-

term recovery management perspective because AUD tends to be
highly heterogeneous in its clinical course and impact, and those
suffering  can  often  have  different  preferences  as  to  the  kinds  of
recovery pathways they wish to follow (Kelly 2013c).

A C K N O W L E D G E M E N T S

The authors thank:

• Ms  Alexandra  Abry  for  her  help 

in  all  aspects  of  the

administration and publication of this review;

• Ms  Zuzanna  Mitrova  for  her  assistance  with  the  literature

searches;

• Dr  Brandon  Bergman,  PhD,  for  his  assistance  in  helping  with
review  administration  and  providing  feedback  and  comments
on this review.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

36

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

R E F E R E N C E S

References to studies included in this review

Blondell 2001 {published data only}

Blondell RD, Looney SW, Northington AP, Lasch ME, Rhodes SB,
McDaniels RL. Using recovering alcoholics to help hospitalized
patients with alcohol problems. Journal of Family Practice
2001;50(5):1-15.

Blondell 2011 {published data only}

Blondell RD, Frydrych LM, Jaanimaqi U, Ashrafioun L,
Homish GG, Foschio EM, et al. A randomized trial of
two behavioral interventions to improve outcomes
following inpatient detoxification for alcohol dependence.
Journal of Addictive Diseases 2011;30(2):136-48. [DOI:
10.1080/10550887.2011.554777]

Services & Research 2000;27(3):286-302. [DOI: doi.org/10.1007/
BF02291740]

Humphreys 1996 {published data only}

Humphreys K, Moos RH. Reduced substance-abuse-related
health care costs among voluntary participants in Alcoholics
Anonymous. Psychiatric Services 1996;47(7):709-13. [DOI:
10.1176/ps.47.7.709]

Kahler 2004 {published data only}

Kahler CW, Read JP, Ramsey SE, Stuart GL, McCrady BS,
Brown RA. Motivational enhancement for 12-step involvement
among patients undergoing alcohol detoxification. Journal
of Consulting and Clinical Psychology 2004;72(4):736-41. [DOI:
10.1037/0022-006X.72.4.736]

Bogenschutz 2014 {published data only}

Kaskutas 2009b {published data only}

Bogenschutz MP, Rice SL, Tonigan JS, Vogel HS, Nowinski J,
Hume D, et al. 12-step facilitation for the dually diagnosed: a
randomized clinical trial. Journal of Substance Abuse Treatment
2014;46(4):403-11. [DOI: 10.1016/j.jsat.2013.12.009]

Bowen 2014 {published data only}

Bowen S, Witkiewitz K, Clifasefi SL, Grow J, Chawla N,
Hsu SH, et al. Relative efficacy of mindfulness-based relapse
prevention, standard relapse prevention, and treatment
as usual for substance use disorders: a randomized clinical
trial. JAMA Psychiatry 2014;71(5):547-56. [DOI: 10.1001/
jamapsychiatry.2013.4546]

Kaskutas LA, Subbaraman MS, Witbrodt J, Zemore SE.
Effectiveness of making alcoholics anonymous easier:
a group format 12-step facilitation approach. Journal of
Substance Abuse Treatment 2009;37(3):228-39. [DOI: 10.1016/
j.jsat.2009.01.004]

Kelly 2017b {published data only}

Kelly JF, Kaminer Y, Kahler CW, Hoeppner B, Yeterian J,
Cristello JV, et al. A pilot randomized clinical trial testing
integrated 12-step facilitation (iTSF) treatment for adolescent
substance use disorder. Addiction 2017;112(12):2155-66. [DOI:
10.1111/add.13920]

Brooks 2003 {published data only}

Litt 2007 {published data only}

Brooks AJ, Penn PE. Comparing treatments for dual diagnosis:
twelve-step and self-management and recovery training.
American Journal of Drug and Alcohol Abuse 2003;29(2):359-83.
[DOI: 10.1081/ADA-120020519]

*  Litt MD, Kadden RM, Kabela-Cormier E, Petry N. Changing
network support for drinking: initial findings from the network
support project. Journal of Consulting and Clinical Psychology
2007;75(4):542-55. [DOI: 10.1037/0022-006X.75.4.542]

Brown 2002 {published data only}

Brown TG, Seraganian P, Tremlay J, Annis H. Process and
outcome changes with relapse prevention versus 12-
step aftercare programs for substance abusers. Addiction
2002;976(6):677-89.

Litt MD, Kadden RM, Kabela-Cormier E, Petry NM. Changing
network support for drinking: Network Support Project 2-
year follow-up. Journal of Consulting and Clinical Psychology
2009;77(2):229-42. [DOI: 10.1037/a0015252]

Litt 2016 {published data only}

Davis 2002 {published data only}

Davis WT, Campbell L, Tax J, Lieber CS. A trial of 'standard'
outpatient alcoholism treatment vs. a minimal treatment
control. Journal of Substance Abuse Treatment 2002;23(1):9-19.
[DOI: 10.1016/S0740-5472(02)00227-1]

Litt MD, Kadden RM, Tennen H, Kabela-Cormier E. Network
Support II: randomized controlled trial of Network Support
treatment and cognitive behavioral therapy for alcohol use
disorder. Drug and Alcohol Dependence 2016;165:203-12. [DOI:
10.1016/j.drugalcdep.2016.06.010]

Grant 2018 {published data only}

Lydecker 2010 {published data only}

Grant KM, Young LB, Tyler KA, Simpson JL, Pulido RD, Timko C.
Intensive referral to mutual-help groups: a field trial of
adaptations for rural veterans. Patient Education and Counseling
2018;101(1):79-84. [DOI: 10.1016/j.pec.2017.07.012]

Lydecker KP, Tate SR, Cummins KM, McQuaid J, Granholm E,
Brown SA. Clinical outcomes of an integrated treatment for
depression and substance use disorders. Psychology of Addictive
Behaviors 2010;24(3):453-65. [DOI: 10.1037/a0019943]

Herman 2000 {published data only}

Manning 2012 {published data only}

Herman SE, Frank KA, Mowbray CT, Ribisl KM, Davidson WS
2nd, Boots Miller B, et al. Longitudinal effects of integrated
treatment on alcohol use for persons with serious mental illness
and substance use disorders. Journal of Behavioral Health

Manning V, Best D, Faulkner N, Titherington E, Morinan A,
Keaney F, et al. Does active referral by a doctor or 12-step
peer improve 12-step meeting attendance? Results from a

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

37

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

pilot randomised control trial. Drug and Alcohol Dependence
2012;126(1-2):131-7. [DOI: 10.1016/j.drugalcdep.2012.05.004]

MATCH 1997 {published data only}

Holder HD, Cisler RA, Longabaugh R, Stout RL, Treno AJ,
Zweben A. Alcoholism treatment and medical care costs from
Project MATCH. Addiction 2000;95(7):999-1013. [DOI: 10.1046/
j.1360-0443.2000.9579993.x]

Longabaugh R, Wirtz PW, Zweben A, Stout RL. Network
support for drinking, Alcoholics Anonymous and long-term
matching effects. Addiction 1998;93(9):1313-33. [DOI: 10.1046/
j.1360-0443.1998.93913133.x]

*  Project MATCH Research Group. Matching alcoholism
treatments to client heterogeneity: Project MATCH
posttreatment drinking outcomes. Journal of Studies on Alcohol
and Drugs 1997;58(1):7-29.

Project MATCH Research Group. Matching alcoholism
treatments to client heterogeneity: Project MATCH
three-year drinking outcomes. Alcoholism: Clinical and
Experimental Research 1998;22(6):1300-11. [DOI: 10.1111/
j.1530-0277.1998.tb03912.x]

Project MATCH Research Group. Matching alcoholism
treatments to client heterogeneity: treatment main effects and
matching effects on drinking during treatment. 1998 Journal
of Studies on Alcohol and Drugs;59(6):631-9. [DOI: 10.15288/
jsa.1998.59.631]

McCrady 1996 {published data only}

*  McCrady BS, Epstein EE, Hirsch LS. Issues in the
implementation of a randomized clinical trial that includes
Alcoholics Anonymous: studying AA-related behaviors
during treatment. Journal of Studies on Alcohol and Drugs
1996;57(6):604-12. [DOI: 10.15288/jsa.1996.57.604]

McCrady BS, Epstein EE, Hirsch LS. Maintaining change after
conjoint behavioral alcohol treatment for men: Outcomes
at 6 months. Addiction 1999;94(9):1381-96. [DOI: 10.1046/
j.1360-0443.1999.949138110.x]

McCrady BS, Epstein EE, Kahler CW. Alcoholics Anonymous and
relapse prevention as maintenance strategies after conjoint
behavioral alcohol treatment for men: 18-Month outcomes.
Journal of Consulting and Clinical Psychology 2004;72(5):870-8.
[DOI: 10.1037/0022-006X.72.5.870]

Mundt 2012 {published data only}

Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI.
12-step participation reduces medical use costs among
adolescents with a history of alcohol and other drug treatment.
Drug and Alcohol Dependence 2012;126(1-2):124-30. [DOI:
10.1016/j.drugalcdep.2012.05.002]

Humphreys K, Moos RH. Encouraging posttreatment self-help
group involvement to reduce demand for continuing care
services: two-year clinical and utilization outcomes. Alcohlism:
Clinical and Experimental Research 2007;31(1):64-8. [DOI:
10.1111/j.1530-0277.2006.00273.x]

*  Ouimette PC, Finney JW, Moos RH. Twelve-step and
cognitive-behavioral treatment for substance abuse:
A comparison of treatment effectiveness. Journal of
Consulting and Clinical Psychology 1997;65(2):230-40. [DOI:
10.1037//0022-006X.65.2.230]

Timko 2006 {published data only}

Timko C, DeBenedetti A. A randomized controlled trial of
intensive referral to 12-step self-help groups: One-year
outcomes. Drug and Alcohol Dependence 2007;90(2-3):270-9.

*  Timko C, Debenedetti A, Billow R. Intensive referral to 12-
step self-help groups and 6-month substance use disorder
outcomes. Addiction 2006;101(5):678-88. [DOI: 10.1111/
j.1360-0443.2006.01391.x]

Timko 2011 {published data only}

Timko C, Sutkowi A, Cronkite RC, Makin-Byrd K, Moos RH.
Intensive referral to 12-step dual-focused mutual-help groups.
Drug and Alcohol Dependence 2011;118(2-3):194-201. [DOI:
10.1016/j.drugalcdep.2011.03.019]

Vederhus 2014 {published data only}

Vederhus JK, Timko C, Kristensen O, Hjemdahl B, Clausen T.
Motivational intervention to enhance post-detoxification 12-
step group affiliation: a randomized controlled trial. Addiction
2014;109(5):766-73. [DOI: 10.1111/add.12471]

Walitzer 2009 {published data only}

Walitzer KS, Dermen KH, Barrick C. Facilitating involvement
in alcoholics anonymous during out-patient treatment: A
randomized clinical trial. Addiction 2009;104(3):391-401. [DOI:
10.1111/j.1360-0443.2008.02467.x]

Walitzer 2015 {published data only}

Walitzer KS, Deffenbacher JL, Shyhalla K. Alcohol-adapted
anger management treatment: a randomized controlled trial
of an innovative therapy for alcohol dependence. Journal
of Substance Abuse Treatment 2015;59:83-93. [DOI: 10.1016/
j.jsat.2015.08.003]

Zemore 2018 {published data only}

Zemore SE, Lui C, Mericle A, Hemberg J, Kaskutas LA. A
longitudinal study of the comparative efficacy of Women
for Sobriety, LifeRing, SMART Recovery, and 12-step groups
for those with AUD. Journal of Substance Abuse Treatment
2018;88:18-26. [DOI: 10.1016/j.jsat.2018.02.004]

Ouimette 1997 {published data only}

References to studies excluded from this review

Humphreys K, Moos R. Can encouraging substance abuse
patients to participate in self-help groups reduce demand for
health care? A quasi-experimental study. Alcoholism: Clinical
and Experimental Research 2001;25(5):711-16.

Banerjee 2007 {published data only}

Banerjee K, Howard M, Mansheim K, Beattie M. Comparison
of Health Realization and 12-step treatment in women's
residential substance abuse treatment programs. American

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

38

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Journal of Drug and Alcohol Abuse 2007;33(2):207-15. [DOI:
10.1080/00952990601174758]

Hailemariam 2018 {published data only}

Hailemariam M, Stein M, Anderson B, Schonbrun YC, Moore K,
Kurth M, et al. Correlates of alcoholics anonymous affiliation
among justice-involved women. BMC Women's Health
2018;18(1):125. [DOI: 10.1186/s12905-018-0614-0]

Lash 2011 {published data only}

Lash SJ, Timko C, Curran GM, McKay JR, Burden JL.
Implementation of evidence-based substance use disorder
continuing care interventions. Psychology of Addictive Behaviors
2011;25(2):238-51. [DOI: 10.1037/a0022608]

Lash 2013 {published data only}

Lash SJ, Burden JL, Parker JD, Stephens RS, Budney AJ,
Horner RD, et al. Contracting, prompting and reinforcing
substance use disorder continuing care. Journal of Substance
Abuse Treatment 2013;44(4):449-56. [DOI: 10.1016/
j.jsat.2012.09.008]

Laudet 2007 {published data only}

Laudet A, Stanick V, Sands B. An exploration of the effect of
on-site 12-step meetings on post-treatment outcomes among
polysubstance-dependent outpatient clients. Evaluation Review
2007;31(6):613-43. [DOI: 10.1177/0193841X07306745]

Moos 1999 {published data only}

Moos RH, Moos BS, Andrassy JM. Outcomes of four treatment
approaches in community residential programs for
patients with substance use disorders. Psychiatry Services
1999;50(12):1577-83. [DOI: 10.1176/ps.50.12.1577]

Morgan-Lopez 2013 {published data only}

Morgan-Lopez AA, Saavedra LM, Hien DA, Campbell AN, Wu E,
Ruglass L. Synergy between seeking safety and twelve-step
affiliation on substance use outcomes for women. Journal of
Substance Abuse Treatment 2013;45(2):179-89. [DOI: 10.1016/
j.jsat.2013.01.015]

Mueller 2007 {published data only}

Mueller SE, Petitjean S, Boening J, Wiezbeck GA. The impact
of self-help group attendance on relapse rates after alcohol
detoxification in a controlled study. Alcohol and Alcoholism
2007;42(2):108-12. [DOI: 10.1093/alcalc/agl122]

Schilling 2002 {published data only}

Schilling RF, El-Bassel N, Finch JB, Roman RJ, Hanson M.
Motivational interviewing to encourage self-help participation
following alcohol detoxification. Research on Social Work
Practice 2002;12(6):711-30. [DOI: 10.1177/104973102237469]

Ståhlbrandt 2007 {published data only}

Ståhlbrandt H, Johnsson KO, Berglund M. Two-year outcome of
alcohol interventions in Swedish university halls of residence:
a cluster randomized trial of a brief skills training program,
twelve-step-influenced intervention, and controls. Alcoholism:
Clinical and Experimental Research 2007;31(3):458-66. [DOI:
10.1111/j.1530-0277.2006.00327.x]

Tonigan 2010 {published data only}

Tonigan JS, Book SW, Pagano ME, Randall PK, Smith JP,
Randall CL. 12-step therapy and women with and without
social phobia: a study of the effectiveness of 12-step
therapy to facilitate alcoholics anonymous engagement.
Alcoholism Treatment Quarterly 2010;28(2):151-62. [DOI:
10.1080/07347321003648596]

Villanueva 2007 {published data only}

Villanueva M, Tonigan JS, Miller WR. Response of Native
American clients to three treatment methods for alcohol
dependence. Journal of Ethnicity in Substance Abuse
2007;6(2):41-8. [DOI: doi: 10.1300/J233v06n02_04]

Walsh 1991 {published data only}

Walsh DC, Hingson RW, Merrigan DM, Levenson SM, Cupples LA,
Heeren T, et al. A randomized trial of treatment options for
alcohol-abusing workers. New England Journal of Medicine
1991;325(11):775-82. [DOI: 10.1056/NEJM199109123251105]

Additional references

Alcoholics Anonymous 2001

Alcoholics Anonymous. Alcoholics Anonymous: The Story of
How Thousands of Men and Women have Recovered from
Alcoholism. 4th edition. New York (NY): Alcoholics Anonymous
World Services, 2001.

Alcoholics Anonymous 2018

Alcoholics Anonymous. One Big Tent. New York (NY): AA
Grapevine, Inc, 2018.

APA 1994

American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. 4th edition. Washington (DC):
American Psychiatric Association, 1994.

APA 2013

American Psychiatric Association. Diagnostic and Statistical
Manual of Mental Disorders. 5th edition. Washington (DC):
American Psychiatric Association, 2013.

Bøg 2017

Bøg M, Filges T, Brännström L, Jørgensen AM, Fredriksson MK.
12-step programs for reducing illicit drug use: a systematic
review. Cambell Systematic Reviews 2017;2. [DOI: 10.4073/
csr.2017.2]

Caetano 1998

Caetano R, Clark CL, Greenfield TK. Prevalence, trends, and
incidence of alcohol withdrawal symptoms: analysis of general
population and clinical samples. Alcohol Health and Research
World 1998;22(1):73-9.

Drummond 2005

Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ,
Stoddart GL. Methods for the Economic Evaluation of Health
Care Programmes. 3rd edition. Oxford (UK): Oxford University
Press, 2005.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

39

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Ducharme 2006

Humphreys 1994

Ducharme LJ, Knudsen HK, Roman PM. Trends in the
adoption of medication for alcohol dependence. Journal
of Clinical Psychopharmacology 2006;26(6):S13-9. [DOI:
10.1097/01.jcp.0000246209.18777.14]

Humphreys K, Mavis BE, Stöffelmayr BE. Are twelve step
programs appropriate for disenfranchised groups? Evidence
from a study of posttreatment mutual help group involvement.
Prevention in Human Services 1994;11(1):165-80.

Dunn 1997

Humphreys 1999

Dunn CW, Donovan DM, Gentilello LM. Practical guidelines for
performing alcohol interventions in trauma centers. Journal of
Trauma: Injury, Infection, and Critical Care 1997;42(2):299-304.

Humphreys K. Professional interventions that facilitate 12-step
self-help group involvement. Alcohol Health and Research World
1999;23(2):93-8.

Evers 2005

Humphreys 2001

Evers S, Goossens M, de Vet H, van Tulder M, Ament A.
Criteria list for assessment of methodological quality of
economic evaluations: Consensus on Health Economic Criteria.
International Journal of Technology Assessment in Health Care
2005;21(2):240-5.

GRADEpro GDT 2015 [Computer program]

GRADE Working Group, McMaster University GRADEpro GDT.
Hamilton (ON): GRADE Working Group, McMaster University,
2015. Available at gradepro.org.

Hedden 2015

Hedden SL, Kennet J, Lipari R, Medley G, Tice P, Copello EA,
et al, SAMHSA. Behavioral health trends in the United States:
results from the 2014 National Survey on Drug Use and Health.
www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/
NSDUH-FRR1-2014.pdf (accessed prior to 25 November 2019).

Herman 1997

Herman SE, BootsMiller B, Jordan L, Mowbray CT, Brown WG,
Deiz N, et al. Immediate outcomes of substance use treatment
within a state psychiatric hospital. Journal of Mental Health
Administration 1197;24(2):126-38.

Higgins 2011a

Higgins JP, Green S, editor(s). Cochrane Handbook for
Systematic Reviews of Interventions. Version 5.1.0 (updated
March 2011). The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.

Higgins 2011b

Higgins JP, Deeks JJ, Altman DG, editor(s). Chapter 16: Special
topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane
Handbook for Systematic Reviews of Interventions Version
5.1.0 (updated March 2011). The Cochrane Collaboration, 2011.
Available from handbook.cochrane.org.

Hoffman 2009

Hoffman F. Cultural adaptations of Alcoholics Anonymous
to serve Hispanic populations. International Journal
of the Addictions 2009;29(4):445-60. [DOI: http://
doi.org/10.3109/10826089409047392]

Holder 2000

Holder HD, Cisler RA, Longabaugh R, Stout RL, Treno AJ,
Zweben A. Alcoholism treatment and medical care costs from
Project MATCH. Addiction 2000;95(7):999-1013. [10.1046/
j.1360-0443.2000.9579993.x]

Humphreys K, Moos R. Can encouraging substance abuse
patients to participate in self-help groups reduce demand for
health care? A quasi-experimental study. Alcoholism: Clinical
and Experimental Research 2001;25(5):711-6.

Humphreys 2004

Humphreys K. Circles of Recovery: Self-Help Organizations for
Addictions. Cambridge, UK: Cambridge University Press, 2004.

Humphreys 2007

Humphreys K, Moos RH. Encouraging posttreatment self-help
group involvement to reduce demand for continuing care
services: two-year clinical and utilization outcomes. Alcohlism:
Clinical and Experimental Research 2007;31(1):64-8. [DOI:
10.1111/j.1530-0277.2006.00273.x]

Humphreys 2014

Humphreys K, Blodgett JC, Wagner TH. Estimating the
efficacy of Alcoholics Anonymous without self-selection
bias: an instrumental variables re-analysis of randomized
clinical trials. Alcoholism, Clinical and Experimental Research
2014;38(11):2688-94. [DOI: 10.1111/acer.12557]

Jilek-Aall 1981

Jilek-Aall L. Acculturation, alcoholism, and Indian-style
Alcoholics Anonymous. Journal of Studies on Alcohol,
Supplement 1981;S9:143-58. [DOI: http://doi.org/10.15288/
jsas.1981.s9.143]

Kaskutas 2009a

Kaskutas LA. Alcoholics Anonymous effectiveness: faith meets
science. Journal of Addictive Diseases 2009;28(2):145-57. [DOI:
10.1080/10550880902772464]

Kelly 2003a

Kelly JF, McKellar JD, Moos RH. Major depression in patients
with substance use disorders: Relationships to 12-step self-
help involvement and substance use outcomes. Addiction
2003;98(4):499-508.

Kelly 2003b

Kelly JF. Self-help for substance-use disorders: history,
effectiveness, knowledge gaps, and research opportunities.
Clinical Psychology Review 2003;23(5):639-663. [DOI: 10.1016/
S0272-7358(03)00053-9]

Kelly 2009a

Kelly JF, McCrady BS. Twelve-step facilitation in non-specialty
settings. In: Research on alcoholism: Alcoholics Anonymous

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

40

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

and spiritual aspects of recovery. New York, NY: Springer,
2009:797-836.

Kelly 2009b

Kelly JF, Magill M, Stout RL. How do people recover from
alcohol dependence? A systematic review of the research on
mechanisms of behavior change in Alcoholics Anonymous.
Addiction Research & Theory 2009;17(3):236-59. [http://
dx.doi.org/10.1080/16066350902770458]

Kelly 2012

Kelly JF, White WL. Broadening the base of addiction
mutual-help organizations. Journal of Groups in
Addiction and Recover 2012;7(2-4):82-101. [DOI:
doi.org/10.1080/1556035X.2012.705646]

Kelly 2013a

Kelly JK, Yeterian J. Mutual-help groups for alcohol and other
substance use disorders. In: McCrady BS, Epstein EE, editors(s).
Addictions: A Comprehensive Guidebook. 2nd edition. New
York, NY: Oxford University Press, 2013:500-25.

Kelly 2013b

Kelly JF, Greene MC. The twelve promises of Alcoholics
Anonymous: psychometric validation and mediational testing
as a 12-step specific mechanism of behavior change. Drug
and Alcohol Dependence 2013;133(2):633-40. [DOI: 10.1016/
j.drugalcdep.2013.08.006]

Kelly 2013c

Kelly JF, Humphreys K, Yeterian J. Mutual-Help Groups. In:
Herie M, Skinner WJW, editors(s). Fundamentals of Addiction:
A Practical Guide for Counsellors. Toronto (ON): Centre on
Addiction and Mental Health, 2013:321-48.

Kelly 2014

Kelly JF, Greene MC, Bergman BG. Do drug dependent patients
attending Alcoholics Anonymous rather than Narcotics
Anonymous do as well? A prospective, lagged, matching
analysis. Alcohol and Alcoholism 2014;49(6):645-53. [DOI:
doi.org/10.1093/alcalc/agu066]

Kelly 2017a

Kelly J. Is Alcoholics Anonymous religious, spiritual, neither?
Findings from 25 years of mechanisms of behavior change
research. Addiction 2017;112(6):929-36. [DOI: 10.1111/
add.13590]

Kelly 2018

Kelly JF, Greene MC, Bergman BG. Beyond abstinence: changes
in indices of quality of life with time in recovery in a nationally
representative sample of U.S. adults. Alcoholism: Clinical and
Experimental Research 2018;42(4):770-80. [DOI: 10.1111/
acer.13604]

Knudsen 2016

Knudsen HK, Roman PM. Service delivery and pharmacotherapy
for alcohol use disorder in the era of health reform: data from a
national sample of treatment organizations. Substance Abuse
2016;37(1):230-7. [DOI: 10.1080/08897077.2015.1028699]

Cochrane Database of Systematic Reviews

Liberati 2009

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC,
Ioannidis JP, et al. The PRISMA statement for reporting
systematic reviews and meta-analyses of studies that evaluate
health care interventions: explanation and elaboration. PLoS
Medicine 2009;6(7):e1000100.

Longabaugh 1998

Longabaugh R, Wirtz PW, Zweben A, Stout RL. Network
support for drinking, Alcoholics Anonymous and long-term
matching effects. Addiction 1998;93(9):1313-33. [DOI: 10.1046/
j.1360-0443.1998.93913133.x]]

Mann 2006a

Mann RE, Zalcman RF, Smart RG, Rush BR, Suurvali H. Alcohol
consumption, alcoholics anonymous membership, and
homicide mortality rates in Ontario 1968 to 1991. Alcoholism:
Clinical and Experimental Research 2006;30(10):1743-51. [DOI:
10.1111/j.1530-0277.2006.00216.x]

Mann 2006b

Mann RE, Zalcman RF, Smart RG, Rush BR, Suurvali H. Alcohol
consumption, alcoholics anonymous membership, and suicide
mortality rates, Ontario, 1968-1991. Journal of Studies on
Alcohol and Drugs 2006;67(3):445-53.

Marlatt 1985

Marlatt GA, Gordon JR. Relapse Prevention: Maintenance
Strategies in the Treatment of Addictive Behaviors. New York
(NY): Guilford Press, 1985.

MATCH 2001

Project MATCH . Project MATCH hypotheses: results and causal
chain analyses. In: Longabaugh R, Wirtz PW, Mattson ME,
Myers JK, editors(s). National Institute on Alcohol Abuse and
Alcoholism Project MATCH Monograph Series Volume 8. Vol. 8.
Rockville, MD: U.S. Department of Health and Human Services,
Public Health Service, National Institutes of Health, 2001.

McCrady 1993

McCrady BS, Miller WR. Research on Alcoholics Anonymous:
Opportunities and Alternatives. New Brunswick (NJ): Rutgers
Center of Alcohol Studies, 1993.

McLellan 1980

McLellan AT, Luborsky L, O’Brien CP, Woody GE. An improved
diagnostic instrument for substance abuse patients: the
addiction severity index. Journal of Nervous & Mental Diseases
1980;168(1):26-33.

Miller 1995

Miller WR, Tonigan JS, Longabaugh R. The Drinker Inventory
of Consequences (DrInC): An Instrument for Assessing Adverse
Consequences of Alcohol Abuse: Test Manual. Vol. 4, Project
MATCH Monograph. Rockville, MD: National Institute on Alcohol
Abuse and Alcoholism, 1995.

Moher 2009

Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA
Group. Preferred reporting items for systematic reviews

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

41

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

and meta-analyses: the PRISMA statement. PLos Medicine
2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097]

Handbook for Systematic Reviews of Intervention.. Available
from handbook.cochrane.org.

OSG 2018

Sterne 2016

US Department of Health and Human Services (HHS), Office of
the Surgeon General. Facing addiction in America: the surgeon
general’s spotlight on opioids. addiction.surgeongeneral.gov/
sites/default/files/Spotlight-on-Opioids_09192018.pdf
September 2018.

Room 2006

Room R, Makela P, Schmidt L, Rehm J. Alcohol, Health
Disparities and Development. www.robinroom.net/
Alchealth.pdf (accessed 9 November 2017).

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND,
Viswanathan M, et al. ROBINS-I: a tool for assessing risk
of bias in non-randomized studies of interventions. BMJ
2016;355:i4919. [DOI: 10.1136/bmj.i4919.]

Tonigan 2018

Tonigan JS, Pearson MR, Magill M, Hagler KJ. AA attendance
and abstinence for dually diagnosed patients: a meta-analytic
review. Addiction 2018;113(11):1970-81. [DOI: 10.1111/
add.14268]

Rosenbaum 2015

White 2012

Rosenbaum BP, Kshettry VR, Kelly ML, Weil RJ. Diagnoses
associated with the greatest years of potential life lost for in-
hospital deaths in the United States, 1988-2010. Public Health
2015;129(2):173-81. [DOI: 10.1016/j.puhe.2014.11.011]

Sacks 2015

Sacks JJ, Gonzales KR, Bouchery EE, Tomedi LE, Brewer RD.
2010 National and State Costs of Excessive Alcohol
Consumption. American Journal of Preventive Medicine
2015;49(5):e73-9. [DOI: http://dx.doi.org/10.1016/
j.amepre.2015.05.031]

Schunemann 2013

Schunemann H, Brozek J, Guyatt G, Oxman A, editor(s).
Handbook for grading the quality of evidence and the strength
of recommendations using the GRADE approach (updated
October 2013). GRADE Working Group, 2013. Available from
gdt.guidelinedevelopment.org/app/handbook/handbook.html.

White WL, Kelly JF, Roth JD. New addiction recovery support
institutions: Mobilizing support beyond professional
addiction treatment and recovery mutual aid. Journal
of Groups in Addiction & Recovery 2012;7:297-317. [DOI:
doi.org/10.1080/1556035X.2012.705719]

WHO 2010

World Health Organization. International Statistical
Classification of Diseases and Related Health Problems: ICD-10.
10th edition. Vol. 2. Geneva: World Health Organization, 2010.

WHO 2014

World Health Organization. Global Status Report on Alcohol and
Health. Geneva, Switzerland: World Health Organization, 2014.

Yalom 2008

Yalom ID, Leszcz M. The Theory and Practice of Group
Psychotherapy. 5th edition. New York (NY): Basic Books, 2008.

Shemilt 2011a

Zemore 2004

Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E,
Knapp M, et al. Chapter 15: Incorporating economics evidence.
In: Higgins JP, Green S, editor(s). Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 (updated
March 2011). The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.

Shemilt 2011b

Shemilt I, Mugford M, Byford S, Drummond M, Eisenstein E,
Knapp M, et al. Chapter 15: Incorporating economics evidence.
In: Higgins JP, Green S, editor(s). Cochrane Handbook for
Systematic Reviews of Interventions Version 5.1.0 (updated
March 2011). The Cochrane Collaboration, 2011. Available from
handbook.cochrane.org.

Zemore SE, Kaskutas LA, Ammon LN. In 12-step groups, helping
helps the helper. Addiction 2004;99(8):1015-23. [DOI: 10.1111/
j.1360-0443.2004.00782.x]

Zemore 2017

Zemore SE, Kaskutas LA, Mericle A, Hemberg J. Comparison of
12-step groups to mutual help alternatives for AUD in a large,
national study: differences in membership characteristics
and group participation, cohesion, and satisfaction. Journal
of Substance Abuse Treatment 2017;73:16-26. [DOI: 10.1016/
j.jsat.2016.10.004]

References to other published versions of this review

Stahre 2014

Ferri 2006a

Stahre M, Roeber J, Kanny D, Brewer R, Zhang X. Contribution
of excessive alcohol consumption to deaths and years of
potential life lost in the United States. Preventing Chronic
Disease 2014;11:E109. [DOI: dx.doi.org/10.5888/pcd11.130293]

Ferri M, Amato L, Davoli M. 12-step programmes and Alcoholics
Anonymous for alcohol dependence. Cochrane Database of
Systematic Reviews 2004, Issue 4. Art. No: CD005032. [DOI:
10.1002/14651858.CD005032.pub2]

Sterne 2011

Ferri 2006b

Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing
reporting biases. In: Higgins JPT, Green S (editors). Cochrane

Ferri M, Amato L, Davoli M. Alcoholics Anonymous and other 12-
step programmes for alcohol dependence. Cochrane Database

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

42

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

of Systematic Reviews 2006, Issue 3. Art. No: CD005032. [DOI:
10.1002/14651858.CD005032.pub2]

Database of Systematic Reviews 2017, Issue 11. Art. No:
CD012880. [DOI: 10.1002/14651858.CD012880]

Kelly 2017c

Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and
other 12-step programs for alcohol use disorder. Cochrane

C H A R A C T E R I S T I C S   O F   S T U D I E S

Characteristics of included studies [ordered by study ID]

* Indicates the major publication for the study

Blondell 2001 

Study characteristics

Methods

Design: prospective, non-randomized study comparing usual physician care to a brief intervention and
a peer intervention for patients with alcohol use disorder who were admitted to an urban teaching hos-
pital with alcohol-related injuries. Participants in the usual physician care intervention did not receive
an addiction medicine consultation because the consultant was not available to see them.

Recruitment and setting: participants recruited from an urban teaching hospital

Fidelity assessment of intervention implementation: 0 (non-manualized)

Participants

N = 314 participants (of whom 140 provided valid responses) who were participants with alcohol-relat-
ed injuries and alcohol use disorder.

Age: age range for the 314 participants in the sample was 18-80 years (mean 37.2, SD 12.5). Mean age of
participants for whom follow-up data were available was 38.1 years (SD 12.8).

Gender: N = 258 (82.2%) males, 56 (17.8%) females. Follow-up data available for 42.2% of men and
55.4% of women (P = 0.051).

Ethnicity: N = 244 (77.7%) white participants, 70 (82.3%) non-white participants. Follow-up data avail-
able for 49.2% white participants and 28.6% non-white participants (P = 0.003).

Interventions

Peer intervention (NM) (n = 70): participants received a brief intervention plus a 30-60 minute visit
from a peer who was in recovery and active in AA. Participants had to agree to a peer visit.

Brief intervention (M) (n = 119): participants received services from the addiction medicine consul-
tant and were given brief advice (5-15 minutes) in accordance with procedures outlined in Dunn 1997,
which includes giving client feedback, stressing the participant's responsibility for change, providing
advice, offering choices, listening with empathy and informing the participant that change is possi-
ble and beneficial. The delivery of these six components depends on the participant's stage of change
(Dunn 1997).

Usual physician care (NM) (n = 125): participants received trauma services but did not receive addic-
tion medicine consultation because the consultant was not available to see them. Doctors and social
workers may or may not have addressed participants' substance use before discharge.

Outcomes

Follow-up assessment points: baseline and 6 months post-discharge (with 6-month follow-up data
collected up to 12 months post-discharge)

Abstinence: complete abstinence from alcohol use during the entire 6 months post-discharge, absti-
nent from alcohol use during the sixth-month (i.e. the past month at the 6-month follow-up assess-
ment) post-discharge.

Notes

Funding source: funded in part by University of Louisville Summer Research Scholarship Program and
the University of Louisville Hospital Trauma Institute

Declaration of Interest: none disclosed

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

43

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Blondell 2001  (Continued)

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Authors' judgement

Support for judgement

High risk

Prospective, non-randomized, design

High risk

Risk is high due to the study being non-randomized

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

High risk

Attrition rates were high across interventions - peer intervention: 44%; brief in-
tervention: 52%; usual care: 65%, but no statistical test was conducted to de-
termine whether these rates differed significantly by study group.

Selective reporting (re-
porting bias)

Low risk

Expected outcomes are reported

Comparability of cohorts
for baseline characteristics
and outcome measures

High risk

No matching or no adjustment for most important confounding fact (more
males in the peer intervention)

Selection of the non-ex-
posed cohort

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (individual interven-
tion provided in private room)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Blondell 2011 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants undergoing detoxification were randomly assigned to receive either TAU, a
peer-delivered TSF (P-TSF) intervention, or a MET intervention.

Recruitment and setting: participants were recruited from an inpatient alcohol and drug detox unit at
a teaching hospital.

Fidelity assessment of intervention implementation: 0 (non-manualized)

Participants

N = 150 participants with alcohol dependence (DSM-IV criteria) who had been hospitalized for medical
management of alcohol detox.

Age: the mean age of participants was 46.58 (SD 9.92), 44.96 (SD 10.75), 44.48 (SD 12.36) years in the
TAU (n = 50), MET (N = 50), and P-TSF (N = 50) groups, respectively (P = 0.61)

Gender: there were 30 (60%), 35 (70%) and 33 (66%) men in the TAU, MET, and P-TSF groups, respec-
tively (P = 0.57).

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

44

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Blondell 2011  (Continued)

Cochrane Database of Systematic Reviews

Ethnicity: there were 44 (88%), 39 (78%) and 43 (86%) white participants in the TAU, MET, and P-TSF
groups, respectively (P = 0.35).

Interventions

P-TSF (NM) (n = 39): intervention included TAU plus a 45 to 60-minute visit by volunteers who were re-
covering from alcoholism

MET (NM) (n = 41): intervention included TAU plus a 45 to 60-minute motivational interview

TAU (NM) (n = 42): included an initial medical evaluation, psychosocial assessments, and required
group therapy sessions (1-hour sessions, twice per day). Individual and family counseling, as well as
self-help groups were available but not required. A benzodiazepine and other medications were admin-
istered for detox as needed.

Outcomes

Follow-up assessment points: baseline and 7, 30 and 90 days post-discharge

Abstinence: PDA measured using TLFB, total 90-day abstinence

Notes

Funding source: NIAAA grant (K23-AA015616) and grant from University of Bufffalo Interdisciplinary Re-
search Fund

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Researchers used block randomization

Allocation concealment
(selection bias)

Low risk

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

High risk

Researchers enrolling participants could not foresee assignment. One of the
investigators assigned the participants to one of three intervention arms using
a 2:2:2 block randomization procedure. The same investigator also arranged
for and coordinated the delivery of the interventions. The other investigators,
the participants, and the other clinical staff, were not informed of the treat-
ment (i.e. were masked).

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. In the report, sufficient details were provided that participants could
be aware of the different interventions - (quote, page 3): "The other investiga-
tors, the participants, and the clinical staff members were not informed (i.e.
were "masked") of the treatment condition; however participants often re-
vealed their intervention assignment to the research assistants at the time of
follow-up data collection."

Incomplete outcome data
(attrition bias)
All outcomes

Unclear risk

Attrition was generally quite low across study interventions (TAU = 16%; MET
= 18%; PTSF = 22) but statistical significance of these differences were not re-
ported.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

45

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Blondell 2011  (Continued)

Protection against conta-
mination

Blinding of outcome as-
sessment (detection bias)
All outcomes

Bogenschutz 2014 

Study characteristics

Methods

Low risk

Unlikely that the control group received the intervention

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants were randomized in a 2:1 (intervention: control) ratio to receive 12 weeks of
either modified TSF or TAU using an urn randomization procedure which contained nine variables.

Recruitment and setting: participants were recruited between April 2006 and June 2010 from the Uni-
versity of New Mexico Hospitals Psychiatric Center dual diagnosis program.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

N = 121 participants with alcohol abuse or dependence (DSM-IV criteria) and serious mental illness who
were outpatients in a dual diagnosis treatment program.

Age: the mean age of participants was 41.09 (SD 8.60) years in the TAU (n = 38) and 42.74 (SD 9.42) years
in the TSF groups (n = 83).

Gender: there were 20 men (54.1%) in the TAU group and 14 (51.9%) in the TSF group.

Ethnicity: there were 17 (45.9%) non-Hispanic white, 16 (43.2%) Hispanic, and 4 (10.8%) other partici-
pants in the TAU group, and 38 (48.7%) non-Hispanic white, 29 (37.2%) Hispanic, and 11 (14.1%) other
participants in the TSF group.

Interventions

TSF (M) (n = 83): adapted from the Project MATCH TSF manual for use with participants with serious
mental illness and alcohol use disorders

TAU (NM) (n = 38): included individual treatment, psychiatric treatment and medication management,
as well as case management on an as-needed basis

Outcomes

Follow-up assessment points: baseline, 4 weeks (mid-treatment), 8 weeks (mid-treatment), 12 weeks
(end of treatment), and 3, 6, and 9 months post-treatment

Abstinence: PDA and complete abstinence from alcohol during the assessment period (Y/N) measured
using Form-90-A/TLFB. Blood alcohol concentration and urine drug screens also obtained at each visit.

Drinking intensity: drinks per drinking day measured using Form-90A.

Notes

Funding source: NIAAA grants R01-AA015419, K24-AA016555, and T32-AA18108

Declaration of interest: none disclosed

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Authors' judgement

Support for judgement

Low risk

Researchers used a computerized urn randomization procedure

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

46

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Bogenschutz 2014  (Continued)

Cochrane Database of Systematic Reviews

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment because a
computerized urn randomization procedure was used.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

High risk

Overall attrition rate was moderately low ranging from 17% to 23% but details
by treatment intervention were not reported for the longer-term outcomes of
interest.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Unclear risk

Unclear if communication between the intervention and comparison groups
occurred

Blinding of outcome as-
sessment (detection bias)
All outcomes

Bowen 2014 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants who had completed initial substance use disorder treatment (intensive out-
patient or inpatient care) were randomly assigned to received 8 weeks of either MBRP, RP, and TAU af-
tercare.

Recruitment and setting: participants were recruited between October 2009 and July 2012 through
research information sessions (hosted by research staff) and advertisements at the two-site private,
non-profit treatment facility where the research took place.

Fidelity assessment of intervention implementation: 2* (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating; *no report of supervision for TAU in-
tervention)

Participants

N = 286 participants with substance use disorder; 72.3% with alcohol use disorder

Age: the mean age was 37.2 (SD 10.8), 38.9 (SD 10.9), and 39.1 (SD 10.9) years in the TAU, RP, and MBRP
groups, respectively.

Gender: 72.6% (n = 69) of the TAU group, 63.6% (n = 56) of the RP group, and 73.8% (n = 76) of the MBRP
group were male.

Ethnicity: participants in the TAU group were 48.4% non-Hispanic white, 23.2% black or African Amer-
ican, 13.7% Hispanic or Latino/Latina, 4.2% Native American, 1.1% Asian, 1.1% Native Hawaiian/Pacif-
ic Islander, 9.5% mixed, and 2.1% other/not specified. Participants in the RP group were 48.9% non-His-
panic white, 14.8% black or African American, 11.4% Hispanic or Latino/Latina, 9.1% Native American,
0% Asian, 1.1% Native Hawaiian/Pacific Islander, 13.6% mixed, and 3.4% other/not specified. Partici-

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

47

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Bowen 2014  (Continued)

Interventions

pants in the MBRP group were 55.3% non-Hispanic white, 25.2% black or African American, 8.7% His-
panic or Latino/Latina, 5.8% Native American, 1.0% Asian, 0% Native Hawaiian/Pacific Islander, 5.8%
mixed, and 0 % other/not specified.

MBRP (M) (n = 103): consisted of 8 weekly, 2-hour groups, each with a central theme and focusing on
awareness of physical, emotional and cognitive phenomena, as well as mindfulness practices, social
support, and self-care, among other topics. Each group included a 20-30 minute guided meditation,
and participants also received mindfulness exercises for homework and tracked their daily cravings
and moods.

RP (M) (n = 88): consisted of 8 weekly, 2-hour groups which focused on identifying and problem-solv-
ing high risk situations, cognitive and behavioral coping skills, goal setting, social support and self-effi-
cacy. Participants also received homework and tracked their daily cravings and moods.

TAU (NM) (n = 95): consisted of weekly groups that met 1-2 times per week for 1.5 hours and that were
abstinence-based, based on the AA/NA 12-step program, and primarily process oriented.

Outcomes

Follow-up assessment points: participants completed baseline and 3-, 6- and 12-month follow-ups

Notes

Risk of bias

Bias

Drinking intensity: percentage days heavy drinking

Funding source: NIH/NIDA grants sponsored project (participant payments, partial support for Drs
Bowen, Witkiewitz, Clifasefi, Grow, Chawla, Collins, and Larimer, and all costs associated with conduct-
ing the study). NIH supplemental grants provided partial support for some researchers (Dr Lustyk and
Ms Carrol). NIH/NIAAA F31 fellowship supported Ms Hsu, Recovery Centers of King County sponsored
project research effort with a consortium agreement, partially supporting salary of Ms Harrop.

Declaration of interest: Drs Bowen, Grow, and Chawla conduct MBRP training for which they receive
monetary incentives. No other disclosures were reported

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Participants were reported as being randomly assigned to receive either the
intervention or comparison treatment but no other details provided.

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

No details on randomization procedures provided.

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

Follow-up rates were at least 80% and did not differ significantly across treat-
ment interventions (TAU = 20%; RP = 18%; MBRP = 19%; P > 0.05).

Selective reporting (re-
porting bias)

Low risk

Expected outcomes are reported.

Comparability of cohorts
for baseline characteristics
and outcome measures

Low risk

RCT; analyses are adjusted for most important confounding factors and imbal-
ance

Selection of the non-ex-
posed cohort

Low risk

Non-exposed cohort drawn from the same sample origin

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

48

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Bowen 2014  (Continued)

Cochrane Database of Systematic Reviews

Protection against conta-
mination

Unclear risk

Unclear if communication between the intervention and comparison groups
occurred

Blinding of outcome as-
sessment (detection bias)
All outcomes

Brooks 2003 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: quasi-RCT. Participants were alternately assigned to a 12-step or cognitive behavioral (SMART)
group, both of which consisted of five hours of treatment, five days a week, for six months.

Recruitment and setting: participants were recruited from an intensive outpatient/partial hospitaliza-
tion program

Fidelity assessment of intervention implementation: 1 (report of attempts to ensure adher-
ence/competence without audio or videotape)

Participants

N = 112 participants with a dual diagnosis of substance abuse or dependence (DSM III-R criteria) and se-
rious mental illness who were in an intensive outpatient/partial hospitalization program

Age: the mean sample age was 34.2 (SD 8.8) years. The mean age in the 12-step group was 34.3 (SD 9.3)
years and 34.2 (SD 8.4) years in the SMART group.

Gender: 42% of the sample was female, and 51.9% of the 12-step group and 32.8% of the SMART group
were female.

Ethnicity: 69.6% of the sample was white, and 66.7% of the 12-step group and 72.4% of the SMART
group was white.

Interventions

Group counselors for both groups focused on the same weekly topics (e.g. RP, mental illness manage-
ment, etc.) but the material used to cover the topics reflected each group's philosophy.

12-step (M) (n = 54): incorporated the 12-step, disease model, and 12 traditions

SMART (M) (n = 58) (cognitive behavioral): followed the national organization's guidelines and tech-
niques

Outcomes

Follow-up assessment points: baseline, during treatment (at 3 and 6 months), and 3 and 12 months
post-treatment.

Alcohol addiction severity: addiction severity index (ASI; alcohol, drug, psychiatric, medical, legal,
employment). Urinalysis for alcohol and drug use at baseline, 2 months, 4 months, 9 months, and 12
months

Notes

Funding source: NIDA grant (R01-DA09531) and La Frontera Center, Inc.

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Researchers use alternation as a non-random component in the sequence
generation process

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

49

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Brooks 2003  (Continued)

Cochrane Database of Systematic Reviews

Allocation concealment
(selection bias)

High risk

Researchers enrolling participants could possibly foresee assignment (alterna-
tion)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Unclear risk

Not reported

Low risk

Expected outcomes are reported

Comparability of cohorts
for baseline characteristics
and outcome measures

Low risk

Analyses are adjusted for most important confounding factors and imbalance
(controlled for gender in the hierarchical linear model)

Selection of the non-ex-
posed cohort

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (groups held at sepa-
rate sites)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Brown 2002 

Study characteristics

Methods

Participants

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Using an urn randomization procedure which contained seven variables, participants
were randomly assigned to receive ten, 90-minute, weekly aftercare sessions of either structured RP or
TSF.

Recruitment and setting: participants were recruited from three residential substance use treatment
programs in Montreal. Participants were recruited within two days of admission to intensive treatment,
at which point they consented to accept randomization and were then randomized into one of two af-
tercare sessions after completing intensive treatment.

Fidelity assessment of intervention implementation: 1 (report of attempts to ensure adher-
ence/competence without audio or videotape)

336 participants with alcohol abuse or dependence (DSM-III criteria) agreed to participate. 266 partici-
pants were randomized into two groups (TSF or RP group) and 70 participants refused randomization
but agreed to complete follow-up assessments (UC group). 151 participants were followed up, includ-
ing 61 RP participants, 70 TSF participants, and 20 UC participants.

Age: the mean sample age was 38.0 (SD 9.3) years. (Note: mean age did not account for 20 participants
in the UC group)

Gender: 31.3% (41 participants) of the sample were female. (Note: gender breakdown did not account
for 20 participants in the UC group)

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

50

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Brown 2002  (Continued)

Cochrane Database of Systematic Reviews

Ethnicity: 92.5% (123 participants) of the sample were white. (Note: ethnic breakdown did not account
for 20 participants in the UC group)

Interventions

TSF (M) (n = 140): based on the TSF manual developed by the Project MATCH Research Group, and em-
phasized steps 1 through to 3, though all 12 steps were explored in the group.

RP (M) (n = 126): included 10 weekly sessions of a manualized treatment process consisting of three
counseling stages, which includes: administering questionnaires to assess for high-risk substance use
situations (first stage), counseling that focuses on change initiation (second stage), and counseling that
focuses on the maintenance of change (third stage).

UC (M) (n= 70): included participants who were not willing to be randomized but consented to com-
plete the four assessment sessions and attend the usual aftercare programs that their treatment center
offered.

Follow-up assessment points: data were collected at intake into intensive treatment, following the
completion of intensive treatment, upon completion of the aftercare program, and 6 months after
completing the intensive treatment. Substance use outcomes were assessed at 3 and 6 months post-
treatment.

Alcohol addiction severity: alcohol and drug use addiction severity (measured using the ASI)

Outcomes

Notes

Funding source: The National Health and Research Development Program of Health Canada and the
Career Awards program of Quebec Council of Psychosocial Research

Declaration of interest: none disclosed

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Authors' judgement

Support for judgement

Low risk

Researchers used an urn randomization procedure

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment because a
computerized urn randomization procedure was used.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Unclear risk

Not enough information provided to permit judgment of low or high risk

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Unclear risk

Unclear if communication between the intervention and comparison groups
occurred

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

51

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Brown 2002  (Continued)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Davis 2002 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants randomly assigned to receive six months of either the standard outpatient
treatment or minimal treatment.

Recruitment and setting: participants who applied at the Bronx VA to attend an outpatient alcohol
program (without having gone through an inpatient program first) were recruited to participate be-
tween April 1985 and April 1987.

Fidelity assessment of intervention implementation: 0 (no report of attempts to ensure adher-
ence/competence of intervention implementation)

Participants

89 participants with alcohol abuse or dependence (DSM-III criteria). 105 participants originally random-
ized; however, 3 ST and 13 MT participants were withdrawn from the study.

Age: participants ranged in age from 29 to 65 years. The mean age was 48.1 (SD 10.5) years in the ST
group (n = 49) and 45.5 (SD 8.25) years in the MT group (n = 40).

Gender: study sample consisted of men only

Ethnicity: in the ST group, 46.9%, 26.5% and 26.5% of participants were black, white and Hispanic, re-
spectively. In the MT group, 45.0, 15.0% and 40.0% of participants were black, white and Hispanic, re-
spectively.

Interventions

ST (M) (n = 49): participants received group therapy (6 sessions) and participated in alcohol education
sessions during which movies were shown (3 sessions), community meetings (3), leisure education ses-
sions (3). Participants attended a minimum of six AA meetings.

MT (M) (n = 40): participants watched an alcoholism education movie once a week with no discussion
afterward, with the exception of once a month when a therapist led the movie discussion and collected
information about participants' sobriety.

Note: participants in both interventions evaluated monthly by medical provider who performed a
breathalyzer test.

Outcomes

Follow-up assessment points: baseline and 6-month follow-up (from both the participant and a col-
lateral), as well as during monthly doctor visits during treatment which included breathalyzer tests

Abstinence: complete abstinence, number of days drinking (from which derived PDA), longest period
of abstinence

Notes

Funding source: not reported

Declaration of Interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Participants randomly assigned to receive either the intervention or compari-
son treatment but no other details are provided.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

52

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Davis 2002  (Continued)

Cochrane Database of Systematic Reviews

Allocation concealment
(selection bias)

Unclear risk

Insufficient details provided in order to make a proper judgment about this
type of bias.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

High risk

Incomplete outcome data
(attrition bias)
All outcomes

High risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. In the report, sufficient details were provided that participants could
be aware of the different interventions: (quote, page 18) "Neither patients, nor
the personnel collecting the follow-up data were blind to the treatment condi-
tion."

Missing outcome data rates were ST = 23%, MT = 38% but no significance test
was provided.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Unclear risk

Unclear if communication between the intervention and comparison groups
occurred

Blinding of outcome as-
sessment (detection bias)
All outcomes

High risk

No blinding of outcome assessment (some assessments completed by thera-
pist and treating doctor), and the outcome measurement is likely to be influ-
enced by lack of blinding

Grant 2018 

Study characteristics

Methods

Design: non-randomized, pretest to post-test design. Participants entering substance use treatment
were assigned a therapist who provided either a standard referral (SR) or rural-adapted intensive refer-
ral (RAIR) to mutual-help groups (MHGs).

Recruitment and setting: participants were recruited from three VA intensive substance use disorder
treatment programs in the Midwest.

Fidelity assessment of intervention implementation: 0 (no report of attempts to ensure adher-
ence/competence of intervention implementation)

Participants

195 participants in substance use disorder treatment at one of three VA treatment programs

Age: the mean sample age was 46.86 (SD 12.25) years. The mean age in the SR (n = 89) group was 46.37
(n = 12.64) years and 47.26 (SD 11.96) years in the RAIR (n = 106) group.

Gender: 91.3% (n = 178) of the sample were male. 93.3% (n = 83) of the SR group and 89.6% (n = 95) of
the RAIR group were male.

Ethnicity: there were 150 (76.9%) Caucasian (understood to be white) and 11 (5.6%) Hispanic partic-
ipants in the sample. There were 69 (77.5%) Caucasian and 7 Hispanic (7.9%) participants in the SR
group, and 81 (76.4%) Caucasian and 4 (3.8%) Hispanic participants in the RAIR group.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

53

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Grant 2018  (Continued)

Interventions

RAIR (M) (n = 106): modified intensive referral intervention consisting of three sessions wherein a MHG
and "recovery buddy" are identified in the participant's home community, and family members are ed-
ucated about the importance of MHGs. Participants also schedule a MHG meeting to attend (session 1)
and follow-up about their MHG attendance (sessions 2 and 3).

SR (NM) (n = 89): standard intensive referral to MHGs, which may include relying on the same MHG
"buddy" during and after treatment. intervention based on intensive referral used in Timko 2007,
which included counselor giving participants an AA/NA schedule, materials about 12-step philosophy,
arranging a meeting between the participant and an existing AA/NA member, agreeing on meeting to
attend, and following up with participants in future sessions.

Outcomes

Follow-up assessment points: baseline and 6-month follow-up
Abstinence: PDA from alcohol, cannabis, methamphetamine, and cocaine (measured using the TLFB),
complete abstinence

Drinking intensity: use per using day for each substance, including drinks per drinking day (DDD; mea-
sured using the TLFB)

Alcohol addiction severity: ASI-L to measure severity of alcohol (ASI-alcohol) and drug (ASI-drug) use

Funding source: Department of Veterans Affairs, Veterans Health Administration, Office of Research
and Development, Health Services Research and Development (RCS 00-001), the VA Office of Rural
Health Midwest Rural Health Resource Center; The Department of Veterans Affairs Substance Use Dis-
orders Quality Enhancement Research Initiative; and the Department of Veterans Affairs Health Ser-
vices Research and Development Service Quality Enhancement Research Initiative

Declaration of interest: none disclosed

Authors' judgement

Support for judgement

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

High risk

Participants were not randomized. Participants entering substance use treat-
ment were "assigned a therapist" but this was not random. The therapist pro-
vided either a SR or RAIR to MHGs.

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

High risk

Risk is high due to the study being non-randomized.

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

High risk

Follow-up attrition rate was moderately high (28%) but differential attrition by
study intervention was not reported.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

Authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

54

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Grant 2018  (Continued)

Cochrane Database of Systematic Reviews

Protection against conta-
mination

Unclear risk

Unclear if communication between the intervention and comparison groups
occurred

Blinding of outcome as-
sessment (detection bias)
All outcomes

Herman 2000 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants were randomly assigned (within gender and order of enrollment) using a 2:1
ratio to either the MHCD program or SWT.

Recruitment and setting: participants were newly admitted patients recruited from a JCAHO-accred-
ited state psychiatric hospital in the Midwest.

Fidelity assessment of intervention implementation: 0 (non-manualized)

Participants

485 participants who met criteria for mental illness and alcohol dependence (47.3%), alcohol abuse
(26.1%), cocaine dependence (39.9%), cocaine abuse (20.3%), cannabis dependence (10.3%), and/or
cannabis abuse (12.4%), based on a modified 28-item version of the Michigan Alcoholism Test and clini-
cal determination. 429 participants completed at least one post-discharge interview.

Age: the mean sample age was 33.2 (SD 7.2) years. (Note: mean age based on 429 participants who
completed at least one post-discharge interview)

Gender: 317 participants (73.9%) were male. (Note: gender information based on 429 participants who
completed at least one post-discharge interview)

Ethnicity: 99 participants (23.1%) were Caucasian (understood to be white) and 330 participants
(76.9%) were African American. (Note: ethnicity information based on 429 participants who completed
at least one post-discharge interview)

Interventions

MHCD (NM) (n = 307): specialized treatment based on a staged theoretical model in which patients
participated in AA/NA groups, family education, and RP. Participants in the MHCD program were also
required to attend two AA and/or NA meetings each week.

SWT (NM) (n = 178): consisted of standard short-term treatment that did not emphasize substance use
treatment, though participants could elect to attend AA and/or NA.

Outcomes

Follow-up assessment points: baseline, 4 weeks or hospital discharge (whichever occurred first), and
2, 6, 10, 14, and 18 months post-discharge.
Abstinence: number of days of alcohol in the month prior to each interview using the ASI

Notes

Participant information also reported in Herman 1997

Funding source: National Institutes of Mental Health, Research in State Mental Health Agencies initia-
tive (MH46307)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Unclear risk

Participants randomly assigned to receive either the intervention or compari-
son treatment but no other details are provided

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

55

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Herman 2000  (Continued)

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Unclear risk

No details on type of randomization procedure provided

High risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. In the report, sufficient details were provided that participants could
be aware of the different interventions: (quote, page 289) "During recruitment,
both treatment programs were described to the person along with the pur-
pose and procedures of the study."

Unclear risk

Not enough information provided to permit judgment of low or high risk

Low risk

Expected outcomes are reported

Unclear risk

Information about comparability of cohorts is unclear

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

High risk

Although on different wards, both treatments were housed within the same
residential treatment hospital and it is likely that participants would have had
interactions during the course of their stay

Blinding of outcome as-
sessment (detection bias)
All outcomes

Humphreys 1996 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: observational cohort study and economic evaluation. Participants initially selected either pro-
fessional outpatient alcohol treatment or AA as their source of help for their alcohol problem.

Recruitment and setting: participants recruited between January 1984 and December 1986 from
detoxification units and alcoholism information and referral services in the San Francisco Bay area.

Fidelity assessment of intervention implementation: 0 (non-manualized)

Participants

201 alcoholic participants who had no prior treatment for alcohol problems

Age: the mean sample age was 35.3 (SD 8.8) years. The mean age in the AA (n = 135) group was 34.7 (n =
9.1) years and 36.4 (SD 8.2) years in the outpatient (n = 66) group.

Gender: 102 participants (50.9%) were male.

Ethnicity: 174 participants (86.6%) were Caucasian (understood to be white)

Interventions

AA group (NM) (n = 135): participants chose AA as their only source of help

Outpatient group (NM) (n = 66): participants chose to receive professional outpatient treatment from
either a social worker, psychologist, psychiatrist, general medical practitioner, or outpatient alco-
holism treatment clinic.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

56

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Humphreys 1996  (Continued)

Outcomes

Follow-up assessment points: baseline, 1- and 3-year follow-ups.

Abstinence: number of days intoxicated in the past month

Cochrane Database of Systematic Reviews

Drinking intensity: number of ounces of ethanol consumed on a typical drinking day in the past
month (DDD and PDHD).

Alcohol-related consequences: adverse consequences scale score (measured using a 9-item scale; in-
formation on adverse consequences also obtained from participants' collaterals)

Alcohol addiction severity: Alcohol Dependence Scale score

Economic savings; healthcare cost offsets: per person alcoholism treatment costs (based on 1994
dollars and calculated using a list of nationally representative costs for services)

Funding source: NIAAA grants AA10652 to Dr Humphreys and AA02863 and AA06699 to Dr Moos and the
Department of Veterans Affairs Health Services Research and Development Service and Mental Health
and Behavioral Sciences Service

Declaration of interest: none disclosed

Authors' judgement

Support for judgement

High risk

Non-random assignment of participants (observational cohort design)

High risk

Risk is high due to the study being non-randomized.

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Unclear risk

Not enough information provided to permit judgment of low or high risk

Low risk

Expected outcomes are reported

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

High risk

No matching or no adjustment for most important confounding factor (AA
group had a worse prognosis at baseline)

Selection of the non-ex-
posed cohort

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

High risk

It is likely that the control group received the intervention (some participants
crossed interventions from their initial intervention)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Blinding of outcome as-
sessment (detection bias)

Unclear risk

Insufficient information to make judgment of high or low risk

Unclear risk

Insufficient information to make judgment of high or low risk

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

57

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Humphreys 1996  (Continued)
Cost-effectiveness only

Kahler 2004 

Study characteristics

Methods

Design: RCT. Participants in inpatient detoxification were randomly assigned by 8-person cohort to re-
ceive either BA to attend AA-NA or an ME-12 intervention designed to increase 12-step attendance.

Recruitment and setting: participants were recruited from an inpatient alcohol detoxification facili-
ty. At least 24 hours after the participant entered detox, research assistants explained study procedures
and participants completed baseline (if they enrolled).

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

48 participants with alcohol dependence who were patients in an inpatient alcohol detox facility

Interventions

Age: participants ranged in age from 18-65 years, with a mean age of 42.0 (SD 7.8) years in the BA group,
and 44.1 (SD 7.0) years in the ME-12 group.

Gender: 29.1% female in the BA group and 16.7% female in the ME-12 group (P = 0.49).

Ethnicity: 79.2% white, 16.6% African American, and 4.2% other in the BA group, and 83.3% white,
12.5% Hispanic-Latino, and 4.2% other in the ME-12 group (all non significant).

ME-12 (M) (n = 24): participants received a manual-guided 60-minute intervention which included: a
focus on increasing the participants' commitment to abstinence, discussion of the participants' goals
for reducing alcohol use and how they plan to meet those goals, a brief explanation of AA-NA and how
to obtain a temporary sponsor, discussion of the positive and negative aspects of 12-step groups, as
well as discussion of the benefits of AA-NA, among other components.

BA (M) (n = 24): participants received a scripted, 5-min session with a therapist who stressed that the
participant had an alcohol problem and the importance of abstinence, and briefly described AA-NA and
its benefits. Therapists recommended the participant be as involved as possible in AA-NA and gave the
participant a meeting schedule.

Outcomes

Follow-up assessment points: baseline and 1-, 3-, and 6-month follow-ups, and significant other inter-
views (regarding participants' drinking) were conducted at 1-, 3-, and 6-month follow-ups.

Abstinence: PDA, measured using TLFB

Drinking intensity: average number of DDD measured using TLFB

Notes

Funding source: not reported

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Participants were randomized by cohort to avoid contamination across treat-
ments. Eight cohorts of six participants was run with each cohort determined
randomly.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

58

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Kahler 2004  (Continued)

Allocation concealment
(selection bias)

Low risk

Cochrane Database of Systematic Reviews

Researchers enrolling participants could not foresee assignment. Participants
were randomized by cohort to avoid contamination across treatments. Eight
cohorts of six participants was run with each cohort determined at random.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Unclear risk

Missing outcome data were low at follow-ups (10% to 15%) but no details on
differential follow-up by study intervention was reported.

Low risk

Expected outcomes are reported

Unclear risk

Information about comparability of cohort is unclear

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (each cohort passed
through before next one began)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Kaskutas 2009b 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: quasi-RCT using an 'ON/OFF' design so that participants in the ON (i.e. intervention) interven-
tion did not discuss MAAEZ content with those in the OFF (i.e. control) intervention. Treatment coun-
selors first delivered the 'OFF' intervention (TAU) and then delivered the 'ON' intervention (MAAEZ)
wherein six MAAEZ sessions replaced six usual care 12-step education groups, and then participants re-
turned to TAU.

Recruitment and setting: participants recruited from 3 July 2005 to 5 May 2006 from two northern
California treatment centers which, together, had day treatment (1 month), outpatient treatment (6
months), short-term residential treatment (1 month), and long-term residential treatment (1 program
up to 9 months, the other up to 12 months) programs.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

508 participants who were in treatment for current drug or alcohol abuse or dependence (as deter-
mined by the Quick-DIS; Diagnostic Interview Schedule Quick Form for Substance Abuse/ Dependence)

Age: the sample was comprised of 30% 18-20 year olds, 29.5% 30-39 year olds, 32.4% 40-49 year olds
and 8.2% 50+ year olds in the long-term residential program; 27.9% 18-20 year olds, 29.4% 30-39 year
olds, 26.5% 40-49 year olds and 16.2% 50+ year olds in the short-term residential program, and 34.2%
18-20 year olds, 29.8% 30-39 year olds, 26.1% 40-49 year olds and 9.9% 50+ year olds in the outpatient
program.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

59

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Kaskutas 2009b  (Continued)

Cochrane Database of Systematic Reviews

Gender: participants were 67.8% male and 32.2% female in the long-term residential program, 74.3%
male and 25.7% female in the short-term residential program, and 59% male and 41.0% female in the
outpatient programs.

Ethnicity: participants were 41.2% white, 26.1% black, 24.6% Hispanic, and 8.1% other in the long-
term residential program; 63.2% white, 19.9% black, 10.3% Hispanic, 6.6% other in the short-term resi-
dential program, and 56.5% white, 10.6% black, 26.7% Hispanic, and 6.2% other in the outpatient pro-
gram.

Interventions

MAAEZ (M) (n = 312): a manual-guided intervention designed to help individuals overcome their resis-
tance to 12-step groups by helping them change their attitudes towards, and connect with, people who
they would encounter in AA.

Treatment as usual (NM) (n = 196): included an introduction to the 12 steps of AA/NA/CA, addiction
education, RP, stress and anger management, as well as process groups and family education.

Outcomes

Follow-up assessment points: baseline, 6- and 12-month follow-ups.

Abstinence: last 30-day abstinence status (dichotomous Y/N variable derived from ASI questions on
past 30-day alcohol and drug use).

Notes

Funding source: NIAAA grant (R01-AA14688)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Researchers use alternation as a non-random component in the sequence
generation process

Allocation concealment
(selection bias)

High risk

Researchers enrolling participants could possibly foresee assignment (alterna-
tion)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Low risk

Incomplete outcome data
(attrition bias)
All outcomes

High risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we believe it is unlikely that participants in this study had
knowledge of the two different interventions because a sequential ON/OFF de-
sign was used to expressly avoid this.

Lost to follow-up rates overall were moderate (25%), but no details of differen-
tial follow-up rates by study intervention were reported.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Protection against conta-
mination

Blinding of outcome as-
sessment (detection bias)

Low risk

Expected outcomes are reported

Unclear risk

Information about comparability of cohort by intervention group not provided

Low risk

Non-exposed cohort drawn from the same sample origin

Low risk

Unlikely that the control group received the intervention (ON-OFF design)

Unclear risk

Insufficient information to make judgment of high or low risk

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

60

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Kaskutas 2009b  (Continued)

All outcomes

Kelly 2017b 

Study characteristics

Methods

Design: RCT. Participants randomly assigned to receive 10 sessions of either the iTSF or MET/CBT
group. Data collected at baseline, 3, 6, and 9 months after treatment entry.

Recruitment and setting: participants were recruited between July 2013 and February 2014 from a
variety of sources, including: through community advertisements, schools, local treatment programs,
and probation offices/drug courts. The study site was the Center for Addiction Medicine at Massachu-
setts General Hospital in Boston, MA.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

59 adolescents with alcohol/drug abuse or dependence (DSM-IV-TR criteria)

Interventions

Age: the mean sample age was 16.8 (SD 1.7) years and the sample age range was 14 to 21 years. The
mean age in the MET/CBT group was 16.9 (SD 2.0) years and 16.8 (SD 1.6) years in the iTSF group.

Gender: the sample was 73% male, 27% female. The MET/CBT group was 73.3% male (n = 22) and
26.7% female (n = 8), and the iTSF group was 72.4% (n = 21) male and 27.6% female (n = 8).

Ethnicity: the sample was 78% non-Hispanic white. The MET/CBT group was 10.7% African American,
7.1% Asian/Pacific Islander, 67.9% white, and 14.3% reported more than one race. The iTSF group was
7.1% African American, 3.6% Asian/Pacific Islander, 82.1% white, and 7.1% reported more than one
race.

iTSF (M) (n = 29): included 1 individual session (60-75 minutes) followed by 8 weekly sessions (90 min-
utes) with an individual booster session prior to the fifth group session (30-50 minutes). Six iTSF groups
were based around recovery-related topics (e.g. 12-step attendance, reducing relapse risk, changing
social networks), and in the two other groups members of 12-Step organizations (i.e. MA or NA) were in-
vited to the group to share their experiences with participants.

MET/CBT (M) (n = 30): included 2 consecutive individual MET sessions (60 minutes each) followed
by 8 weekly group CBT sessions (90-minutes each). CBT groups focused on teaching and practicing a
CBT skill (e.g. coping with urges) and participants were assigned topic-related homework after each
group.

Outcomes

Follow-up assessment points: baseline and 3, 6, 9 months after treatment entry

Abstinence: PDA from any drugs or alcohol (excluding nicotine) measured using TLFB; longest period
of abstinence (derived from TLFB and Form-90); abstinent/mostly abstinent as a dichotomous variable
(Y/N)

Alcohol-related consequences: 15-item Short Inventory of Problems-Recent (SIP-2R)

Notes

Funding source: NIAAA grant (R01-AA019664)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

61

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Kelly 2017b  (Continued)

Cochrane Database of Systematic Reviews

Random sequence genera-
tion (selection bias)

Low risk

Participants randomly assigned to receive either the intervention or compari-
son treatment using a computerized urn randomization procedure.

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment because par-
ticipants randomly assigned to receive either the intervention or comparison
treatment using a computerized urn randomization procedure.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Low risk

Incomplete outcome data
(attrition bias)
All outcomes

High risk

This is a subjective outcome, likely to be influenced by knowledge of the in-
tervention. However, the report states that the participants in this trial had no
knowledge of the different interventions: (quote page 6) "Following random-
ization, the research coordinator informed each participant of their assign-
ment to either the 'Tuesday group' or 'Wednesday group', but did not refer to
the treatment interventions by name."

Missing outcome data are balanced across intervention and comparison
groups (iTSF = 21%; MET/CBT = 30%).

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (groups took place on
different days of the week)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Litt 2007 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants randomly assigned to one of three outpatient treatment interventions that
were conducted over 12 weekly, 60-minute sessions: NS, NS + CM or CaseM; a control intervention. Da-
ta were collected at baseline, post-treatment (3 months), and at 6 (phone), 9 (in person), 12 (phone), 15
(in person), 18 (phone), 21 (in person), 24 (phone), and 27 (in person) months follow-up.

Recruitment and setting: participants were recruited from October 2002 to March 2005 through news-
paper and radio advertisements, as well as the research programs at the site, which is a university med-
ical center.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

210 men and women with alcohol abuse or dependence (DSM-IV criteria)

Age: the mean sample age was 45 (SD 11.4) years.

Gender: the sample was 58% male.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

62

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Litt 2007  (Continued)

Interventions

Outcomes

Ethnicity: the sample was 86% white, 8% black, 4% Hispanic, and 2% other.

NS (M) (n = 71): included core topics that were based on the ones used in the Project MATCH TSF, but
emphasized and sought to help participants change their social networks from one that reinforces
drinking to one that reinforces sobriety. AA attendance was encouraged, and recovery tasks (i.e. home-
work) were assigned each session and intended to help participants expand their sober social network.

NS + CM (M) (n = 70): included the same NS treatment as above, but included reinforcements that
were contingent upon participants' completion of tasks (verified by signed slips) between sessions.

CaseM (M) (n = 69): with the help of their therapist, participants identified problems in various do-
mains (e.g. interpersonal, psychiatric, medical, financial, etc) that could create barriers to abstinence,
selected goals to overcome them, and identified resources for doing so. AA attendance was neither en-
couraged nor discouraged. CaseM served as an active control intervention and was based on the inter-
vention used in the Marijuana Treatment Project.

Abstinence: PDA (measured using Form-90) and continuous abstinence during the 90-day period pri-
or to each follow-up (measured using Form-90). Self-reports verified using urine samples (at baseline
and post-treatment to screen for drug use), breathalyzer (at intake, every treatment session in all inter-
vention interventions, and every in-person follow-up), and collaterals for one third of participants (ran-
domly selected).

Drinking intensity: DDD; measured using Form-90

Alcohol-related consequences: DrInC

Notes

Included sibling paper(s)

• Litt 2007: evaluated outcomes at 1-year post-treatment (15 months). Outcomes include: PDA (mea-
sured using Form-90), continuous abstinence during the 90-day period prior to each follow-up (mea-
sured using Form-90), and DrInC.

• Litt 2009: reported on 2-year post-treatment outcomes (27 months). Outcomes include: PDA (mea-
sured using Form-90), continuous abstinence during the 90-day period prior to each follow-up (mea-
sured using Form-90), DDD (measured using Form-90), and DrInC.

Funding source: NIAAA grant (R01-AA12827) and in part by NIH General Clinical Research Center Grant
M01-RR06192

Declaration of interest: none disclosed

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Authors' judgement

Support for judgement

Low risk

Researchers used a computerized urn randomization procedure

Low risk

Researchers enrolling participants could not foresee assignment.

High risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. In the report, sufficient details were provided that participants could
be aware of the different interventions: (quote, page 543) "Given the proce-
dures used in each treatment, participants, therapists, and research assistants
could not be blinded as to experimental condition."

Incomplete outcome data
(attrition bias)
All outcomes

Unclear risk

Missing outcome data do not appear to be significantly different across inter-
vention and comparison groups (CASE M = 7%; NS = 11%; NS + CM = 16%) but
significance test results are not reported.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

63

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Litt 2007  (Continued)

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (treatments were in-
dividually-delivered)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Litt 2016 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants randomly assigned to receive 12 weekly 60-minute sessions of either an up-
dated NS treatment or PCBT.

Recruitment and setting: participants were recruited through newspaper and radio ads from June
2010 through March 2012.

Fidelity assessment of intervention implementation: 1 (report of attempts to ensure adher-
ence/competence without audio or videotape)

Participants

193 men and women with alcohol dependence (DSM-IV criteria)

Interventions

Age: the mean sample age was 46.0 (SD 10.5) years. The mean age was 45.1 (SD 9.8) years in the PCBT
group and 47.2 (SD 11.2) years in the NS group.

Gender: the sample was 65.8% male. The PCBT group was 70.1% male and the NS group was 61.5%
male.

Ethnicity: the sample was 92.7% white, 2.6% black, 3.1% Hispanic, and 1.6% other. The participants in
the PCBT group were 92.8% white, 2.1% black, 3.1% Hispanic, and 2.0% other, and the participants in
the NS group were 92.7% white, 3.1% black, 3.1% Hispanic, and 1.0% other.

NS (M) (n = 96): included core topics that were based on the ones used in the Project MATCH TSF, but
emphasized and sought to help participants change their social networks from one that reinforces
drinking to one that reinforces sobriety. AA attendance was encouraged, and recovery tasks (i.e. home-
work) were assigned weekly and intended to help participants expand their sober social network. Im-
portantly, the updated NS program increased the emphasis and amount of time spent on social skills
training.

PCBT (M) (n = 97): manualized, skill-based, CBT designed to improve coping skills for interpersonal
and intrapersonal problems or experiences that may lead to drinking. AA attendance was neither en-
couraged nor discouraged, and skills training assignments (i.e. homework) were assigned each week.

Outcomes

Follow-up assessment points: baseline and 3, 9, 15, 21, and 27 months follow-up (24 months post-
treatment)

Abstinence: (PDA; Form-90) and complete 90-day abstinent status prior to each follow-up

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

64

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Litt 2016  (Continued)

Cochrane Database of Systematic Reviews

Drinking intensity: (PDD; Form-90) and (PDHD; Form-90) in the 90-day period prior to each follow-up

Alcohol-related consequences: DrInC

Notes

Funding source: NIAAA grant (R01-AA12827) and in part by NIH General Clinical Research Center Grant
M01-RR06192

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Participants randomly assigned to receive either the intervention or compari-
son treatment using a computerized urn randomization procedure.

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment. Participants
were randomly assigned to receive either the intervention or comparison
treatment using a computerized urn randomization procedure.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

High risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. In the report, sufficient details were provided that participants could
be aware of the different interventions: (quote, page 207) "Given the proce-
dures used in each treatment, neither participants, therapists, nor research as-
sistants could be blinded as to treatment condition."

Incomplete outcome data
(attrition bias)
All outcomes

Unclear risk

Missing outcome data do not appear to be significantly different across inter-
vention and comparison groups (PCBT 15%; NS 17%); but significance test re-
sults are not reported.

Low risk

Expected outcomes are reported.

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Low risk

Unlikely that the control group received the intervention

Unclear risk

Insufficient information to make judgment of high or low risk

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Protection against conta-
mination

Blinding of outcome as-
sessment (detection bias)
All outcomes

Lydecker 2010 

Study characteristics

Methods

Design: quasi-RCT. Participants randomly assigned to receive 24 weeks of either ICBT + P or TSF + P.

Recruitment and setting: participants recruited from referrals to the VA SAMI program. SAMI is a dual
diagnosis outpatient clinic for veterans with co-occurring substance use disorder and Axis I disorders.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

65

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Lydecker 2010  (Continued)

Cochrane Database of Systematic Reviews

Fidelity assessment of intervention implementation: 0 (no report of attempts to ensure adher-
ence/competence of intervention implementation)

Participants

206 veterans with depression and substance use disorder (DSM-IV criteria)

Age: the mean sample age was 48.2 (SD 7.7) years. The mean age was 48.4 (SD 8.1) years in the TSF + P
group and 48.0 (SD 7.5) years in the ICBT + P group.

Gender: the sample was 92% male, and the TSF + P group and ICBT + P groups were 91% and 93%
male, respectively.

Ethnicity: the sample was 71% white, and the TSF + P group and ICBT + P groups were 69% and 73%
white, respectively.

Interventions

TSF + P (M) (n = 99): based on the Project MATCH TSF manual, but adapted to include group sessions
(rather than individual).

ICBT + P (M) (n = 107): based on CBT for depression and included cognitive behavioral coping skills
training for addiction. Treatment consisted of two phases which focused on developing core skills (e.g.
managing cognitions, building social network, and increasing healthy activities; phase I), and reviewing
and reinforcing the core skills (phase II).

Outcomes

Follow-up assessment points: baseline (intake), mid-treatment (12 weeks), end of treatment (24
weeks) and 3, 6, 9, and 12 months post-treatment

Abstinence: PDA, measured using TLFB and monthly toxicology screens (required by SAMI) used to
help participant recall dates of use

Notes

Funding source: VA Medical Research Merit Review Grant awarded to Sandra A Brown and VA Merit Re-
view Entry Program Grant awarded to Susan R Tate

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Researchers use alternation as a non-random component in the sequence
generation process

Allocation concealment
(selection bias)

High risk

Researchers enrolling participants could possibly foresee assignment (alterna-
tion)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

High risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. In the report, sufficient details were provided that participants could
be aware of the different interventions: (quote page 456) "Given the nature of
this study in a clinical context, participants, administrators, and interviewers
were not blinded to patients' treatment assignment."

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Low risk

Missing outcome data is balanced across intervention and comparison groups

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

66

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Lydecker 2010  (Continued)

Selection of the non-ex-
posed cohort

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (sequential treat-
ment delivery)

Unclear risk

Insufficient information to make judgment of high or low risk

Blinding of outcome as-
sessment (detection bias)
All outcomes

Manning 2012 

Study characteristics

Methods

Design: RCT. Participants randomly assigned to one of three interventions: 12-Step PI, DI, or NI.

Recruitment and setting: participants recruited from a 10-14 day inpatient alcohol/drug detoxifica-
tion treatment at the South London and Maudsley NHS Foundation Trust in London.

Fidelity assessment of intervention implementation: 0 (no report of attempts to ensure adher-
ence/competence of intervention implementation)

Participants

151 participants with alcohol or drug dependence (DSM-IV criteria)

Interventions

Age: the mean sample age was 39.9 (SD 8.9) years, and 41.0 (SD 9.5) years, 39.8 (SD 8.3) years, and 38.9
(SD 8.9) years in the NI, DI, and PI groups, respectively (P = 0.49).

Gender: the sample was 67.2% male (n = 102) , and the NI, DI, and PI groups were 70.8% (n = 34), 67.3%
(n = 33), and 64.8% (n = 35) male, respectively (P = 0.81).

Ethnicity: the sample was 86.1% white British (n = 130), and the NI, DI, and PI groups were 89.6% (n =
43), 89.9% (n = 44), and 76.9% (n = 43) white British, respectively (P = 0.23).

PI (M) (n = 54): included a single, one-on-one 30-45 minute session wherein a peer shared their own
story about how 12-step groups had helped them, explained the history of AA/NA/CA and how meetings
are structured, discussed stereotypes and barriers to attending AA/NA/CA, and encouraged patients to
attend several meetings to find one that fits. This active intervention was based on the manuals and
study materials from earlier studies (Blondell 2001; Timko 2006).

DI (M) (n = 49): included a single, one-on-one 30-45 minute session wherein a doctor provided encour-
agement and shared success stories of former patients, explained the history of AA/NA/CA and how
meetings are structured, discussed stereotypes and barriers to attending AA/NA/CA, and encouraged
patients to attend several meetings to find one that fits. This active intervention was based on the man-
uals and study materials from earlier studies (Blondell 2001; Timko 2006).

NI (NM) (n = 48): patients were provided with a list of meetings on the ward only.

Outcomes

Follow-up assessment points: baseline (second day of detox admission), end of treatment (pre-dis-
charge), and 2-3 months post-treatment (post-discharge)

Abstinence: complete abstinence from the substance for which the participant was receiving treat-
ment

Notes

Funding source: Action on Addiction and the Wates Foundation

Declaration of interest: none disclosed

Risk of bias

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

67

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Manning 2012  (Continued)

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Researchers used random number tables to generate a randomly assigned in-
tervention for each participant.

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment. Researchers
used random number tables to generate a randomly assigned intervention for
each participant.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

Missing outcome data is balanced across intervention and comparison groups
(PI 16.7%; DI 14.3%; NI 18.8%; P > 0.05).

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Unclear risk

Unclear if communication between the intervention and comparison groups
occurred

Blinding of outcome as-
sessment (detection bias)
All outcomes

MATCH 1997 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants randomly assigned to one of three manual-guided, 12-week, individually-de-
livered treatments: CBT, MET, or TSF. Participants were assigned to groups using an urn randomization
procedure that matched participants on several key variables.

Recruitment and setting: participants were recruited after completing inpatient or intensive day hos-
pital treatment (aftercare arm) or directly from the community or outpatient treatment centers (outpa-
tient arm). Participants were recruited from five outpatient and five aftercare sites across nine perfor-
mance sites.

9 performance sites, but one of the sites was both an outpatient and aftercare site, for a total of five
outpatient and five aftercare sites

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

1726 participants with alcohol abuse or dependence (DSM-III-R) who were receiving aftercare (n = 774)
or outpatient (n = 952) therapy at one of nine treatment sites.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

68

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

MATCH 1997  (Continued)

Cochrane Database of Systematic Reviews

Age: the mean age was 38.9 (SD= 10.7) years in the outpatient arm, and 41.9 (SD 11.1) in the aftercare
arm.

Gender: the outpatient arm was 28% female and 72% male, and the aftercare arm was 20% female and
80% male.

Ethnicity: participants in the outpatient arm were 80% white, 6% African American, 12% Hispanic, and
2% other, and 80% white, 15% African American, 3% Hispanic, and 1% other in the aftercare arm.

Interventions

TSF (M) (n = 582): designed to facilitate AA participation and work on the 12 steps, and encouraged
participants to accept alcoholism as a disease, which was viewed as both a spiritual and medical dis-
ease. TSF treatment included weekly treatment sessions.

CBT (M) (n = 567): designed to help participants develop skills to cope with situations that can lead to
relapse, as drinking behavior was viewed as functionally related to problems in participants' lives. In-
cluded weekly treatment sessions.

MET (M) (n = 577): designed to produce internally-motivated change that the participant could then
mobilize throughout their recovery. MET treatment included four sessions occurring in weeks 1, 2, 6
and 12.

Outcomes

Follow-up assessment points: baseline (across three intake sessions), 3 months (end of treatment),
and at 3, 6, 9, and 12 months post-treatment, as well as 3 and 10 years post-treatment

Abstinence: PDA; complete abstinence

Drinking intensity: DDD

Alcohol-related consequences: DrInC

Economic savings; healthcare cost offsets: total medical care costs/medical care cost savings

Notes

Included sibling paper(s)

• Holder 2000 : to evaluate the cost of medical care before and for 3 years after alcoholism treatment
among a subset of participants at two treatment sites who were randomly assigned to receive TSF,
CBT, MET. Outcomes include total medical costs and medical care cost saving.

• MATCH 1998 [DOI: 10.1111/j.1530-0277.1998.tb03912.x ]: to evaluate the status of matching hypothe-
ses and 3-year outcomes of alcohol dependent participants in the outpatient arm who had been ran-
domized into one of 3 treatment interventions: CBT, MET, TSF. Outcomes include: PDA, Form-90; com-
plete abstinence; and DDD, Form-90.

• MATCH 1998 [DOI:10.15288/jsa.1998.59.631]: to assess drinking and psychosocial functioning during
treatment among participants in the outpatient and aftercare arms randomly assigned to CBT, MET
or TSF. Outcomes assessed at end of treatment include: PDA, Form-90; complete abstinence; DDD,
Form-90; and DrInC.

Funding source: NIAAA Project MATCH

• Holder  2000  :  NIAAA  grant  No.  5  R01-AA09228  to  the  Pacific  Institute  for  Research  and  Evaluation,

Chapel Hill, North Carolina

Declaration of interest: the Project MATCH Research Group is composed of the steering committee
members who developed this research protocol and executed all aspects of the trial

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Authors' judgement

Support for judgement

Low risk

Researchers used a computerized urn randomization procedure

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

69

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

MATCH 1997  (Continued)

Cochrane Database of Systematic Reviews

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment. Researchers
used a computerized urn randomization procedure.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

Unclear risk

Overall, a minimum of 90% of all participants completed the follow-up assess-
ments but it's unclear whether there were attrition differences between treat-
ment interventions as these were not specified.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (individually-deliv-
ered treatment)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Blinding of outcome as-
sessment (detection bias)
Cost-effectiveness only

McCrady 1996 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Unclear risk

Insufficient information to make judgment of high or low risk

Design: RCT. Participants randomly assigned to receive 15 weekly, 90-minute sessions of ABMT, AA +
ABMT, or RP + ABMT.

Recruitment and setting: participants recruited through an outpatient treatment program, advertise-
ments announcing low-cost couple's therapy for alcoholism, as well as through community referrals.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

90 couples (males with alcohol abuse or dependence (DSM-III-R criteria) and their female partners)
who were seeking joint outpatient behavioral alcoholism treatment

Age: the mean age was 39.44 (SD 10.27) years for men and 37.4 (SD 10.3) years for women.

Gender: sample was comprised of 90 male participants and their female partners.

Ethnicity: participants in the sample were 92.3% Caucasian (understood to be white), 5.7% African
American, 1% Hispanic, and 1% Native American.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

70

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

McCrady 1996  (Continued)

Interventions

AA + ABMT (M) (n = 31): included ABMT and focused on AA. Participants and their partners learned
about AA and its philosophy, identified and set attendance goals for meetings, and were encouraged to
get a sponsor and work the first steps of AA.

RP + ABMT (M) (n = 29): included ABMT plus RP, which included lessons about anticipating high-risk
situations for drinking, identifying relapse warning signs and developing coping skills, as well as four
maintenance sessions in the 12 months after treatment (with therapists having the option to schedule
two additional sessions each time they met with the couple).

ABMT (M) (n = 30): included CBT for both the participant and his partner, behavioral marital therapy,
and behavioral self-recording.

Outcomes

Follow-up assessment points: baseline, throughout treatment using daily self-recording cards, up-
on treatment completion (15 weeks), and monthly for 18 months post-treatment (with in-person inter-
views at 6, 12, and 18 months post-treatment, and the rest over the phone)

Abstinence: PDA, measured using TLFB; abstinent/mostly abstinent across follow-up period

Drinking intensity: time to first heavy drinking day (at follow-up); DDD, during treatment. During treat-
ment, participants reported the number of drinks per day on daily self-recording cards and their part-
ners also used daily self-recording cards to report subjective estimates of the participant's drinking (i.e.
abstinent, light, moderate, or heavy).

Notes

Included sibling paper(s)

• McCrady 1996 : evaluated post-treatment within-treatment outcomes among couples randomly as-
signed  to  receive  ABCT,  AA/ABCT,  and  RP/ABCT.  Outcomes  include:  percentage  drinking  days  and
drinks per drinking day (DDD).

• McCrady 1999: evaluated 6-month outcomes. Data collected at baseline and post-treatment through
monthly phone calls to participants and their spouses, with data aggregated over 6 months post-treat-
ment. Outcomes include: PDA, complete abstinence, and PDHD.

• McCrady 2004: reported on 18-month outcomes. Outcomes include PDA, measured using TLFB.

Additional notes

• McCrady 1999 and McCrady 2004 refer to interventions as alcohol-focused behavioral couple's ther-
apy (ABCT), ABCT plus AA (AA/ABCT), and ABCT plus RP (RP/ABCT), rather than ABMT, AA/ABMT, and
RP/ABMT, respectively.

• There was no limit on the number of weeks required to complete treatment and therapists had the
option of scheduling up to two additional sessions for emergencies. Additionally, couples who com-
pleted at least 5 sessions were scheduled for booster sessions at 1, 3, 6, 12 months, with therapists
having the option of scheduling 2 additional sessions after each booster.

Funding source: NIAAA grant AA07070

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Following an inquiry and direct correspondence to clarify the nature of the
randomization from the first author (Barbara McCrady) on 21 Jan 2018, the re-
searchers used sealed, opaque, envelopes which were prepared with an index
card inside each one with the treatment intervention on it (with an equal num-
ber of cards for each intervention). The Research Assistant pulled out an en-
velope at the end of the baseline assessment and opened it to find out which
treatment intervention the patient was assigned to.

Allocation concealment
(selection bias)

Low risk

Researchers prepared opaque envelopes (9-12 per batch) with an index card
inside each one with the treatment intervention on it (with an equal number of

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

71

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

McCrady 1996  (Continued)

Cochrane Database of Systematic Reviews

cards for each intervention). The Research Assistant would then pull out an en-
velope at random at the end of the baseline assessment and open it with the
participant to find out the intervention to which they had been assigned.

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Unclear risk

Not mentioned

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (individually-deliv-
ered as outpatient)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Unclear risk

Insufficient information to make judgment of high or low
risk

Mundt 2012 

Study characteristics

Methods

Design: cost-benefit study. Compared healthcare use and costs among individuals who reported any
12-step participation after alcohol and other drug treatment (i.e. during follow-up) to those who did
not.

Recruitment and setting: participants were recruited between March 2000 and May 2002 from four
Chemical Dependency Recovery Programs of Kaiser Permanente Northern California, which are absti-
nence-based and last approximately 1 year (including treatment and aftercare).

Fidelity assessment of intervention implementation: 0 (not applicable)

Participants

419 participants enrolled in the study. 403 adolescents completed at least one follow-up interview and
were included in the analyses.

Age: participants ranged from 13-18 years old at baseline (i.e. ranged in age from 18-25 at 7-year fol-
low-up) and the mean age at baseline was 16.14 (SD 1.26) years.

Gender: the sample was 66% male.

Ethnicity: the sample was 49% white, 20% Hispanic, 16% African-American, 9% Native American, and
6% Asian.

Interventions

12-step participants (n = 201): participants reported attending 10 or more 12-step meetings at 6
months, or 1-, 3- or 5-year follow-up.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

72

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Mundt 2012  (Continued)

No 12-step (n = 202): did not participate in 12-step at 6 months, or 1-, 3- or 5-year follow-up.

Outcomes

Follow-up assessment points: baseline, 6 months post-intake, and 1, 3, 5, and 7 years post-intake.
Medical care use data examined for three time periods: 1 to 3, 3 to 5, and 5 to 7 years post-intake.

Economic savings; healthcare cost offsets: number of hospital inpatient days, emergency room (ER)
visits, primary care visits, and psychiatric visits; alcohol and other drug treatment costs; and total med-
ical care costs.

Funding source: Robert Wood Johnson Foundation (Grant #037863), the Center for Substance
Abuse Treatment (Grant #00M007436), NIDA (R01-DA15803), and NIAAA (K01-AA018410-01 and R01-
AA018142-01A1)

Declaration of interest: none disclosed

Authors' judgement

Support for judgement

High risk

Non-random assignment of participants (observational cohort design)

High risk

Non-random assignment of participants (observational cohort design)

Low risk

This is not a subjective outcome (i.e. economic) and therefore unlikely to be in-
fluenced by knowledge of the intervention.

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Unclear risk

Although general follow-up rates across the seven-year follow-up were all
above 84%, there was no mention of follow-up rates between 12-step atten-
dees versus non-attendees.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported.

Low risk

Adjusted analyses for most important confounding factors and imbalance

Low risk

Non-exposed cohort drawn from the same sample origin.

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (community AA open
to everyone, but the group definition (i.e. "No 12-Step") prevents overlap)

Blinding of outcome as-
sessment (detection bias)
Cost-effectiveness only

Ouimette 1997 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: non-randomized. A naturalistic, multiple-site evaluation of 15 Department of VA substance
abuse treatment programs that were either 12-step, CBT, or eclectically (12-step/CBT) oriented.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

73

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Ouimette 1997  (Continued)

Cochrane Database of Systematic Reviews

Recruitment and setting: participants recruited from 15 VA Medical Center inpatient substance use
disorder treatment programs that had either a CBT (5 programs), 12-step (5 programs), or eclectic
(combined 12-step/CBT; 5 programs) treatment orientation.

Fidelity assessment of intervention implementation: 0 (non-manualized)

Participants

3018 substance-dependent (DSM-III-R, ICD-9) male participants who completed medical detoxification
and were admitted to the inpatient treatment program

Interventions

Age: mean sample age was 43 (SD 9.63) years.

Gender: sample participants were male only (women were excluded due to their small numbers).

Ethnicity: 49% of sample participants were African American, 46% were Caucasian (understood to
be white), 3% were Hispanic/Latino, and 2% were Native American, Asian, or of another racial/ethnic
background.

12-step (NM) (n = 897): treatment programs emphasized 12-step meeting attendance (in the hospital
and in the community), therapy groups that covered related topics such as working the steps and the
Big Book, accepting an alcoholic identity, acknowledging powerlessness over the problem substance,
and abstinence.

Eclectic (combined 12-step/CBT; NM) (n = 973): treatment programs used a combination of CBT and
12-step treatment approaches.

CB (NM) (n = 1148): treatment programs emphasized cognitive and behavioral skills training, absti-
nence skills training, and RP with the goal of enabling participants to learn ways to cope with and man-
age high-risk situations, and to better understand and acknowledge the effects of using their problem
substance.

Outcomes

Follow-up assessment points: data collected at baseline (Intake Information Form; IIF), discharge
(Discharge Information Form; DIF), 1-year follow-up (Follow-up Information Form; FIF; Ouimette 1997,
Humphreys 2001), and 2-year follow-up (Humphreys 2007).

Abstinence: proportion completely abstinent/abstinence from alcohol and drugs (verified using bio-
logical tests when possible)

Economic savings; healthcare cost offsets: compared healthcare utilization and costs in the year be-
fore and the year after inpatient treatment

Notes

Included sibling paper(s):

• Humphreys 2001: examined 1-year outcomes to determine whether participants treated in 12-step
programs versus CBT programs rely more on self-help groups and less on professionally provided ser-
vices after discharge, thereby reducing long-term healthcare costs. Economic savings and healthcare
costs offset outcomes include a comparison of mental healthcare utilization and costs in the year be-
fore and the year after inpatient treatment (based on VA budgets and 1999 dollars).

• Humphreys 2007: to determine whether the reduced healthcare costs and positive clinical outcomes
found at the 1-year follow-up were present at the 2-year follow-up. Substance use outcomes include
complete abstinence from alcohol and drugs. Economic savings and healthcare cost offset outcomes
included the number of mental health outpatient visits and number of inpatient days between one
and two years post-treatment, as well as their costs, which were calculated using 2006 dollars and VA
budget.

Funding source: Department of Veterans Affairs Mental Health Strategic Health Group at the Veterans
Affairs National Headquarters, Washington, DC

• Humphreys 2001: Department of Veterans Affairs Mental Health Strategic Health Group, Health Ser-

vices Research and Development Service, and a VA Young Investigator Award (KH)

• Humphreys 2007: Department of Veterans Affairs Health Services Research and Development Service
Career Research Scientist Awards #04-141 (KH) and #90-001 (RHM). Additional support was provided
by the NIAAA and the Robert Wood Johnson Foundation

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

74

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Ouimette 1997  (Continued)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Non-randomized study. Participants were compared who were being treated
naturalistically in one of three different types of VA residential treatment pro-
grams (TSF, CBT, or eclectic).

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

High risk

Risk is high due to the study being non-randomized.

Low risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, because the interventions were delivered in discreet hospi-
tals in different regions of the country, participants had no knowledge of the
different types of interventions being delivered other than their own.

High risk

CBT treatment follow-up rate 85%; TSF 78%; TSF/CB (eclectic) 81%; P < 0.001)

Low risk

Expected outcomes are reported.

Low risk

Adjusted analyses for most important confounding factors and imbalance

Low risk

Non-exposed cohort drawn from the same sample origin.

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (no chance of conta-
mination because study sites were very far apart)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Unclear risk

Insufficient information to make judgment of high or low risk

Blinding of outcome as-
sessment (detection bias)
Cost-effectiveness only

Low risk

Researchers enrolling participants could not foresee assignment (healthcare
data were coded automatically with no knowledge of intervention)

Timko 2006 

Study characteristics

Methods

Design: RCT. Participants randomly assigned to receive either a standard referral to self-help or an in-
tensive referral to self-help.

Recruitment and setting: participants were recruited upon entry to a VA outpatient substance use dis-
order treatment program that had a combined CB/TSF orientation and was abstinence-based.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

75

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Timko 2006  (Continued)

Participants

345 individuals with substance use disorder who were entering a new treatment episode. 281 at 6-
month follow-up.

Age: the mean sample age was 50 years. The mean age in the standard referral group was 50.7 years
and 50.2 years in the intensive referral group (P = 0.49).

Gender: the sample was 98% male. The standard referral group was 97.6% male and the intensive re-
ferral group was 97.8% male (P = 1.00).

Ethnicity: the sample was 43% white. 39% of participants in the standard referral group and 47.0% of
participants in the intensive referral group were white (P = 0.17).

Interventions

Intensive referral (M) (n = 181): involved giving participants an AA/NA schedule and encouraging
them to attend.

Standard referral (M) (n = 164): involved counselors giving participants an AA/NA schedule and mate-
rials about the 12-step philosophy, arranging a meeting between the participant and an existing AA/NA
member, agreeing on a meeting for the participant to attend, providing participants with sponsor infor-
mation, and following up with patients in future sessions.

Outcomes

Follow-up assessment points: baseline, 6- (Timko 2006) and 12-month (Timko 2007) follow-ups.

Abstinence: complete abstinence from alcohol and from drugs (measured using the ASI)

Alcohol addiction severity: ASI alcohol and drug composites score to measure the number, extent and
duration of symptoms in participants' lifetimes and in the past 30 days

Notes

Included sibling paper(s)

• Timko 2006 : evaluated 6-month outcomes among those who received either a standard or intensive
referral to 12-step self-help groups. Outcomes include: proportion completely abstinent (measured
using the ASI) and drug and alcohol addiction severity (measured using the ASI).

• Timko 2007: evaluated 1-year outcomes. Outcomes include: proportion completely abstinent (mea-

sured using the ASI) and drug and alcohol addiction severity (measured using the ASI)

Funding source: Department of Veterans Affairs Office of Research and Development (Health Services
Research and Development Service, IIR 20-067 and RCS 00-001)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

Low risk

Allocation concealment
(selection bias)

Low risk

Participants randomly assigned to receive either the intervention or compari-
son treatment using a randomized procedure wherein ID numbers, to be given
sequentially to participants, were randomly preselected within different sized
blocks to be assigned to each intervention.

Researchers enrolling participants could not foresee assignment. Participants
randomly assigned to receive either the intervention or comparison treatment
using a randomized procedure wherein ID numbers, to be given sequentially
to participants, were randomly preselected within different sized blocks to be
assigned to each intervention.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

76

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Timko 2006  (Continued)

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Unclear risk

Data not provided

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (treatments were in-
dividually-delivered)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Timko 2011 

Study characteristics

Methods

Unclear risk

Insufficient information to make judgment of high or low risk

Design: quasi-RCT study using an 'ON/OFF' design wherein standard or intensive referral interventions
were delivered through group counseling in alternate 3-month periods over 12 months. Participants re-
ceived either standard or intensive referral to DFGs.

Recruitment and setting: participants were recruited from a VA outpatient mental health treatment
program in Northern California.

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

287 individuals with a dual diagnosis of a substance use disorder and a psychiatric disorder who were
beginning a new treatment episode.

Interventions

Age: the mean sample age was 51.0 (SD 8.9) years. The mean age in the standard referral group was
51.2 (SD 8.8) years and 50.9 (SD 9.0) years in the intensive referral group (P = 0.78).

Gender: the sample was 90.9% male. The standard referral group was 89.7% male and the intensive re-
ferral group was 92.3% male (P = 0.44).

Ethnicity: the sample was 48.8% white. 51.7% of participants in the standard referral group and 45.8%
of participants in the intensive referral group were white (P = 0.31).

Intensive referral (M) (n = 142): participants were required to attend four additional outpatient ses-
sions within one month. The group counselor gave participants the DFG schedule, specific directions to
meetings and reviewed a DFG handout (session 1); further discussed the DFG handout and facilitated
a practice meeting (session 2); arranged to have a DFG member go to the group to give a personal his-
tory and meet participants (session 3); and followed-up with participants to see if they had attended a
meeting (session 4).

Standard referral (M) (n = 145): counselor gave participants the DFG schedule and using a standard-
ized script, encouraged them to attend.

Outcomes

Follow-up assessment points: baseline and 6-month follow-up

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

77

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Timko 2011  (Continued)

Cochrane Database of Systematic Reviews

Abstinence: number of days in the past 30 days that the participant used alcohol and used drugs (mea-
sured using ASI), from which PDA was derived; complete abstinence from alcohol, from other drugs,
from alcohol and other drugs

Alcohol addiction severity: ASI composite scores (alcohol, drug, psychiatric) to measure number and
duration of symptoms in the participant's life and in the past 30 days

Funding source: Department of Veterans Affairs (VA) Office of Research and Development (Health Ser-
vices Research & Development Service, IIR 05-014, RCS 00-001, and RCS 90-001), and the VA Office of
Academic Affiliations (TPP 65-500)

Declaration of interest: none disclosed

Authors' judgement

Support for judgement

Notes

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

High risk

Researchers use alternation as a non-random component in the sequence
generation process

Allocation concealment
(selection bias)

High risk

Researchers enrolling participants could possibly foresee assignment (alterna-
tion)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we believe it is unlikely that participants in this study had
knowledge of the two different interventions because a sequential ON/OFF de-
sign was used to expressly avoid this.

Unclear risk

No details provided

Low risk

Expected outcomes are reported

Low risk

Authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (alternating groups
were used to reduce contamination risk)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Low risk

Blinding of outcome assessment (trained research
interviewers blind to intervention), and unlikely that blinding
could have been broken

Vederhus 2014 

Study characteristics

Methods

Design: quasi-RCT. Participants were randomly assigned to receive either a MI or BA to attend 12-step
groups.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

78

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Vederhus 2014  (Continued)

Cochrane Database of Systematic Reviews

Recruitment and setting: participants were recruited between September 2008 and August 2010 from
an in-patient detox in Norway

Fidelity assessment of intervention implementation: 0 (no report of attempts to ensure adher-
ence/competence of intervention implementation)

Participants

140 participants with substance use disorder (confirmed at baseline using the Mini International Neu-
ropsychiatric Interview) who were being discharged back to their home and thus able to attend 12-step
groups.

Age: the mean sample age was 41 (SD 14) years. The mean age was 43 (SD 13) years in the MI group and
40 (SD 14) years in the BA group.

Gender: the sample was 33% female and 67% male. The MI group was 72% male (n = 49) and the BA
group was 63% (n = 45) male.

Ethnicity: 96% of the sample were native Norwegians or European-born. The MI group and BA group
were 96% (n = 65) and 96% (n = 69) native Norwegians or European-born, respectively.

Interventions

MI (M) (n = 68): participants received standard detox and two weekly 30-minute sessions wherein par-
ticipants were educated about addiction as a chronic disease, discussed personal experiences with and
misconceptions about AA, and 12-step volunteers were invited to the unit to meet with participants.

BA (M) (n = 72): participants received standard detox and were given a list of local 12-step groups and
briefly advised to attend.

Outcomes

Follow-up assessment points: baseline (in hospital) and 6-month post-treatment follow-up

Abstinence: number of days of alcohol use and drug use in the past 30 days, from which PDA was de-
rived; no alcohol or drug use in the past 30 days (i.e. complete abstinence)

Alcohol addiction severity: Alcohol use and drug use severity measured using the ASI, European Ver-
sion (EuropASI)

Notes

Funding source: The Norweigan Research Council; United States: Christine Timko was supported by VA
HSR&D (RCS 00-001)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Researchers used alternation as a non-random component in the sequence
generation process

Allocation concealment
(selection bias)

High risk

Researchers enrolling participants could possibly foresee assignment (alterna-
tion)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

High risk

Missing outcome data were generally moderate and did not appear to differ
significantly across interventions (MI 18%; BA 21%), but no statistical test for
this difference was reported.

Selective reporting (re-
porting bias)

Low risk

Expected outcomes are reported

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

79

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Vederhus 2014  (Continued)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (alternating groups
were used to reduce contamination risk)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Low risk

Blinding of outcome assessment (trained research
interviewers blind to intervention), and unlikely that blinding
could have been broken

Walitzer 2009 

Study characteristics

Methods

Design: RCT. Participants randomly assigned to 1 of 3 interventions, each consisting of a 12-session
manualized skills-based treatment package but differing in the discussion of AA and extent to which AA
materials were covered: MOT, DIR, or TAU (no specific emphasis on AA). Data collected at baseline, end
of treatment, and 3 (phone), 6 (in person), 9 (phone), and 12 (in person) months post-treatment.

Recruitment and setting: participants were recruited from the outpatient Clinical Research Center at
the Research Institute on Addictions in Buffalo, NY

Fidelity assessment of intervention implementation: 2 (report of attempts to ensure adher-
ence/competence with audio or videotape monitoring and rating)

Participants

169 alcoholic participants recruited from the Clinical Research Center

Age: the mean age of the sample was 43.8 (SD 11.0) years. The mean age was 45.2 (SD 11.8) years in the
TAU group, 40.8 (SD 10.9) years in the DIR group, and 45.3 (SD 9.9) in the MOT group.

Gender: the sample was 66.3% male and 33.7% female. The TAU group was 65.5% male and 34.5% fe-
male, the DIR group 62.3% male and 37.7% female, and the MOT group 70.7% male and 29.3% female.

Ethnicity: the sample was 88.2% white, 9.5% black, and 2.4% other. The TAU group was 86.2% white,
12.1% black, and 1.7% other; the DIR group 88.7% white, 9.4% black, and 1.9% other; and the MOT
group 89.7% white, 6.9% black, and 3.4% other.

Interventions

DIR (M) (n = 53): therapists used a therapist-directed AA facilitation consistent with the Project MATCH
TSF

MOT (M) (n = 58): therapists used a motivational enhancement approach to encouraging AA atten-
dance

TAU (M) (n = 58): therapists provided CBT and the standard instruction to "attend at least a couple of
AA meetings each week" (p. 5)

Outcomes

Follow-up assessment points: baseline, end of treatment, and 3 (phone), 6 (in person), 9 (phone), and
12 months (in person) post-treatment

Abstinence: PDA; measured using TLFB interview, reported by the participant and participant's collat-
eral

Drinking intensity: PDHD; using TLFB interview, reported by the participant and participant's collater-
al

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

80

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Walitzer 2009  (Continued)

Alcohol-related consequences: DrInC to assess a range of negative effects of alcohol use

Notes

Funding source: NIH grant AA11529

Declaration of interest: none disclosed

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Authors' judgement

Support for judgement

Low risk

Researchers used a computerized urn randomization procedure.

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment because a
computerized urn randomization procedure was conducted.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

Low risk

Missing outcome data overall were low and moderately low also across treat-
ment interventions (TAU 24%; DIR 11%; MOT 17%) but no significance test was
reported.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (treatments were in-
dividually-delivered)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Unclear risk

Insufficient information to make judgment of high or low
risk

Walitzer 2015 

Study characteristics

Methods

Design: RCT. Participants randomly assigned to receive 12, 60-minute sessions of either an AM treat-
ment or AAF treatment. Researchers used an urn randomization procedure that balanced groups by
gender and pre-treatment Brief Symptom Inventory-hostility scores.

Recruitment and setting: participants recruited through newspaper ads over a 17-month period that
began in March, 2011. Data collected at the University at Buffalo Research Institute on Addictions' Clini-
cal Research Center.

Fidelity assessment of intervention implementation: 1 (report of attempts to ensure adher-
ence/competence without audio or videotape)

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

81

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Walitzer 2015  (Continued)

Cochrane Database of Systematic Reviews

Participants

76 alcohol dependent (DSM-IV) men and women who scored moderate or above on anger measure

Age: the mean age of the sample was 46.3 (SD 8.8) years. The mean age was 46.7 (SD 8.6) years in the
AAF group and 45.9 (SD 9.0) in the AM group.

Gender: the sample was 55.3% male and 44.7% female. The AAF group was 57.5% male and 42.5% fe-
male and the AM group was 52.8% male and 47.2% female.

Ethnicity: the sample was 77.3% white, 12.0% black, and 10.7% other. The AAF group was 74.4% white,
15.4% black, and 10.3% other, and the AM group 80.6% white, 8.3% black, and 11.1% other.

Interventions

AAF (M) (n = 40): treatment focused primarily on facilitating mutual-help groups (e.g. AA), monitoring
client progress, and structured problem solving of alcohol-related problems. The treatment content
was derived from Project MATCH TSF and another AAF treatment.

AM (M) (n = 36): treatment focused on developing relaxation and cognitive coping skills for anger, as
well as applying these skills to cope with anger situations identified as high risk for alcohol use/relapse

Outcomes

Follow-up assessment points: baseline (pre-treatment), end of treatment, and 3- and 6-month post-
treatment follow-ups.

Abstinence: PDA; TLFB interview

Drinking intensity: DDD; TLFB interview

Alcohol-related consequences: short inventory of problems

Notes

Funding source: NIAAA grant (R01-AA17603)

Declaration of interest: none disclosed

Risk of bias

Bias

Random sequence genera-
tion (selection bias)

Authors' judgement

Support for judgement

Low risk

Researchers used a computerized urn randomization procedure

Allocation concealment
(selection bias)

Low risk

Researchers enrolling participants could not foresee assignment, because re-
searchers used a computerized urn randomization procedure.

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Unclear risk

This is a subjective outcome, likely to be influenced by knowledge of the inter-
vention. However, we could find no information in the report that the partici-
pants in this study had no knowledge of the different interventions.

Incomplete outcome data
(attrition bias)
All outcomes

High risk

Missing outcome data were moderately high in one intervention (AM 30%) but
low in the other (AAF 12.5%), but no significance test was provided.

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

Low risk

Expected outcomes are reported

Low risk

RCT; authors demonstrated balance between groups for the confounders

Low risk

Non-exposed cohort drawn from the same sample origin

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

82

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Walitzer 2015  (Continued)

Cochrane Database of Systematic Reviews

Protection against conta-
mination

Low risk

Unlikely that the control group received the intervention (manualized treat-
ments and supervision for fidelity to treatment)

Blinding of outcome as-
sessment (detection bias)
All outcomes

Low risk

Blinding of outcome assessment (research assessment separate from clinical
care), and unlikely that blinding could have been broken: (quote, page 84) "In-
terviewers were blind to intervention condition."

Zemore 2018 

Study characteristics

Methods

Design: non-randomized study. Mutual-help organization (12-step and non-12-step) members com-
pleted a baseline assessment, and followed up 6 and 12 months later. All assessments were completed
online.

Recruitment and setting: non-12-step participants recruited with the help of WFS, LifeRing, SMART
Recovery leaders (i.e. Executive Directors, Board Chair, and/or President) who sent email advertise-
ments to group leaders and individual members. 12-step participants recruited using advertisements
on InTheRooms, a social network for the recovery community.

Fidelity assessment of intervention implementation: 0 (non-manualized)

Participants

647 men and women with a lifetime alcohol use disorder (DSM-5) who had attended at least one in-per-
son 12-step, SMART Recovery, LifeRing, or WFS meeting in the past 30 days.

Age: the age breakdown of the sample is as follows: in the 12-step group, 5.3% of participants were
20-29, 12.0% were 30-39, 27.4% were 40-49, 34.1% were 50-50, 16.8% were 60-69, and 4.3% were ≥
70 years old; in the WFS group, 1.7% of participants were 20-29, 20.9% were 30-39, 15.3% were 40-49,
35.0% were 50-50, 21.5% were 60-69, and 5.6% were ≥ 70 years old; in the LifeRing group, 4.0% of par-
ticipants were 20-29, 13.1% were 30-39, 12.1% were 40-49, 30.3% were 50-50, 28.3% were 60-69, and
12.1% were ≥ 70 years old; in the SMART group, 6.0% of participants were 20-29, 18.0% were 30-39,
26.3% were 40-49, 25.1% were 50-50, 21.6% were 60-69, and 3.0% were ≥ 70 years old.

Gender: the 12-step group was 68.3% female and 31.7% male, the WFS group 100% female, the LifeR-
ing group 38.4% female and 61.6% male, and the SMART group 39.5% female and 60.5% male.

Ethnicity: the 12-step group was 94.2% white, 3.4% black/African American, 1.4% Latino/Hispanic,
and 1.0% other; the WFS group 91.4% white, 1.7% black/African American, 4.6% Latino/Hispanic, and
2.3% other; the LifeRing group 85.9% white, 0% black/African American, 10.1% Latino/Hispanic, and
4.0% other; and the SMART group 94.0% white, 1.2% black/African American, 3.0% Latino/Hispanic,
and 1.8% other.

Interventions

Twelve-step (NM) (n = 208): participants who attend 12-step groups only, or those who attend 12-step
and non-12 step groups, but who identify a 12-step group as their primary group. The proportion of par-
ticipants in the 12-step group who attended AA (e.g. as opposed to NA) could not be determined from
the report, though all participants met criteria for a lifetime alcohol use disorder.

WFS (NM) (n = 175): participants who attend WFS only, or those who attend multiple mutual-help or-
ganizations but who identify WFS as their primary group

LifeRing (NM) (n = 98): participants who attend LifeRing only, or those who attend multiple mutu-
al-help organizations but who identify LifeRing as their primary group

SMART Recovery (NM) (n = 166): participants who attend SMART Recovery only, or those who attend
multiple mutual-help organizations but who identify SMART Recovery as their primary group

Outcomes

Follow-up assessment points: baseline, 6- and 12-month follow-ups

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

83

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Zemore 2018  (Continued)

Cochrane Database of Systematic Reviews

Abstinence: alcohol abstinence, complete abstinence from alcohol and drugs (Composite Internation-
al Diagnostic Interview alcohol section)

Alcohol-related consequences: short inventory of problems

Notes

Participant demographic information reported in Zemore 2017

Funding source: NIAAA grant (R21-AA022747)

Declaration of interest: none disclosed

Risk of bias

Bias

Authors' judgement

Support for judgement

Random sequence genera-
tion (selection bias)

High risk

Non-randomized

Allocation concealment
(selection bias)

Blinding of participants
and personnel (perfor-
mance bias)
All outcomes

Incomplete outcome data
(attrition bias)
All outcomes

Selective reporting (re-
porting bias)

Comparability of cohorts
for baseline characteristics
and outcome measures

Selection of the non-ex-
posed cohort

High risk

Risk is high due the study being non-randomized

High risk

This is a subjective outcome, likely to be influenced by knowledge of the in-
tervention. In the report, sufficient details were provided that participants
were definitely aware of the interventions as patients themselves self-select-
ed into the various mutual-help group interventions and this was not under re-
searcher control.

Unclear risk

Overall there was an attrition rate of 17% at 12 months; there was no statistical
difference in attrition by mutual-help organization participation.

Low risk

Expected outcomes are reported

Low risk

Recruited cohorts appear reasonably similar.

Low risk

Non-exposed cohort drawn from the same sample origin

Protection against conta-
mination

Unclear risk

This was a naturalistic, observational cohort design and some mutual help-or-
ganization members attending one organization (e.g. SMART Recovery) also
could attend another (e.g. 12-step).

Blinding of outcome as-
sessment (detection bias)
All outcomes

Low risk

Lack of specific details provided but outcomes are unlikely to be influenced by
lack of blinding.

AA: Alcoholics Anonymous
AAF: Alcoholics Anonymous facilitation
AA-NA: Alcoholics Anonymous-Narcotics Anonymous
ABMT: alcohol-focused behavioral marital therapy
AM: alcohol-adapted anger management
ASI: Addiction Severity Index
ASI-Lite: Addiction Severity Index-Lite
BA: brief advice
CA: Cocaine Anonymous
CaseM: case management

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

84

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

CBT: cognitive behavioral therapy
CM: contingency management
DDD: drinks per drinking day
DFG: dual-focused mutual-help group
DI: doctor intervention
DIR: directive approach to facilitating AA
DrInC: Drinker Inventory of Consequences
DSM III-R: Diagnostic and Statistical Manual of Mental Disorders - 3rd Edition revised
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders - 4th Edition
ICBT + P: integrated cognitive behavioral therapy plus standard pharmacotherapy
i-TSF: integrated 12-Step Facilitation
MAAEZ: Making AA Easier
ME-12: extended motivational enhancement
MET: motivational enhancement therapy
MBRP: mindfulness-based relapse prevention
MHCD: Mental Health Chemical Dependence
MHG: mutual-help group
MI: motivational intervention
MOT: motivational enhancement approach to facilitating AA
MT: minimal treatment
NA: Narcotics Anonymous
NI: no intervention
NM: non-manualized
NS: network support
PCBT: packaged CBT
PDA: percentage days abstinent
PDHD: percentage days heavy drinking
PI: peer intervention
P-TSF: peer-delivered Twelve-Step Facilitation
RAIR: rural-adapted intensive referral
RCT: randomized controlled trial
RP: relapse prevention
SAMI: Substance Abuse Mental Illness
SD: standard deviation
SMART: Self-Management and Recovery Training
SR: standard referral
ST: standard outpatient treatment
SWT: standard short-term treatment ward
TAU: treatment as usual;
TLFB: Timeline Followback
TSF: Twelve-Step Facilitation
TSF + P: Twelve-Step Facilitation plus standard pharmacotherapy
UC: usual care
VA: Veterans Affairs
WFS: Women for Sobriety

Characteristics of excluded studies [ordered by study ID]

Study

Reason for exclusion

Banerjee 2007

The participants did not meet inclusion criteria because the majority of the sample had a primary
substance other than alcohol (methamphetamine).

Hailemariam 2018

The study design did not meet inclusion criteria because it was a cross-sectional study.

Lash 2011

Lash 2013

The study design did not meet inclusion criteria because it was a literature review.

The study participants did not meet inclusion criteria because only a subset of participants (33%)
had an alcohol use disorder only, and the remaining participants were drug dependent with or

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

85

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Study

Reason for exclusion

Laudet 2007

Moos 1999

without alcohol dependence. The proportion of drug dependent participants who were also alco-
hol dependent was unclear.

The study participants did not meet inclusion criteria, as they were described as all polysubstance
dependent and only a small proportion (< 20%) reported alcohol as a 'problem substance'.

The study participants did not meet inclusion criteria as it was unclear which proportion of the
sample had an alcohol use disorder or had alcohol as a primary substance.

Morgan-Lopez 2013

The study intervention did not meet inclusion criteria, as the treatment interventions did not in-
clude AA/TSF.

Mueller 2007

Schilling 2002

Ståhlbrandt 2007

Tonigan 2010

Villanueva 2007

The study design and intervention did not meet inclusion criteria, as it was a correlational study
and neither intervention included AA/TSF.

The study intervention did not meet inclusion criteria, as neither the standard care intervention nor
the comparison intervention (motivational interviewing) included AA/TSF.

This study participants did not meet inclusion criteria because it was not a study of people with al-
cohol use disorder (i.e. was a non-clinical sample, which included non-drinkers)

The study intervention did not meet inclusion criteria, as it was a moderator study examining so-
cial phobia as a moderator of the effect of gender on 12-step participation and substance use out-
comes.

The study design did not meet inclusion criteria, as it was a secondary analysis of only a subset of
Project MATCH participants (i.e. was an investigation of racial-ethnic moderators and not main ef-
fects).

Walsh 1991

The study participants did not meet inclusion criteria, because some participants were coerced to
participate.

TSF: Twelve-Step Facilitation
VA: Veteran Affairs

D A T A   A N D   A N A L Y S E S

Comparison 1.   1A Grouping: RCT/quasi-RCT, all treatments manualized, compared to different theoretical
orientation

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1.1 Proportion completely
abstinent

1.1.1 End of treatment

1.1.2 6-month follow-up

1.1.3 12-month follow-up

1.1.4 24-month follow-up

6

1

3

2

2

Risk Ratio (M-H, Random, 95% CI)

Subtotals only

1726

238

1936

403

Risk Ratio (M-H, Random, 95% CI)

1.07 [0.92, 1.25]

Risk Ratio (M-H, Random, 95% CI)

1.66 [1.09, 2.54]

Risk Ratio (M-H, Random, 95% CI)

1.21 [1.03, 1.42]

Risk Ratio (M-H, Random, 95% CI)

1.37 [1.04, 1.82]

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

86

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1.1.5 36-month follow-up

1.2 Percentage days absti-
nent (PDA)

1.2.1 End of treatment

1.2.2 6-month follow-up

1.2.3 12-month follow-up

1.2.4 18-month follow-up

1.2.5 24-month follow-up

1.2.6 36-month follow-up

1.3 Longest period of absti-
nence (LPA, months)

1.3.1 6-month follow-up

1.4 Drinks per drinking day
(DDD)

1.4.1 End of treatment

1.4.2 6-month follow-up

1.4.3 12-month follow-up

1.4.4 24-month follow-up

1.4.5 36-month follow-up

1.5 Percentage days heavy
drinking (PDHD)

1.5.1 6-month follow-up

1.5.2 12-month follow-up

1

8

1

3

4

1

2

1

2

2

5

2

1

1

2

1

3

1

1

952

Risk Ratio (M-H, Random, 95% CI)

1.42 [1.17, 1.73]

1586

191

1999

58

302

806

136

1636

76

1516

302

806

70

91

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

1.91 [-1.42, 5.24]

Mean Difference (IV, Random, 95%
CI)

-1.21 [-10.82, 8.41]

Mean Difference (IV, Random, 95%
CI)

3.03 [-4.36, 10.43]

Mean Difference (IV, Random, 95%
CI)

-8.89 [-30.65, 12.87]

Mean Difference (IV, Random, 95%
CI)

12.91 [7.55, 18.27]

Mean Difference (IV, Random, 95%
CI)

6.64 [1.54, 11.75]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

0.60 [-0.30, 1.50]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.30 [-1.07, 0.47]

Mean Difference (IV, Random, 95%
CI)

-0.96 [-3.22, 1.30]

Mean Difference (IV, Random, 95%
CI)

-0.17 [-1.11, 0.77]

Mean Difference (IV, Random, 95%
CI)

-0.16 [-0.80, 0.47]

Mean Difference (IV, Random, 95%
CI)

-1.02 [-1.83, -0.21]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

9.62 [-0.93, 20.17]

Mean Difference (IV, Random, 95%
CI)

-5.51 [-14.15, 3.13]

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

87

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

1.5.3 24-month follow-up

1.6 Alcohol-related conse-
quences (DrInC)

1.6.1 End of treatment

1.6.2 12-month follow-up

1.6.3 24-month follow-up

1.7 Alcohol-related conse-
quences (SIP)

1.7.1 6-month follow-up

1.8 Alcohol-related conse-
quences (SIP-2R)

1.8.1 6-month follow-up

1.9 Addiction Severity Index
(ASI)

1.9.1 6-month follow-up

1.10 Addiction Severity Index
(ASI)

1

4

1

3

2

1

1

1

1

1

1

1

129

1532

1762

295

76

59

336

Mean Difference (IV, Random, 95%
CI)

-1.09 [-11.57, 9.39]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-3.38 [-8.66, 1.90]

Mean Difference (IV, Random, 95%
CI)

-2.88 [-6.81, 1.04]

Mean Difference (IV, Random, 95%
CI)

-2.09 [-8.11, 3.93]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

0.71 [-4.51, 5.93]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.10 [-0.43, 0.23]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.05 [-0.09, -0.01]

Other data

No numeric data

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

88

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.1.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized, compared to different
theoretical orientation, Outcome 1: Proportion completely abstinent

Study or Subgroup

Events

Total

Events

Total

Weight

AA/TSF

Comparison

Risk Ratio
M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

1.1.1 End of treatment
MATCH 1997 (1)
MATCH 1997 (2)
MATCH 1997 (3)
MATCH 1997 (4)
Subtotal (95% CI)
217
Total events:
Heterogeneity: Tau² = 0.01; Chi² = 4.26, df = 3 (P = 0.23); I² = 30%
Test for overall effect: Z = 0.90 (P = 0.37)

316
261
301
266
1144

168
124
167
123
582

54
133
72
149

42
67
42
66

408

1.1.2 6-month follow-up
Davis 2002
Kelly 2017b
McCrady 1996 (5)
McCrady 1996 (6)
Subtotal (95% CI)
39
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.20, df = 3 (P = 0.98); I² = 0%
Test for overall effect: Z = 2.34 (P = 0.02)

49
29
16
15
109

18
10
6
5

40
30
29
30
129

8
6
7
7

28

1.1.3 12-month follow-up
Litt 2007 (7)
Litt 2007 (8)
MATCH 1997 (4)
MATCH 1997 (3)
MATCH 1997 (2)
MATCH 1997 (1)
Subtotal (95% CI)
265
Total events:
Heterogeneity: Tau² = 0.01; Chi² = 7.91, df = 5 (P = 0.16); I² = 37%
Test for overall effect: Z = 2.35 (P = 0.02)

69
70
266
301
261
316
1283

36
35
123
167
124
168
653

15
19
128
74
111
96

15
14
58
59
59
60

443

1.1.4 24-month follow-up
Litt 2007 (7)
Litt 2007 (8)
Litt 2016
Subtotal (95% CI)
63
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 1.84, df = 2 (P = 0.40); I² = 0%
Test for overall effect: Z = 2.22 (P = 0.03)

36
35
96
167

16
16
31

21
18
28

69
70
97
236

67

1.1.5 36-month follow-up
MATCH 1997 (1)
MATCH 1997 (3)
Subtotal (95% CI)
121
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.28, df = 1 (P = 0.59); I² = 0%
Test for overall effect: Z = 3.50 (P = 0.0005)

168
167
335

61
60

85
72

157

316
301
617

14.7%
33.7%
16.7%
34.8%
100.0%

34.8%
23.7%
22.1%
19.4%
100.0%

6.2%
6.9%
24.2%
18.7%
23.5%
20.6%
100.0%

1.46 [1.02 , 2.09]
1.06 [0.87 , 1.30]
1.05 [0.76 , 1.46]
0.96 [0.79 , 1.17]
1.07 [0.92 , 1.25]

1.84 [0.89 , 3.78]
1.72 [0.72 , 4.13]
1.55 [0.63 , 3.83]
1.43 [0.54 , 3.75]
1.66 [1.09 , 2.54]

1.92 [1.06 , 3.46]
1.47 [0.84 , 2.58]
0.98 [0.78 , 1.23]
1.44 [1.08 , 1.91]
1.12 [0.89 , 1.41]
1.18 [0.90 , 1.53]
1.21 [1.03 , 1.42]

30.0%
27.0%
43.0%
100.0%

1.46 [0.88 , 2.43]
1.78 [1.04 , 3.04]
1.12 [0.73 , 1.71]
1.37 [1.04 , 1.82]

52.7%
47.3%
100.0%

1.35 [1.03 , 1.77]
1.50 [1.13 , 2.00]
1.42 [1.17 , 1.73]

Footnotes
(1) Outpatient TSF vs. MET
(2) Aftercare TSF vs. MET

0.1

0.5
0.2
Favors comparison

1

2

10
Favors AA/TSF

5

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

89

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.1.   (Continued)

(1) Outpatient TSF vs. MET
(2) Aftercare TSF vs. MET
(3) Outpatient TSF vs. CBT
(4) Aftercare TSF vs. CBT
(5) AA/ABCT vs. RP/ABCT
(6) AA/ABCT vs. ABCT
(7) NS vs. Case M
(8) NS vs. NS + CM

Favors comparison

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

90

 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.2.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized, compared to different
theoretical orientation, Outcome 2: Percentage days abstinent (PDA)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.2.1 End of treatment
MATCH 1997 (1)
MATCH 1997 (2)
MATCH 1997 (3)
MATCH 1997 (4)
Subtotal (95% CI)
Heterogeneity: Tau² = 2.57; Chi² = 3.86, df = 3 (P = 0.28); I² = 22%
Test for overall effect: Z = 1.13 (P = 0.26)

82.39
87.03
82.39
87.03

28.58
27.46
28.58
27.46

76.02
88.58
81.87
84.9

156
114
156
114
540

1.2.2 6-month follow-up
Kelly 2017b
McCrady 1996 (5)
McCrady 1996 (6)
Walitzer 2015
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 2.18, df = 3 (P = 0.54); I² = 0%
Test for overall effect: Z = 0.25 (P = 0.81)

57.28
72.8
72.8
73.49

42.44
33.6
33.6
32.82

23
13
13
40
89

51.84
82.4
82.6
68.73

30.45
25.8
28.85
28.05

37.91
25.3
24.5
33.38

284
244
282
236
1046

26.0%
24.2%
26.8%
23.0%
100.0%

6.37 [0.66 , 12.08]
-1.55 [-7.54 , 4.44]
0.52 [-5.09 , 6.13]
2.13 [-4.05 , 8.31]
1.91 [-1.42 , 5.24]

21
21
24
36
102

16.4%
20.5%
21.5%
41.6%
100.0%

5.44 [-18.30 , 29.18]
-9.60 [-30.83 , 11.63]
-9.80 [-30.53 , 10.93]
4.76 [-10.15 , 19.67]
-1.21 [-10.82 , 8.41]

1.2.3 12-month follow-up
Litt 2007 (7)
Litt 2007 (8)
Lydecker 2010
MATCH 1997 (1)
MATCH 1997 (3)
MATCH 1997 (2)
MATCH 1997 (4)
Walitzer 2009 (9)
Subtotal (95% CI)
Heterogeneity: Tau² = 100.00; Chi² = 80.99, df = 7 (P < 0.00001); I² = 91%
Test for overall effect: Z = 0.80 (P = 0.42)

16.49
16.49
8.5
34.59
34.59
34.41
34.41
20.908

62.33
71
84
71.59
72.13
80.9
79.71
69.02

77
77
74
74.37
74.37
78.65
78.65
83.81

32
31
99
152
152
106
106
47
725

17.66
17.01
7.5
35.36
34.22
31.2
33.28
30.35

64
59
107
275
269
235
221
44
1274

12.6%
12.5%
14.1%
12.7%
12.7%
12.3%
12.3%
10.9%
100.0%

14.67 [7.50 , 21.84]
6.00 [-1.25 , 13.25]
-10.00 [-12.20 , -7.80]
2.78 [-4.13 , 9.69]
2.24 [-4.61 , 9.09]
-2.25 [-9.92 , 5.42]
-1.06 [-8.94 , 6.82]
14.79 [4.01 , 25.57]
3.03 [-4.36 , 10.43]

1.2.4 18-month follow-up
McCrady 1996 (6)
McCrady 1996 (5)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.03, df = 1 (P = 0.86); I² = 0%
Test for overall effect: Z = 0.80 (P = 0.42)

70.35
70.35

40.4
40.4

9
8
17

81.03
77.16

1.2.5 24-month follow-up
Litt 2007 (7)
Litt 2007 (8)
Litt 2016
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.92, df = 2 (P = 0.38); I² = 0%
Test for overall effect: Z = 4.72 (P < 0.00001)

19.27
19.27
33.38

29
29
64
122

64
62.17
67

78
78
73

1.2.6 36-month follow-up
MATCH 1997 (1)
MATCH 1997 (3)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.34, df = 1 (P = 0.56); I² = 0%
Test for overall effect: Z = 2.55 (P = 0.01)

144
144
288

34.76
34.76

73.52
73.52

68.38
65.35

31.81
35.27

21
20
41

53.7%
46.3%
100.0%

-10.68 [-40.37 , 19.01]
-6.81 [-38.79 , 25.17]
-8.89 [-30.65 , 12.87]

18.94
19.4
32.69

60
54
66
180

39.9%
37.9%
22.3%
100.0%

14.00 [5.51 , 22.49]
15.83 [7.11 , 24.55]
6.00 [-5.36 , 17.36]
12.91 [7.55 , 18.27]

35.98
37.2

255
263
518

50.3%
49.7%
100.0%

5.14 [-2.05 , 12.33]
8.17 [0.93 , 15.41]
6.64 [1.54 , 11.75]

Footnotes
(1) Outpatient TSF vs. MET
(2) Aftercare TSF vs. CBT
(3) Outpatient TSF vs. CBT
(4) Aftercare TSF vs. MET
(5) AA/ABCT vs. ABCT

-100

-50

0

Favors comparison

50

100
Favors AA/TSF

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

91

 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.2.   (Continued)
(3) Outpatient TSF vs. CBT
(4) Aftercare TSF vs. MET
(5) AA/ABCT vs. ABCT
(6) AA/ABCT vs. RP/ABCT
(7) NS vs. Case M
(8) NS vs. NS + CM
(9) DIR vs. TAU

Analysis 1.3.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized, compared
to different theoretical orientation, Outcome 3: Longest period of abstinence (LPA, months)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.3.1 6-month follow-up
Davis 2002
Kelly 2017b
Subtotal (95% CI)
Heterogeneity: Tau² = 0.28; Chi² = 2.47, df = 1 (P = 0.12); I² = 60%
Test for overall effect: Z = 1.31 (P = 0.19)

2.96
0.743

2.69
0.793

1.71
0.467

44
29
73

2.48
0.577

33
30
63

33.2%
66.8%
100.0%

1.25 [0.09 , 2.41]
0.28 [-0.08 , 0.63]
0.60 [-0.30 , 1.50]

-4

-2

0

Favors comparison

2

4
Favors AA/TSF

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

92

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.4.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized,
compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.4.1 End of treatment
MATCH 1997 (1)
MATCH 1997 (2)
MATCH 1997 (3)
MATCH 1997 (4)
McCrady 1996 (5)
McCrady 1996 (6)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 2.65, df = 5 (P = 0.75); I² = 0%
Test for overall effect: Z = 0.76 (P = 0.44)

114
156
156
114
10
9
559

4.67
4.92
4.92
4.67
5.94
5.94

9.12
6.87
6.87
9.12
5.05
5.05

4.38
5.84
5.39
4.32
4.61
7.27

8.81
6.74
7.82
7.59
2.73
9.75

244
284
282
236
17
14
1077

14.7%
33.2%
29.6%
15.8%
5.1%
1.6%
100.0%

0.29 [-1.72 , 2.30]
-0.92 [-2.25 , 0.41]
-0.47 [-1.88 , 0.94]
0.35 [-1.58 , 2.28]
1.33 [-2.06 , 4.72]
-1.33 [-7.41 , 4.75]
-0.30 [-1.07 , 0.47]

1.4.2 6-month follow-up
Walitzer 2015
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.83 (P = 0.40)

3.67

4.13

4.63

5.69

40
40

36
36

100.0%
100.0%

-0.96 [-3.22 , 1.30]
-0.96 [-3.22 , 1.30]

1.4.3 12-month follow-up
MATCH 1997 (1)
MATCH 1997 (2)
MATCH 1997 (3)
MATCH 1997 (4)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.29; Chi² = 4.40, df = 3 (P = 0.22); I² = 32%
Test for overall effect: Z = 0.35 (P = 0.73)

106
152
152
106
516

5.95
4.57
4.57
5.95

4.66
5.23
5.38
5.04

9.69
5.71
5.71
9.69

1.4.4 24-month follow-up
Litt 2007 (7)
Litt 2007 (8)
Litt 2016
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.17, df = 2 (P = 0.92); I² = 0%
Test for overall effect: Z = 0.50 (P = 0.62)

29
29
64
122

2.23
2.23
6.17

3.56
3.56
4.05

3.87
3.6
4.1

1.4.5 36-month follow-up
MATCH 1997 (2)
MATCH 1997 (3)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.38, df = 1 (P = 0.54); I² = 0%
Test for overall effect: Z = 2.48 (P = 0.01)

144
144
288

5.35
5.35

4.34
4.34

5.12
5.63

8.2
6.27
6.72
8.54

1.84
2.13
3.98

235
275
269
221
1000

15.6%
35.3%
33.9%
15.2%
100.0%

1.29 [-0.83 , 3.41]
-0.66 [-1.83 , 0.51]
-0.81 [-2.02 , 0.40]
0.91 [-1.25 , 3.07]
-0.17 [-1.11 , 0.77]

54
60
66
180

44.9%
42.5%
12.6%
100.0%

-0.31 [-1.26 , 0.64]
-0.04 [-1.01 , 0.93]
-0.05 [-1.84 , 1.74]
-0.16 [-0.80 , 0.47]

5.58
6.49

255
263
518

52.8%
47.2%
100.0%

-0.78 [-1.89 , 0.33]
-1.29 [-2.46 , -0.12]
-1.02 [-1.83 , -0.21]

Footnotes
(1) Aftercare TSF vs. CBT
(2) Outpatient TSF vs. MET
(3) Outpatient TSF vs. CBT
(4) Aftercare TSF vs. MET
(5) AA/ABCT vs. RP/ABCT
(6) AA/ABCT vs. ABCT
(7) NS vs. NS + CM
(8) NS vs. Case M

-4

-2

0

2

4

Favors AA/TSF

Favors comparison

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

93

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.5.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized, compared
to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.5.1 6-month follow-up
McCrady 1996 (1)
McCrady 1996 (2)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.07, df = 1 (P = 0.79); I² = 0%
Test for overall effect: Z = 1.79 (P = 0.07)

25.2
25.2

17.1
17.1

13
13
26

9
6.1

17
11.3

24
20
44

47.6%
52.4%
100.0%

8.10 [-7.19 , 23.39]
11.00 [-3.57 , 25.57]
9.62 [-0.93 , 20.17]

1.5.2 12-month follow-up
Walitzer 2009 (3)
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.25 (P = 0.21)

7.87

18.77

1.5.3 24-month follow-up
Litt 2016
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.20 (P = 0.84)

16.06

30.91

47
47

64
64

13.38

22.92

44
44

100.0%
100.0%

-5.51 [-14.15 , 3.13]
-5.51 [-14.15 , 3.13]

17.15

29.8

65
65

100.0%
100.0%

-1.09 [-11.57 , 9.39]
-1.09 [-11.57 , 9.39]

Footnotes
(1) AA/ABCT vs. RP/ABCT
(2) AA/ABCT vs. ABCT
(3) DIR vs. TAU

-50
Favors AA/TSF

-25

0

25

50

Favors comparison

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

94

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.6.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized, compared
to different theoretical orientation, Outcome 6: Alcohol-related consequences (DrInC)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.6.1 End of treatment
MATCH 1997 (1)
MATCH 1997 (2)
MATCH 1997 (3)
MATCH 1997 (4)
Subtotal (95% CI)
Heterogeneity: Tau² = 1.66; Chi² = 3.18, df = 3 (P = 0.36); I² = 6%
Test for overall effect: Z = 1.26 (P = 0.21)

46.712
52.127
46.712
52.127

58.288
42.121
58.288
42.121

153
107
153
108
521

68.045
39.444
59.909
43.54

1.6.2 12-month follow-up
Litt 2007 (5)
Litt 2007 (6)
MATCH 1997 (3)
MATCH 1997 (1)
MATCH 1997 (4)
MATCH 1997 (2)
Walitzer 2009 (7)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 3.48, df = 6 (P = 0.75); I² = 0%
Test for overall effect: Z = 1.44 (P = 0.15)

25.554
25.554
42.729
42.729
52.903
52.903
25.308

67.793
67.793
48.02
48.02
49.482
49.482
19.501

72.889
70.187
55.15
52.835
45.494
46.754
21.8

27
26
148
148
110
110
43
612

1.6.3 24-month follow-up
Litt 2007 (5)
Litt 2007 (6)
Litt 2016
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.25, df = 2 (P = 0.54); I² = 0%
Test for overall effect: Z = 0.68 (P = 0.50)

25.555
25.555
28.141

67.912
67.912
64.868

29
28
64
121

68.279
66.192
70.964

43.981
51.573
45.948
51.444

289
232
264
226
1011

32.1%
18.8%
30.3%
18.8%
100.0%

-9.76 [-18.73 , -0.79]
2.68 [-9.22 , 14.58]
-1.62 [-10.87 , 7.63]
-1.42 [-13.32 , 10.48]
-3.38 [-8.66 , 1.90]

27.653
19.486
42.029
44.349
47.52
53.464
23.573

51
47
274
267
235
236
40
1150

10.2%
12.1%
21.3%
20.3%
11.4%
10.7%
13.9%
100.0%

-5.10 [-17.36 , 7.17]
-2.39 [-13.69 , 8.90]
-7.13 [-15.62 , 1.36]
-4.81 [-13.51 , 3.88]
3.99 [-7.62 , 15.59]
2.73 [-9.28 , 14.74]
-2.30 [-12.81 , 8.22]
-2.88 [-6.81 , 1.04]

24.15
20.262
26.508

57
51
66
174

28.8%
30.1%
41.0%
100.0%

-0.37 [-11.58 , 10.85]
1.72 [-9.26 , 12.70]
-6.10 [-15.50 , 3.31]
-2.09 [-8.11 , 3.93]

Footnotes
(1) Outpatient TSF vs. MET
(2) Aftercare TSF vs. CBT
(3) Outpatient TSF vs. CBT
(4) Aftercare TSF vs. MET
(5) NS vs. Case M
(6) NS vs. NS + CM
(7) DIR vs. TAU

-50
Favors AA/TSF

-25

0

25

50

Favors comparison

Analysis 1.7.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized,
compared to different theoretical orientation, Outcome 7: Alcohol-related consequences (SIP)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.7.1 6-month follow-up
Walitzer 2015
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.27 (P = 0.79)

12.31

12.44

11.6

10.77

40
40

36
36

100.0%
100.0%

0.71 [-4.51 , 5.93]
0.71 [-4.51 , 5.93]

-10
Favors AA/TSF

-5

0

5

10

Favors comparison

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

95

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 1.8.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized, compared
to different theoretical orientation, Outcome 8: Alcohol-related consequences (SIP-2R)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.8.1 6-month follow-up
Kelly 2017b
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.59 (P = 0.56)

0.9

0.7

29
29

1

0.6

30
30

100.0%
100.0%

-0.10 [-0.43 , 0.23]
-0.10 [-0.43 , 0.23]

-10
Favors AA/TSF

-5

0

5

10

Favors comparison

Analysis 1.9.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized,
compared to different theoretical orientation, Outcome 9: Addiction Severity Index (ASI)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

1.9.1 6-month follow-up
Brown 2002 (1)
Brown 2002 (2)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.00, df = 1 (P = 1.00); I² = 0%
Test for overall effect: Z = 2.25 (P = 0.02)

70
70
140

0.19
0.19

0.15
0.15

0.2
0.2

0.22
0.2

126
70
196

54.7%
45.3%
100.0%

-0.05 [-0.11 , 0.01]
-0.05 [-0.11 , 0.01]
-0.05 [-0.09 , -0.01]

Footnotes
(1) TSF vs. RP
(2) TSF vs. UC

-0.5

-1
Favors AA/TSF

0

0.5

1

Favors comparison

Analysis 1.10.   Comparison 1: 1A Grouping: RCT/quasi-RCT, all treatments manualized,
compared to different theoretical orientation, Outcome 10: Addiction Severity Index (ASI)

Addiction Severity Index (ASI)

Study

Brooks 2003

Result

This study found an advantage for the AA/TSF condition over the SMART Recovery
condition in the slope for improvement over a 12-month follow-up period, as mea-
sured by the ASI alcohol composite score (P < 0.05).

Comparison 2.   1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to different theoretical
orientation

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

2.1 Proportion completely ab-
stinent

2.1.1 3-month follow-up

2.1.2 9-month follow-up

2.2 Percentage days abstinent
(PDA)

2

1

1

2

Risk Ratio (M-H, Random, 95% CI)

Subtotals only

126

93

Risk Ratio (M-H, Random, 95% CI)

1.18 [0.80, 1.73]

Risk Ratio (M-H, Random, 95% CI)

1.71 [0.70, 4.18]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

96

 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

2.2.1 3-month follow-up

2.2.2 9-month follow-up

2.3 Percentage days abstinent
(PDA)

2.4 Drinks per drinking day
(DDD)

2.4.1 9-month follow-up

2.5 Percentage days heavy
drinking (PDHD)

2.5.1 12-month follow-up

1

1

1

1

1

1

1

125

93

93

286

Mean Difference (IV, Random, 95%
CI)

-3.94 [-14.73, 6.85]

Mean Difference (IV, Random, 95%
CI)

3.00 [0.31, 5.69]

Other data

No numeric data

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-1.76 [-2.23, -1.29]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

2.09 [-1.24, 5.42]

Analysis 2.1.   Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized,
compared to different theoretical orientation, Outcome 1: Proportion completely abstinent

Study or Subgroup

Events

Total

Events

Total

Weight

AA/TSF

Comparison

Risk Ratio
M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

2.1.1 3-month follow-up
Blondell 2011 (1)
Blondell 2011 (2)
Subtotal (95% CI)
21
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.10, df = 1 (P = 0.75); I² = 0%
Test for overall effect: Z = 0.83 (P = 0.41)

20
21
41

10
11

19
18

37

42
43
85

49.0%
51.0%
100.0%

1.11 [0.64 , 1.92]
1.25 [0.73 , 2.14]
1.18 [0.80 , 1.73]

2.1.2 9-month follow-up
Bogenschutz 2014
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 1.19 (P = 0.24)

18

18

63
63

5

5

30
30

100.0%
100.0%

1.71 [0.70 , 4.18]
1.71 [0.70 , 4.18]

Footnotes
(1) P-TSF vs. TAU
(2) P-TSF vs. MET

0.1

0.5
0.2
Favors comparison

1

2

10
Favors AA/TSF

5

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

97

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.2.   Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized,
compared to different theoretical orientation, Outcome 2: Percentage days abstinent (PDA)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

2.2.1 3-month follow-up
Blondell 2011 (1)
Blondell 2011 (2)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.35, df = 1 (P = 0.56); I² = 0%
Test for overall effect: Z = 0.72 (P = 0.47)

30.5
30.5

81.3
81.3

20
19
39

81.8
88.3

28
18.7

44
42
86

47.1%
52.9%
100.0%

-0.50 [-16.22 , 15.22]
-7.00 [-21.83 , 7.83]
-3.94 [-14.73 , 6.85]

2.2.2 9-month follow-up
Bogenschutz 2014
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.18 (P = 0.03)

73

Footnotes
(1) P-TSF vs. MET
(2) P-TSF vs. TAU

4

63
63

70

7

30
30

100.0%
100.0%

3.00 [0.31 , 5.69]
3.00 [0.31 , 5.69]

-100

-50

0

Favors comparison

50

100
Favors AA/TSF

Analysis 2.3.   Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized,
compared to different theoretical orientation, Outcome 3: Percentage days abstinent (PDA)

Percentage days abstinent (PDA)

Study

Herman 2000

Result

Using a log transformed days of drinking variable, this study found a slight advan-
tage at 2-months post-treatment (P = 0.03) that favored the AA/TSF condition rel-
ative to the comparison condition, but between two and 18 months post-treat-
ment, there was no evidence of a difference on average between the two groups (P
= 0.05). The treatment by time interaction was not reported.

Analysis 2.4.   Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized,
compared to different theoretical orientation, Outcome 4: Drinks per drinking day (DDD)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

2.4.1 9-month follow-up
Bogenschutz 2014
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 7.32 (P < 0.00001)

6.26

0.82

8.02

1.19

63
63

30
30

100.0%
100.0%

-1.76 [-2.23 , -1.29]
-1.76 [-2.23 , -1.29]

-4

-2

0

2

4

Favors AA/TSF

Favors Comparison

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

98

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 2.5.   Comparison 2: 1B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized,
compared to different theoretical orientation, Outcome 5: Percentage days heavy drinking (PDHD)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

2.5.1 12-month follow-up
Bowen 2014 (1)
Bowen 2014 (2)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 0.52, df = 1 (P = 0.47); I² = 0%
Test for overall effect: Z = 1.23 (P = 0.22)

14.93
14.93

4.65
4.65

48
47
95

3.89
1.44

12.17
7.66

88
103
191

45.6%
54.4%
100.0%

0.76 [-4.17 , 5.69]
3.21 [-1.31 , 7.73]
2.09 [-1.24 , 5.42]

Footnotes
(1) TAU vs. RP
(2) TAU vs. MBRP

-20
Favors AA/TSF

-10

0

10

20

Favors comparison

Comparison 3.   2A Grouping: RCT/quasi-RCT, all treatments manualized, compared to TSF variant

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

3.1 Proportion of participants
completely abstinent

3.1.1 6-month follow-up

3.1.2 12-month follow-up

3.2 Percentage days absti-
nent (PDA)

3.2.1 6-month follow-up

3.2.2 12-month follow-up

3.3 Days of use (PDA)

3.3.1 6-month follow-up

3.4 Drinks per drinking day
(DDD)

3.4.1 6-month follow-up

3.5 Addiction Severity Index
(ASI)

3.5.1 6-month follow-up

3.5.2 12-month follow-up

3

3

1

2

1

1

2

2

1

1

2

2

1

772

307

42

95

427

42

690

307

Risk Ratio (M-H, Random, 95% CI)

Subtotals only

Risk Ratio (M-H, Random, 95% CI)

1.07 [0.96, 1.18]

Risk Ratio (M-H, Random, 95% CI)

1.28 [1.00, 1.63]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-5.50 [-25.35, 14.35]

Mean Difference (IV, Random, 95%
CI)

16.40 [5.12, 27.68]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-1.93 [-4.55, 0.69]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-4.10 [-10.44, 2.24]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

0.03 [-0.07, 0.13]

Mean Difference (IV, Random, 95%
CI)

0.08 [0.02, 0.15]

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

99

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

3.6 European Addiction
Severity Index (EuropASI)

3.6.1 6-month follow-up

1

1

Mean Difference (IV, Random, 95%
CI)

Subtotals only

113

Mean Difference (IV, Random, 95%
CI)

-0.07 [-0.08, -0.06]

Analysis 3.1.   Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized,
compared to TSF variant, Outcome 1: Proportion of participants completely abstinent

Study or Subgroup

Events

Total

Events

Total

Weight

AA/TSF

Comparison

Risk Ratio
M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

138
85
30

3.1.1 6-month follow-up
Timko 2006
Timko 2011
Vederhus 2014
Subtotal (95% CI)
253
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.45, df = 2 (P = 0.80); I² = 0%
Test for overall effect: Z = 1.20 (P = 0.23)

181
142
68
391

115
83
33

164
145
72
381

231

64.1%
28.0%
7.9%
100.0%

1.09 [0.96 , 1.24]
1.05 [0.86 , 1.27]
0.96 [0.67 , 1.39]
1.07 [0.96 , 1.18]

3.1.2 12-month follow-up
Timko 2006
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 1.93 (P = 0.05)

83

83

161
161

59

59

146
146

100.0%
100.0%

1.28 [1.00 , 1.63]
1.28 [1.00 , 1.63]

0.1

0.5
0.2
Favors less intensive

1

2

5

10

Favors more intensive

Analysis 3.2.   Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments
manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

3.2.1 6-month follow-up
Kahler 2004
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.54 (P = 0.59)

81.8

37.1

3.2.2 12-month follow-up
Walitzer 2009 (1)
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.85 (P = 0.004)

83.81

20.908

21
21

47
47

87.3

27.9

21
21

100.0%
100.0%

-5.50 [-25.35 , 14.35]
-5.50 [-25.35 , 14.35]

67.41

33.831

48
48

100.0%
100.0%

16.40 [5.12 , 27.68]
16.40 [5.12 , 27.68]

Footnotes
(1) DIR vs. MOT

-100

-50

0

50

100

Favors less intensive

Favors more intensive

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

100

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.3.   Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments
manualized, compared to TSF variant, Outcome 3: Days of use (PDA)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

3.3.1 6-month follow-up
Timko 2011
Vederhus 2014
Subtotal (95% CI)
Heterogeneity: Tau² = 3.37; Chi² = 16.25, df = 1 (P < 0.0001); I² = 94%
Test for overall effect: Z = 1.44 (P = 0.15)

142
68
210

1.31
2.2

1.83
5.4

4.56
0.8

6.17
1.3

145
72
217

47.4%
52.6%
100.0%

-0.52 [-1.77 , 0.73]
-3.20 [-3.56 , -2.84]
-1.93 [-4.55 , 0.69]

-10

-5

0

5

10

Favors more intensive

Favors less intensive

Analysis 3.4.   Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments
manualized, compared to TSF variant, Outcome 4: Drinks per drinking day (DDD)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

3.4.1 6-month follow-up
Kahler 2004
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 1.27 (P = 0.21)

2.6

5.9

21
21

6.7

13.6

21
21

100.0%
100.0%

-4.10 [-10.44 , 2.24]
-4.10 [-10.44 , 2.24]

-20

-10

0

10

20

Favors more intensive

Favors less intensive

Analysis 3.5.   Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments
manualized, compared to TSF variant, Outcome 5: Addiction Severity Index (ASI)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

3.5.1 6-month follow-up
Timko 2006
Timko 2011
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 8.35, df = 1 (P = 0.004); I² = 88%
Test for overall effect: Z = 0.63 (P = 0.53)

181
181
362

0.215
0.095

0.281
0.178

0.13
0.111

0.266
0.171

164
164
328

47.5%
52.5%
100.0%

0.08 [0.03 , 0.14]
-0.02 [-0.05 , 0.02]
0.03 [-0.07 , 0.13]

3.5.2 12-month follow-up
Timko 2006
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 2.51 (P = 0.01)

0.218

0.3

161
161

0.133

0.292

146
146

100.0%
100.0%

0.08 [0.02 , 0.15]
0.08 [0.02 , 0.15]

-1

-0.5

0

0.5

1

Favors less intensive

Favors more intensive

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

101

 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 3.6.   Comparison 3: 2A Grouping: RCT/quasi-RCT, all treatments manualized,
compared to TSF variant, Outcome 6: European Addiction Severity Index (EuropASI)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

3.6.1 6-month follow-up
Vederhus 2014
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 12.40 (P < 0.00001)

0.03

0.17

0.24

0.03

56
56

57
57

100.0%
100.0%

-0.07 [-0.08 , -0.06]
-0.07 [-0.08 , -0.06]

-1

-0.5

0

0.5

1

Favors more intensive

Favors less intensive

Comparison 4.   2B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized, compared to TSF variant

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

4.1 Proportion of participants
completely abstinent

4.1.1 3-month follow-up

4.1.2 12-month follow-up

2

1

1

126

382

Risk Ratio (M-H, Random, 95%
CI)

Subtotals only

Risk Ratio (M-H, Random, 95%
CI)

1.16 [0.76, 1.79]

Risk Ratio (M-H, Random, 95%
CI)

1.15 [1.02, 1.29]

Analysis 4.1.   Comparison 4: 2B Grouping: RCT/quasi-RCT, 1 + treatments non-manualized,
compared to TSF variant, Outcome 1: Proportion of participants completely abstinent

Study or Subgroup

Events

Total

Events

Total

Weight

AA/TSF

Comparison

Risk Ratio
M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

4.1.1 3-month follow-up
Manning 2012 (1)
Manning 2012 (2)
Subtotal (95% CI)
20
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.03, df = 1 (P = 0.86); I² = 0%
Test for overall effect: Z = 0.69 (P = 0.49)

23
22
45

10
10

14
17

31

39
42
81

46.7%
53.3%
100.0%

1.21 [0.65 , 2.27]
1.12 [0.62 , 2.02]
1.16 [0.76 , 1.79]

190

4.1.2 12-month follow-up
Kaskutas 2009b
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 2.29 (P = 0.02)

190

232
232

107

107

150
150

100.0%
100.0%

1.15 [1.02 , 1.29]
1.15 [1.02 , 1.29]

Footnotes
(1) PI vs. NI
(2) PI vs. DI

0.1

0.5
0.2
Favors less intensive

1

2

5

10

Favors more intensive

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

102

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Comparison 5.   3B: Non-randomized, 1+ treatments non-manualized, compared to different theoretical orientation

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

5.1 Proportion of participants
completely abstinent

5.1.1 6-month follow-up

5.1.2 12-month follow-up

5.1.3 24-month follow-up

5.2 Drinks per drinking day
(DDD)

5.2.1 36-month follow-up

5.3 Alcohol-related conse-
quences (SIP)

5.3.1 12-month follow-up

5.4 Alcohol-related conse-
quences

5.4.1 36-month follow-up

5.5 Alcohol addiction severity
(Alcohol Dependence Scale)

5.5.1 36-month follow-up

3

1

2

1

1

1

1

1

1

1

1

1

314

2692

1774

201

647

201

201

Risk Ratio (M-H, Random, 95% CI)

Subtotals only

Risk Ratio (M-H, Random, 95% CI)

1.50 [1.16, 1.92]

Risk Ratio (M-H, Random, 95% CI)

1.25 [1.09, 1.43]

Risk Ratio (M-H, Random, 95% CI)

1.34 [1.20, 1.49]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

0.00 [-3.38, 3.38]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.71 [-1.68, 0.27]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

0.20 [-1.34, 1.74]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.30 [-2.20, 1.60]

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

103

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 5.1.   Comparison 5: 3B: Non-randomized, 1+ treatments non-manualized, compared to
different theoretical orientation, Outcome 1: Proportion of participants completely abstinent

Study or Subgroup

Events

Total

Events

Total

Weight

AA/TSF

Comparison

Risk Ratio
M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

5.1.1 6-month follow-up
Blondell 2001 (1)
Blondell 2001 (2)
Subtotal (95% CI)
41
Total events:
Heterogeneity: Tau² = 0.00; Chi² = 0.55, df = 1 (P = 0.46); I² = 0%
Test for overall effect: Z = 3.14 (P = 0.002)

35
35
70

43
52

20
21

125
119
244

95

226
47
47
47

5.1.2 12-month follow-up
Ouimette 1997 (3)
Zemore 2018 (4)
Zemore 2018 (5)
Zemore 2018 (6)
Subtotal (95% CI)
367
Total events:
Heterogeneity: Tau² = 0.01; Chi² = 5.56, df = 3 (P = 0.14); I² = 46%
Test for overall effect: Z = 3.16 (P = 0.002)

1148
175
98
166
1587

897
70
69
69
1105

205
105
61
83

454

44.9%
55.1%
100.0%

1.66 [1.14 , 2.42]
1.37 [0.98 , 1.93]
1.50 [1.16 , 1.92]

30.1%
24.9%
22.4%
22.6%
100.0%

1.41 [1.19 , 1.67]
1.12 [0.91 , 1.37]
1.09 [0.88 , 1.37]
1.36 [1.09 , 1.70]
1.25 [1.09 , 1.43]

328

328

887
887

100.0%
100.0%

1.34 [1.20 , 1.49]
1.34 [1.20 , 1.49]

0.1

0.5
0.2
Favors comparison

1

439

5.1.3 24-month follow-up
Ouimette 1997 (3)
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 5.26 (P < 0.00001)

887
887

439

Footnotes
(1) PI vs. UC
(2) PI vs. BI
(3) TSF vs. CB
(4) TSF vs. WFS
(5) TSF vs. LifeRing
(6) TSF vs. SMART

2

10
Favors AA/TSF

5

Analysis 5.2.   Comparison 5: 3B: Non-randomized, 1+ treatments non-manualized,
compared to different theoretical orientation, Outcome 2: Drinks per drinking day (DDD)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

5.2.1 36-month follow-up
Humphreys 1996
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.00 (P = 1.00)

6.28

11.34

6.28

11.54

135
135

66
66

100.0%
100.0%

0.00 [-3.38 , 3.38]
0.00 [-3.38 , 3.38]

-20
Favors AA/TSF

-10

0

10

20

Favors comparison

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

104

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 5.3.   Comparison 5: 3B: Non-randomized, 1+ treatments non-manualized, compared
to different theoretical orientation, Outcome 3: Alcohol-related consequences (SIP)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

5.3.1 12-month follow-up
Zemore 2018 (1)
Zemore 2018 (2)
Zemore 2018 (3)
Subtotal (95% CI)
Heterogeneity: Tau² = 0.00; Chi² = 1.13, df = 2 (P = 0.57); I² = 0%
Test for overall effect: Z = 1.42 (P = 0.15)

70
69
69
208

4.2
4.2
4.2

5.9
5.9
5.9

5.3
4.1
5.2

Footnotes
(1) TSF vs. WFS
(2) TSF vs. LifeRing
(3) TSF vs. SMART

5.7
5.6
6.1

175
98
166
439

36.2%
30.0%
33.9%
100.0%

-1.10 [-2.72 , 0.52]
0.10 [-1.68 , 1.88]
-1.00 [-2.67 , 0.67]
-0.71 [-1.68 , 0.27]

-10
Favors AA/TSF

-5

0

5

10

Favors comparison

Analysis 5.4.   Comparison 5: 3B: Non-randomized, 1+ treatments non-manualized,
compared to different theoretical orientation, Outcome 4: Alcohol-related consequences

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

5.4.1 36-month follow-up
Humphreys 1996
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.25 (P = 0.80)

2.8

5.5

135
135

2.6

5.1

66
66

100.0%
100.0%

0.20 [-1.34 , 1.74]
0.20 [-1.34 , 1.74]

-10
Favors AA/TSF

-5

0

5

10

Favors comparison

Analysis 5.5.   Comparison 5: 3B: Non-randomized, 1+ treatments non-manualized, compared to
different theoretical orientation, Outcome 5: Alcohol addiction severity (Alcohol Dependence Scale)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

5.5.1 36-month follow-up
Humphreys 1996
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.31 (P = 0.76)

3.2

7.1

135
135

3.5

6.1

66
66

100.0%
100.0%

-0.30 [-2.20 , 1.60]
-0.30 [-2.20 , 1.60]

-10
Favors AA/TSF

-5

0

5

10

Favors comparison

Comparison 6.   4B: Non-randomized, 1+ treatments non-manualized, compared to TSF variant

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

6.1 Proportion completely ab-
stinent

2

Risk Ratio (M-H, Random, 95% CI)

Subtotals only

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

105

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Outcome or subgroup title

No. of studies

No. of partici-
pants

Statistical method

Effect size

6.1.1 6-month follow-up

6.1.2 12-month follow-up

6.2 Percentage days abstinent
(PDA)

6.2.1 6-month follow-up

6.3 Drinks per drinking day
(DDD)

6.4 Addition Severity In-
dex-Lite (ASI-L)

6.4.1 6-month follow-up

1

1

1

1

1

1

1

140

1870

140

Risk Ratio (M-H, Random, 95% CI)

1.01 [0.86, 1.19]

Risk Ratio (M-H, Random, 95% CI)

1.24 [1.05, 1.46]

Mean Difference (IV, Random, 95%
CI)

Subtotals only

Mean Difference (IV, Random, 95%
CI)

-0.01 [-7.14, 7.12]

Other data

No numeric data

Mean Difference (IV, Random, 95%
CI)

Subtotals only

140

Mean Difference (IV, Random, 95%
CI)

0.01 [-0.05, 0.07]

Analysis 6.1.   Comparison 6: 4B: Non-randomized, 1+ treatments non-
manualized, compared to TSF variant, Outcome 1: Proportion completely abstinent

Study or Subgroup

Events

Total

Events

Total

Weight

AA/TSF

Comparison

Risk Ratio
M-H, Random, 95% CI

Risk Ratio
M-H, Random, 95% CI

6.1.1 6-month follow-up
Grant 2018
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 0.13 (P = 0.90)

63

63

226

6.1.2 12-month follow-up
Ouimette 1997
Subtotal (95% CI)
Total events:
Heterogeneity: Not applicable
Test for overall effect: Z = 2.49 (P = 0.01)

226

77
77

897
897

51

51

198

198

63
63

100.0%
100.0%

1.01 [0.86 , 1.19]
1.01 [0.86 , 1.19]

973
973

100.0%
100.0%

1.24 [1.05 , 1.46]
1.24 [1.05 , 1.46]

0.1

0.5
0.2
Favors less intensive

1

2

5

10

Favors more intensive

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

106

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Analysis 6.2.   Comparison 6: 4B: Non-randomized, 1+ treatments non-
manualized, compared to TSF variant, Outcome 2: Percentage days abstinent (PDA)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

6.2.1 6-month follow-up
Grant 2018
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.00 (P = 1.00)

92.42

21.69

92.43

21.19

77
77

63
63

100.0%
100.0%

-0.01 [-7.14 , 7.12]
-0.01 [-7.14 , 7.12]

-100

-50

0

50

100

Favors less intensive

Favors more intensive

Analysis 6.3.   Comparison 6: 4B: Non-randomized, 1+ treatments non-
manualized, compared to TSF variant, Outcome 3: Drinks per drinking day (DDD)

Drinks per drinking day (DDD)

Study

Grant 2018

Result

This study reported drinks per drinking day (DDD) only for those participants (n =
25) who were not abstinent during the follow-up period and found no difference in
DDD between the Rural Adapted Intensive Referral (mean 17.63, SD 23.71) and the
standard referral (mean 11.47, SD 5.94), P = 0.49.

Analysis 6.4.   Comparison 6: 4B: Non-randomized, 1+ treatments non-manualized,
compared to TSF variant, Outcome 4: Addition Severity Index-Lite (ASI-L)

Study or Subgroup

Mean

AA/TSF
SD

Total

Mean

Comparison
SD

Total

Weight

Mean Difference
IV, Random, 95% CI

Mean Difference
IV, Random, 95% CI

6.4.1 6-month follow-up
Grant 2018
Subtotal (95% CI)
Heterogeneity: Not applicable
Test for overall effect: Z = 0.33 (P = 0.74)

0.17

0.19

0.16

0.17

77
77

63
63

100.0%
100.0%

0.01 [-0.05 , 0.07]
0.01 [-0.05 , 0.07]

-1

-0.5

0

0.5

1

Favors more intensive

Favors less intensive

A D D I T I O N A L   T A B L E S

Table 1.   Follow-up time points, treatment duration and treatment setting 

Study

Follow-up time pe-
riod (months)

Treatment duration

Blondell 2001

Blondell 2011

6

3

A single session of either a peer intervention (30-60 minutes),
brief intervention (5-15 minutes), or usual care (60 minutes)

TAU: 3 to 5 calendar days treatment
TSF: TAU + single 45- to 60-minute session of TSF

MET: TAU + single 45- to 60-minute session of MET

Setting

Inpatient/

residential facility

Inpatient/

residential facility

Bogenschutz 2014

9

TSF: TAU + 12 weekly sessions of TSF therapy

Outpatient

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

107

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 1.   Follow-up time points, treatment duration and treatment setting  (Continued)

TAU: TAU in the clinical dual diagnosis program

Bowen 2014

12

8 weeks of either MBRP (1 weekly 2-hour session), RP (1 weekly
2-hour session),

Outpatient

Brooks 2003

Brown 2002

12

6

Davis 2002

6

or TAU (1-2 sessions/week for 1.5 hours)

Both treatment groups met for 5 hours per day, 5 days per week
over a 6-month course of treatment

Outpatient

Outpatient

Outpatient

TSF: 10 weekly 90-minute 12-step aftercare group sessions
RP: 10 weekly 90-minute relapse prevention aftercare group
sessions
UC: non-specific support groups that encourage participants
to maintain their substance use goals and include discussion of
problems and potential solutions

6 months of either MT (1 weekly session during which partici-
pants viewed an alcoholism education movie, with a post-film
discussion held once per month) or ST (3-week orientation pe-
riod consisting of 6 group therapy sessions, 3 alcohol educa-
tion sessions during which alcohol education films were shown,
3 community meetings and a minimum of 6 AA meetings, fol-
lowed by weekly group and/or individual therapy sessions for
the remainder of the treatment period, and optional alcohol
education sessions beyond the orientation period)

Grant 2018

6

RAIR: standard treatment + rural-adapted intensive referral (3
sessions)

Herman 2000

18

SR: standard treatment and referral

STW: treatment in the standard short-term treatment ward on-
ly (average length of stay = 31.1 days; staff not trained in sub-
stance use treatment)
MHCD program: treatment provided by mental health staff
trained in substance use treatment and included educational
lectures, AA and/or NA groups (participants required to attend
at least 2 meetings per week), gender-specific support groups,
and family education sessions (average length of stay = 51.4
days)

Inpatient/

residential facility

Inpatient/

residential facility

Holder 2000

36

12 weeks of either TSF/CBT with weekly treatment sessions, or
MET with four sessions that occurred during weeks 1, 2, 6, and
12

Outpatient

Humphreys 1996

36

Continuous assessment of community-based AA participation
during the follow-up period (i.e. 36 months)

See footnote*

Humphreys 2001

12

21 to 28 days

Humphreys 2007

24

21 to 28 days

Kahler 2004

6

ME-12: one 60-minute session
BA: one 5-minute session

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Inpatient/

residential facility

Inpatient/

residential facility

Inpatient/

residential facility

108

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 1.   Follow-up time points, treatment duration and treatment setting  (Continued)

Both interventions also included daily sessions with a psychi-
atrist, daily AA/NA meetings, and one group session per day
(range of program stay = 2 to 8 days (mean 4.6, SD 1.6))

Kaskutas 2009b

12

Kelly 2017b

6

MAAEZ: six 90-minute MAAEZ sessions replaced six usual care
12-step education groups
TAU: usual care groups only

Outpatient,

inpatient/

(mean length of program stay was 112 days (SD 80) for long-
term residents, 33 days (SD 32) for short-term residents, 44 days
(SD 42) for outpatients)

residential facility

10 weekly sessions: iTSF consisted of one 60- to 75-minute in-
dividual session, one 30- to 50-minute individual session, and
eight 90-minute group sessions; MET/CBT consisted of two 60-
minute individual MET sessions and eight 90-minute group CBT
sessions

Litt 2007

Litt 2016

Lydecker 2010

12 & 24

12 weeks (weekly 60-minute sessions)

24

12

12 weeks (weekly 60-minute sessions)

24 weeks. Both interventions consisted of two consecutive
phases of treatment. Phase I included bi-weekly hour-long
group sessions and monthly individual medication manage-
ment visits. Phase II included weekly hour-long group sessions
and monthly medication management.

Manning 2012

3

PI: one 30- to 45-minute session

DI: one 30- to 45-minute session

NI: participants provided with a list of meetings only

Outpatient

Outpatient

Outpatient

Outpatient

Inpatient/

residential facility

MATCH 1997

12, 36 & EOT

12 weeks: TSF/CBT consisted of weekly treatment sessions;
MET consisted of four sessions that occurred during weeks 1, 2,
6, and 12

Outpatient

McCrady 1996

6, 18 & EOT

15 weeks (weekly 90-minute sessions)

Mundt 2012

Ouimette 1997

60

12

Continuous assessment of community-based AA participation
during the follow-up period (i.e. 60 months)

21 to 28 days

Outpatient

Outpatient

Inpatient/

residential facility

Timko 2006

6 & 12

3 sessions of either IR or SR across the course of 1 month

Outpatient

Timko 2011

Vederhus 2014

6

6

IR: standard outpatient mental health care + four additional
outpatient group sessions within one month
SR: standard outpatient mental health care during which coun-
selors gave participants a schedule of local dual-focused 12-
step meetings

Outpatient

MI: two weekly, 30-minute education sessions + standard detox
BA: brief advice to attend 12-step groups in participants' home
communities + standard detox (days on the ward averaged 12.6

Inpatient/

residential facility

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

109

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 1.   Follow-up time points, treatment duration and treatment setting  (Continued)

days (SD 6.5) in the MI group and 9.9 days (SD 3.2) in the BA
group)

Walitzer 2009

Walitzer 2015

Zemore 2018

12

6

12

11 x 60-minute sessions and one 90-minute session over the
course of 12 weeks

Outpatient

12 x 60-minute sessions over the course of 12 weeks

Outpatient

Continuous assessment of community-based AA participation
during the follow-up period (i.e. 12 months)

Outpatient

*This  study  consisted  of  participants  recruited  from  inpatient/residential  facilities  as  well  as  those  seeking  treatment  through  an
information and referral helpline (Humphreys 1996), and were naturalistically followed.
AA: Alcoholics Anonymous
BA: brief advice
CBT: cognitive behavioral therapy
DI: doctor intervention
EOT: end of treatment
IR: intensive referral
iTSF: integrated 12-Step Facilitation
MAAEZ: Making AA Easier
ME-12: extended motivational enhancement
MET: motivational enhancement therapy
MBRP: mindfulness-based relapse prevention
MHCD: Mental Health Chemical Dependence
MI: motivational intervention
MT: minimal treatment
NA: Narcotics Anonymous
NI: no intervention
PI: peer intervention
RAIR: rural-adapted intensive referral
RP: relapse prevention
SD: standard deviation
SR: standard referral
ST: standard outpatient treatment
STW: standard short-term treatment ward
TAU: treatment as usual
TSF: Twelve-Step Facilitation
UC: usual care

Table 2.   How studies handled any missing data 

Study

Missing data

Blondell 2001

Procedures for accounting for missing data were not reported.

Blondell 2011

Procedures for accounting for missing data were not reported.

Bogenschutz 2014

Missing data were reconstructed by participant self-report when participants returned for later fol-
low-up assessments.

Bowen 2014

Brooks 2003

Intention-to-treat analyses conducted using sample size weighted orthogonal contrasts and pa-
rameters estimated using maximum likelihood estimation, which provides the estimated vari-
ance-covariance matrix for the available data.

Hierarchical linear modeling used to analyze change over time in the whole sample and to test for
treatment intervention differences on the outcome variables. Hierarchical linear modeling allows

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

110

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 2.   How studies handled any missing data  (Continued)

for the inclusion of cases with incomplete data, weighting cases with more complete data and reli-
able trajectories more heavily.

Brown 2002

Davis 2002

Grant 2018

Procedures for accounting for missing data were not reported.

Procedures for accounting for missing data were not reported.

Procedures for accounting for missing data were not reported.

Herman 2000

Procedures for accounting for missing data were not reported.

Holder 2000

Providers, hospitals and insurance companies were contacted to provide cost and utilization data
for all patient contacts in order to collect data that may have otherwise been unreported by partici-
pants via self-report.

Humphreys 1996

Intention-to-treat analyses were conducted with worst case scenarios attributed to participants
who were lost to follow-up.

Humphreys 2001

No missing data (healthcare utilization data extracted from Veterans Affair's centralized database)

Humphreys 2007

No missing data (Veterans Affairs healthcare data available for all participants)

Kahler 2004

Kaskutas 2009b

Kelly 2017b

Litt 2007

Litt 2016

Lydecker 2010

Only participants who provided outcome data for at least two-thirds of follow-up (i.e. 4 months)
were included in the analyses.

Intention-to-treat analyses were conducted with worst case scenarios attributed to participants
who were lost to follow-up.

Intention-to-treat analyses were conducted with worst case scenarios attributed to participants
who were lost to follow-up.

Intention-to-treat analyses were conducted with worst case scenarios attributed to participants
who were lost to follow-up. Participants who had missing data were excluded from the analyses.

Generalized estimating equations were used to maximize use of all available data.

To compensate for missing observations and variation in covariate values, comparisons of out-
come summary data were made with adjusted means.

Manning 2012

Procedures for accounting for missing data were not reported.

MATCH 1997

Participants who missed a follow-up assessment were asked at the next assessment period to pro-
vide data regarding their alcohol consumption for the previous period. Participants for whom more
than 4 of the 12 months of drinking outcome data were missing were excluded from latent growth
analyses.

McCrady 1996

Procedures for accounting for missing data were not reported.

Mundt 2012

Data was analyzed for the 403 participants who completed at least 1 follow-up interview.

Ouimette 1997

Procedures for accounting for missing data were not reported.

Timko 2006

Timko 2011

Procedures for accounting for missing data were not reported.

Procedures for accounting for missing data were not reported.

Vederhus 2014

Procedures for accounting for missing data were not reported.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

111

 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 2.   How studies handled any missing data  (Continued)

Walitzer 2009

Walitzer 2015

Zemore 2018

Missing data imputed using the expectation maximization algorithm in Statistical Package for the
Social Sciences and cases were only included if participants had completed at least one post-treat-
ment Timeline Followback.

Mixed effects models were used to accommodate for missing data with maximum likelihood esti-
mation.

Preliminary and main analyses were conducted using cases with outcome data at 6 and/or 12
months and data on all model covariates.

Table 3.   Assessment of methodological quality of economic evaluationsa 

Item number

Item

Humphreys
1996

Holder 2000

Mundt 2012

Humphreys
2001,
Humphreys
2007

1

2

3

4

5

6

7

8

9

10

11

12

13

14

Is the study population clearly described?

Are competing alternatives clearly de-
scribed?

Is a well-defined research question posed in
answerable form?

Is the economic study design appropriate to
the stated objective?

Is the chosen time horizon appropriate to in-
clude relevant costs and consequences?

Is the actual perspective chosen appropri-
ate?

Are all important and relevant costs for each
alternative identified?

Are all costs measured appropriately in
physical units?

Are costs valued appropriately?

Are all important and relevant outcomes for
each alternative identified?

Are all outcomes measured appropriately?

Are outcomes valued appropriately?

Is an incremental analysis of costs and out-
comes of alternatives performed?

Are all future costs and outcomes discount-
ed appropriately?

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

N/Ab

N/Ab

N/Ac

N/Ad

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

112

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

Cochrane Database of Systematic Reviews

Table 3.   Assessment of methodological quality of economic evaluationsa  (Continued)

15

16

17

18

19

Are all important variables, whose values
are uncertain, appropriately subjected to
sensitivity analysis?

Do the conclusions follow from the data re-
ported?

Does the study discuss the generalizabil-
ity of the results to other settings and pa-
tient/client groups?

Does the article indicate that there is no
potential conflict of interest of study re-
searcher(s) and funder(s)?

Are ethical and distributional issues dis-
cussed appropriately?

Total

N/Ae

N/Af

N/Af

1

1

0

1g

16

1

1

0

1g

16

1

1

0

1g

16

1

1

1

1

1g

18

aAccording to Evers 2005.
bThe data were retrospective analyses over a period of three years.
cThe data were retrospective analyses over a period of one year (2001) and two years (2007).
dThe data were retrospective analyses over a period of seven years.
eWe made this N/A because none of the values were 'uncertain', but rather estimated based on Veterans Affairs clinical data costs.
rWe made this N/A because none of the values were 'uncertain'.
gWe understood this to mean the potential for the benefits to healthcare system utilizers because they could obtain the same effects or
better from AA instead of utilizing health care.

A P P E N D I C E S

Appendix 1. Search strategy

Cochrane Central Register of Controlled Trials (CENTRAL) in the Cochrane Library

#1 MeSH descriptor: [Alcohol-Related Disorders] explode all trees

#2 MeSH descriptor: [Drinking Behavior] explode all trees

#3 alcoholism:ti,ab,kw (Word variations have been searched)

#4 alcohol:ti,ab,kw (Word variations have been searched)

#5 #1 or #2 or #3 or #4

#6 MeSH descriptor: [Self-Help Groups] explode all trees

#7 self next help next group*

#8 alcoholic* near/2 anonymou*

#9 mutual next help

#10 mutual next aid

#11 twelve next step*

#12 #6 or #7 or #8 or #9 or #10 or #11

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

113

 
 
 
 
 
Cochrane Database of Systematic Reviews

Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

#13 #5 and #12

Cochrane Drugs and Alcohol Group Specialized Register

#1 alcohol*:ti,ab,kw,xdi AND INREGISTER

#2 self next help next group* AND INREGISTER

#3 twelve near2 step AND INREGISTER

#4 12 near2 step AND INREGISTER

#5 (mutual near2 (help OR aid)) AND INREGISTER

#6 self help AND INREGISTER

#7 #2 OR #3 OR #4 OR #5 OR #6

#8 #7 AND #1

MEDLINE PubMed

#1 Alcohol-Related Disorders[Mesh]

#2 Drinking Behavior[Mesh]

#3 alcohol*[tiab]

#4 #1 OR #2 OR #3

#5 Self-Help Groups[Mesh]

#6 self help group*[tiab]

#7 alcoholic* anonymou* [tiab]

#8 "mutual help" [tiab]

#9 "mutual aid" [tiab]

#10 twelve step* [tiab]

#11 12 step* [tiab]

#12 #5 OR #6 OR #7 OR #9 OR #10 OR #11

#13 #4 AND #12

Embase Ovid

#1 exp alcohol abuse/

#2 exp alcoholism/

#3 (alcohol adj3 (drink* or use* or abus* or misus* or risk* or consum* or withdraw* or detox* or

treat* or therap* or excess* or reduc* or cessation or intervention)).ti,ab.

#4 (drink* adj3 (excess or heavy or heavily or harmful or problem*)).ti,ab.

#5 exp drinking behaviour/

#6 1 or 2 or 3 or 4 or 5

#7 exp self help/

#8 (self adj2 help adj2 group$).ti,ab.

#9 (twelve adj2 step).ti,ab.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

114

 
 
Cochrane Database of Systematic Reviews

Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

#10 12-step.ti,ab.

#11 exp alcoholics anonymous/

#12 (alcoholic$ adj anonymou$).ti,ab.

#13 (mutual adj2 (help or aid)).ti,ab.

#14 7 or 8 or 9 or 10 or 11 or 12 or 13

#15 6 and 14

CINAHL EBSCO (Cumulative Index to Nursing and Allied Health Literature)

#1 (MH "Alcohol Abuse")

#2 (MH "Drinking Behavior+")

#3 TI ((drug or substance*) N2 (abuse or misuse* or addict* or dependen*) ) OR AB ( (drug or

substance*) N2 (abuse or misuse* or addict* or dependen*) )

#4 TI alcohol* OR AB alcohol*

#5 S1 OR S2 OR S3 OR S4

#6 (MH "Alcohol Rehabilitation Programs+")

#7 TI self help w2 group* OR AB self help w2 group*

#8 TI twelve W2 step OR AB twelve W2 step

#9 TI( twelve W2 step) or TI(12 W2 step) or AB( twelve W2 step) or AB(12 W2 step)

#10 TI mutual W2 help OR AB mutual W2 help

#11 TI mutual W2 aid OR AB mutual W2 aid

#12 (MH "Alcoholics Anonymous")

#13 TI( alcoholic* W2 anonymou* ) or AB( alcoholic* W2 anonymou* )

#14 S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13

#15 S5 AND S14

PsycINFO

#1 AB ( “12 step” OR “12-step” OR “twelve step” OR “twelve-step” OR “TSF” OR “alcoholics anonymous” OR “AA” ) AND AB ( “Alcohol*” OR
“cost-benefit” OR “cost benefit” OR “cost-offset” OR “cost-offset” OR “cost-effectiveness” OR “cost effectiveness” )

#2 AB ( “12 step” OR “12-step” OR “twelve step” OR “twelve-step” OR “TSF” OR “alcoholics anonymous” OR “AA” ) AND TI ( “Alcohol*” OR
“cost-benefit” OR “cost benefit” OR “cost-offset” OR “cost-offset” OR “cost-effectiveness” OR “cost effectiveness” )

#3 TI ( “12 step” OR “12-step” OR “twelve step” OR “twelve-step” OR “TSF” OR “alcoholics anonymous” OR “AA” ) AND AB ( “Alcohol*” OR
“cost-benefit” OR “cost benefit” OR “cost-offset” OR “cost-offset” OR “cost-effectiveness” OR “cost effectiveness” )

#4 TI ( “12 step” OR “12-step” OR “twelve step” OR “twelve-step” OR “TSF” OR “alcoholics anonymous” OR “AA” ) AND TI ( “Alcohol*” OR
“cost-benefit” OR “cost benefit” OR “cost-offset” OR “cost-offset” OR “cost-effectiveness” OR “cost effectiveness” )

Appendix 2. Criteria for 'Risk of bias' assessment of randomized controlled trials (RCTs), quasi-RCTs, and
prospective observational studies that include a comparison group

Item

Judgment

Description

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

115

 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

  (Continued)

1. Random sequence
generation (selection
bias)

Low risk

High risk

Cochrane Database of Systematic Reviews

The investigators describe a random component in the sequence generation
process, such as: random number table; computer random number generator;
coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots; mini-
mization

The investigators describe a non-random component in the sequence gener-
ation process, such as: odd or even date of birth; date (or day) of admission;
hospital or clinic record number; alternation; judgment of the clinician; results
of a laboratory test or a series of tests; availability of the intervention or

observational prospective study

Unclear risk

Insufficient information to permit judgment of low or high risk

2. Allocation conceal-
ment (selection bias)

Low risk

High risk

Unclear risk

Low risk

3a. Blinding of outcome
assessor (detection
bias)

Objective outcomes

Investigators enrolling participants could not foresee assignment because one
of the following, or an equivalent method, was used to conceal allocation: cen-
tral allocation (including telephone, web-based, and pharmacy-controlled,
randomization); sequentially numbered drug containers of identical appear-
ance; sequentially numbered, opaque, sealed envelopes

Investigators enrolling participants could possibly foresee assignments be-
cause one of the following method was used: open random allocation sched-
ule (e.g. a list of random numbers); assignment envelopes without appropriate
safeguards (e.g. if envelopes were unsealed or nonopaque or not sequentially
numbered); alternation or rotation; date of birth; case record number; any oth-
er explicitly unconcealed procedure

Observational prospective study

Insufficient information to permit judgment of low or high risk. This is usually
the case if the method of concealment is not described or not described in suf-
ficient detail to allow a definite judgment

No blinding of outcome assessment, but the review authors judge that the out-
come measurement is not likely to be influenced by lack of blinding;

blinding of outcome assessment ensured, and unlikely that the blinding could
have been broken

Record linkage

High risk

No blinding of outcome assessment, and the outcome measurement is likely
to be influenced by lack of blinding;

blinding of outcome assessment, but likely that the blinding could have been
broken, and the outcome measurement is likely to be influenced by lack of
blinding

3b. Blinding of outcome
assessor (detection
bias)

Subjective outcomes

Unclear risk

Insufficient information to permit judgment of low or high risk

Low risk

No blinding of outcome assessment, but the review authors judge that the out-
come measurement is not likely to be influenced by lack of blinding;

blinding of outcome assessment ensured, and unlikely that the blinding could
have been broken

High risk

No blinding of outcome assessment, and the outcome measurement is likely
to be influenced by lack of blinding;

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

116

 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

  (Continued)

Cochrane Database of Systematic Reviews

blinding of outcome assessment, but likely that the blinding could have been
broken, and the outcome measurement is likely to be influenced by lack of
blinding

Unclear risk

Insufficient information to permit judgment of low or high risk

4. Incomplete outcome
data (attrition bias)

Low risk

For all outcomes except
retention in treatment
or dropout

High risk

No missing outcome data;

reasons for missing outcome data unlikely to be related to true outcome (for
survival data, censoring unlikely to be introducing bias);

missing outcome data balanced in numbers across intervention groups, with
similar reasons for missing data across groups;

for dichotomous outcome data, the proportion of missing outcomes com-
pared with observed event risk not enough to have a clinically relevant impact
on the intervention effect estimate;

for continuous outcome data, plausible effect size (difference in means or
standardized difference in means) among missing outcomes not enough to
have a clinically relevant impact on observed effect size; missing data have
been imputed using appropriate methods;

all randomized participants are reported/analyzed in the group they were allo-
cated to by randomization irrespective of noncompliance and co-interventions
(intention-to-treat)

Reason for missing outcome data likely to be related to true outcome, with
either imbalance in numbers or reasons for missing data across intervention
groups; for dichotomous outcome data, the proportion of missing outcomes
compared with observed event risk enough to induce clinically relevant bias in
intervention effect estimate;

for continuous outcome data, plausible effect size (difference in means or
standardized difference in means) among missing outcomes enough to induce
clinically relevant bias in observed effect size;

'as-treated' analysis done with substantial departure of the intervention re-
ceived from that assigned at randomization

Unclear risk

Insufficient information to permit judgment of low or high risk (e.g. num-
ber randomized not stated, no reasons for missing data provided; number of
dropouts not reported for each group)

5. Selective reporting
(reporting bias)

Low risk

The study protocol is available and all of the study's prespecified (primary and
secondary) outcomes that are of interest in the review have been reported in
the prespecified way;

the study protocol is not available but it is clear that the published reports in-
clude all expected outcomes, including those that were prespecified (convinc-
ing text of this nature may be uncommon)

High risk

Not all of the study's prespecified primary outcomes have been reported;

one or more primary outcome(s) is reported using measurements, analysis
methods, or subsets of the data (e.g. subscales) that were not prespecified;

one or more reported primary outcome(s) were not prespecified (unless clear
justification for their reporting is provided, such as an unexpected adverse ef-
fect);

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

117

 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

  (Continued)

Cochrane Database of Systematic Reviews

one or more outcomes of interest in the review are reported incompletely so
that they cannot be entered in a meta-analysis;

the study report fails to include results for a key outcome that would be ex-
pected to have been reported for such a study

Unclear risk

Insufficient information to permit judgment of low or high risk

6. Free of other bias:

Low risk

comparability of co-
horts for baseline char-
acteristics and outcome
measures on the basis
of the design or analysis

Exposed and non-exposed individuals are matched in the design for most im-
portant confounding factors;

authors demonstrated balance between groups for the confounders;

analyses are adjusted for most important confounding factors and imbalance;

randomized controlled trial.

High risk

No matching or no adjustment for most important confounding factor

Unclear risk

No information about comparability of cohort

Low risk

The sample has been drawn from the same community as the exposed cohort

7. Free of other bias: se-
lection of the non-ex-
posed cohort

High risk

The sample has been drawn from a different source

Unclear risk

No description of the derivation of the non-exposed cohort

8. Free of other bias:
protection against cont-
amination

Low risk

Allocation was by community, institution, or practice and it is unlikely that the
control group received the intervention

High risk

It is likely that the control group received the intervention

Unclear risk

It is possible that communication between intervention and control groups
could have occurred

Appendix 3. Evers 2005 Health Economic Criteria

1

2

3

4

5

6

7

8

Is the study population clearly described?

Are competing alternatives clearly described?

Is a well-defined research question posed in answerable form?

Is the economic study design appropriate to the stated objective?

Is the chosen time horizon appropriate to include relevant costs and consequences?

Is the actual perspective chosen appropriate?

Are all important and relevant costs for each alternative identified?

Are all costs measured appropriately in physical units?

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

118

 
 
 
 
 
 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

  (Continued)

Cochrane Database of Systematic Reviews

9

10

11

12

13

14

15

16

17

18

19

Are costs valued appropriately?

Are all important and relevant outcomes for each alternative identified?

Are all outcomes measured appropriately?

Are outcomes valued appropriately?

Is an incremental analysis of costs and outcomes of alternatives performed?

Are all future costs and outcomes discounted appropriately?

Are all important variables, whose values are uncertain, appropriately subjected to sensitivity
analysis?

Do the conclusions follow from the data reported?

Does the study discuss the generalizability of the results to other settings and patient/client
groups?

Does the article indicate that there is no potential conflict of interest of study researcher(s) and
funder(s)?

Are ethical and distributional issues discussed appropriately?

W H A T ' S   N E W

Date

Event

Description

10 September 2020

Amended

Minor typos corrected.

H I S T O R Y

Protocol first published: Issue 11, 2017
Review first published: Issue 3, 2020

Date

Event

Description

12 March 2020

Amended

Minor amendment to abstract

C O N T R I B U T I O N S   O F   A U T H O R S

JK: conceived the review together with KH and MF. Wrote the first draft of the protocol and review; edited review drafts; conducted data
searches and extractions; rated risk of bias and data quality; conducted data analysis and synthesis.

KH: conceived the review together with JK and MF. Helped to draft the protocol; edited review drafts; conducted data extractions; rated
risk of bias; data analysis and synthesis.

MF: conceived the review together with JK and KH. Helped to draft the protocol; edited review drafts; conducted data extractions; rated
risk of bias; data analysis and synthesis.

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

119

 
 
 
 
 
 
 
Cochrane
Library

Trusted evidence.
Informed decisions.
Better health.

D E C L A R A T I O N S   O F   I N T E R E S T

Cochrane Database of Systematic Reviews

JK: has received funding from the US National Institues of Health and the US Veterans Health Administration to conduct research into
alcohol use disorders, comorbidities, treatment response, and mechanisms of behavior change in Alcoholics Anonymous (AA) and Self-
Management and Recovery Training (SMART).

KH: has received funding from the US National Institutes of Health and US Veterans Health Administration to evaluate a range of treatments
and mutual-help organizations focused on alcohol and other drugs.

MF: none known

S O U R C E S   O F   S U P P O R T

Internal sources

• Recovery Research Institute, Center for Addiction Medicine, Massachusetts General Hospital and Harvard Medical School, USA
• John F. Kelly is supported in part also by the Elizabeth R. Spallin Professorship in the Field of Addiction Medicine at Havard Medical

School, USA

External sources

• John F. Kelly was funded in part by a career award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) K24 AA022136,

USA

This award (K24) from NIAAA partially covers Professor Kelly's time to work on recovery-related research on treatment and recovery
support services for alcohol use disorder.

• Keith Humphreys was funded by a Senior Research Career Scientist Award from the U.S. Veterans Health Administration, and, the Esther

Ting Memorial Professorship at Stanford, USA

D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W

• Added fourth primary outcome: alcohol addiction severity (e.g. Addiction Severity Index (ASI)), as a post hoc decision was made that

this is an important outcome for decision makers and therefore should be included in this review.

• Changed  coercion  wording  (eligible  participants)  as  we  had  omitted  to  mention  coercion  beyond  the  criminal  justice  system  (e.g.

employer, family).

• Changed 'Risk of bias' ratings (added three other types of bias risks and removed one other) to help enhance and make the ratings for

risk of bias comprehensive.

I N D E X   T E R M S

Medical Subject Headings (MeSH)

*Alcoholics Anonymous;  Alcoholism  [*psychology]  [*therapy];  Cognitive Behavioral Therapy;  Health Care Costs;  Motivational
Interviewing  [methods];  Psychotherapy;  Randomized Controlled Trials as Topic;  Treatment Outcome

MeSH check words

Adult; Female; Humans; Male; Middle Aged

Alcoholics Anonymous and other 12-step programs for alcohol use disorder (Review)
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

120
